BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chen G, Wu D, Guo W, Cao Y, Huang D, Wang H, Wang T, Zhang X, Chen H, Yu H, Zhang M, Wu S, Song J, Chen T, Han M, Li S, Luo X, Zhao J, Ning Q. Clinical and immunological features of severe and moderate coronavirus disease 2019. J Clin Invest. 2020;130:2620-2629. [PMID: 32217835 DOI: 10.1172/jci137244] [Cited by in Crossref: 1925] [Cited by in F6Publishing: 1406] [Article Influence: 962.5] [Reference Citation Analysis]
Number Citing Articles
1 [DOI: 10.1101/2020.08.10.20171371] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
2 Volpatti LR, Wallace RP, Cao S, Raczy MM, Wang R, Gray LT, Alpar AT, Briquez PS, Mitrousis N, Marchell TM, Sasso MS, Nguyen M, Mansurov A, Budina E, Solanki A, Watkins EA, Schnorenberg MR, Tremain AC, Reda JW, Nicolaescu V, Furlong K, Dvorkin S, Yu SS, Manicassamy B, LaBelle JL, Tirrell MV, Randall G, Kwissa M, Swartz MA, Hubbell JA. Polymersomes Decorated with the SARS-CoV-2 Spike Protein Receptor-Binding Domain Elicit Robust Humoral and Cellular Immunity. ACS Cent Sci 2021;7:1368-80. [PMID: 34466656 DOI: 10.1021/acscentsci.1c00596] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
3 Chernyak BV, Popova EN, Prikhodko AS, Grebenchikov OA, Zinovkina LA, Zinovkin RA. COVID-19 and Oxidative Stress. Biochemistry (Mosc) 2020;85:1543-53. [PMID: 33705292 DOI: 10.1134/S0006297920120068] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 15.0] [Reference Citation Analysis]
4 Aranda-Narváez JM, Tallón-Aguilar L, Pareja-Ciuró F, Martín-Martín G, González-Sánchez AJ, Rey-Simó I, Tamayo-Medel G, Yánez-Benítez C, Costa-Navarro D, Montón-Condón S, Navarro-Soto S, Turégano-Fuentes F, Pérez-Díaz MD, Ceballos-Esparragón J, Jover-Navalón JM, Balibrea JM, Morales-Conde S. [Emergency Surgery and Trauma Care During COVID-19 Pandemic. Recommendations of the Spanish Association of Surgeons]. Cir Esp (Engl Ed) 2020;98:433-41. [PMID: 32439139 DOI: 10.1016/j.ciresp.2020.04.031] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
5 Griffin DE. Are T cells helpful for COVID-19: the relationship between response and risk. J Clin Invest 2020;130:6222-4. [PMID: 32976117 DOI: 10.1172/JCI142081] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
6 Meng L, Xu J, Zhang J, Zhang K, Shang P, Li Q, Li Y, Wang L, Cai B. Monitoring peripheral neutrophil and T-lymphocyte subsets could assist in differentiating the severity and disease progression of coronavirus disease 2019. Aging (Albany NY) 2021;13:7723-32. [PMID: 33741750 DOI: 10.18632/aging.202701] [Reference Citation Analysis]
7 Perico L, Benigni A, Casiraghi F, Ng LFP, Renia L, Remuzzi G. Immunity, endothelial injury and complement-induced coagulopathy in COVID-19. Nat Rev Nephrol. 2021;17:46-64. [PMID: 33077917 DOI: 10.1038/s41581-020-00357-4] [Cited by in Crossref: 85] [Cited by in F6Publishing: 81] [Article Influence: 42.5] [Reference Citation Analysis]
8 Wang LL, Yang JW, Xu JF. Coronavirus (SARS-CoV-2) causes lung inflammation and injury. Clin Microbiol Infect 2021:S1198-743X(21)00674-1. [PMID: 34861410 DOI: 10.1016/j.cmi.2021.11.022] [Reference Citation Analysis]
9 Awogbindin IO, Ben-Azu B, Olusola BA, Akinluyi ET, Adeniyi PA, Di Paolo T, Tremblay MÈ. Microglial Implications in SARS-CoV-2 Infection and COVID-19: Lessons From Viral RNA Neurotropism and Possible Relevance to Parkinson's Disease. Front Cell Neurosci 2021;15:670298. [PMID: 34211370 DOI: 10.3389/fncel.2021.670298] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
10 Del Turco S, Vianello A, Ragusa R, Caselli C, Basta G. COVID-19 and cardiovascular consequences: Is the endothelial dysfunction the hardest challenge? Thromb Res 2020;196:143-51. [PMID: 32871306 DOI: 10.1016/j.thromres.2020.08.039] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 14.0] [Reference Citation Analysis]
11 Tang L, Yin Z, Hu Y, Mei H. Controlling Cytokine Storm Is Vital in COVID-19. Front Immunol 2020;11:570993. [PMID: 33329533 DOI: 10.3389/fimmu.2020.570993] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 7.0] [Reference Citation Analysis]
12 Yonas E, Alwi I, Pranata R, Huang I, Lim MA, Yamin M, Nasution SA, Setiati S, Virani SS. Elevated interleukin levels are associated with higher severity and mortality in COVID 19 - A systematic review, meta-analysis, and meta-regression. Diabetes Metab Syndr 2020;14:2219-30. [PMID: 33395783 DOI: 10.1016/j.dsx.2020.11.011] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 6.5] [Reference Citation Analysis]
13 Law JC, Koh WH, Budylowski P, Lin J, Yue F, Abe KT, Rathod B, Girard M, Li Z, Rini JM, Mubareka S, McGeer A, Chan AK, Gingras AC, Watts TH, A Ostrowski M. Systematic Examination of Antigen-Specific Recall T Cell Responses to SARS-CoV-2 versus Influenza Virus Reveals a Distinct Inflammatory Profile. J Immunol 2021;206:37-50. [PMID: 33208459 DOI: 10.4049/jimmunol.2001067] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
14 El-Ashmawy NE, Lashin AA, Okasha KM, Abo Kamer AM, Mostafa TM, El-Aasr M, Goda AE, Haggag YA, Tawfik HO, Abo-Saif MA. The plausible mechanisms of tramadol for treatment of COVID-19. Med Hypotheses 2021;146:110468. [PMID: 33385878 DOI: 10.1016/j.mehy.2020.110468] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
15 Vistoli F, Furian L, Maggiore U, Caldara R, Cantaluppi V, Ferraresso M, Zaza G, Cardillo M, Biancofiore G, Menichetti F, Russo A, Turillazzi E, Di Paolo M, Grandaliano G, Boggi U; Italian National Kidney Transplantation Network., the Joint Committee of the Italian Society of Organ Transplantation and the Italian Society of Nephrology. COVID-19 and kidney transplantation: an Italian Survey and Consensus. J Nephrol 2020;33:667-80. [PMID: 32495231 DOI: 10.1007/s40620-020-00755-8] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 11.0] [Reference Citation Analysis]
16 Derruau S, Bouchet J, Nassif A, Baudet A, Yasukawa K, Lorimier S, Prêcheur I, Bloch-Zupan A, Pellat B, Chardin H, Jung S, On Behalf Of Task Force Covid-Collège National des EnseignantS En Biologie Orale Cnesbo-France. COVID-19 and Dentistry in 72 Questions: An Overview of the Literature. J Clin Med 2021;10:779. [PMID: 33669185 DOI: 10.3390/jcm10040779] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
17 Lockhart SM, O'Rahilly S. When Two Pandemics Meet: Why Is Obesity Associated with Increased COVID-19 Mortality? Med (N Y) 2020;1:33-42. [PMID: 32838359 DOI: 10.1016/j.medj.2020.06.005] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 9.5] [Reference Citation Analysis]
18 Neidleman J, Luo X, George AF, McGregor M, Yang J, Yun C, Murray V, Gill G, Greene WC, Vasquez J, Lee S, Ghosn E, Lynch K, Roan NR. Distinctive features of SARS-CoV-2-specific T cells predict recovery from severe COVID-19. medRxiv 2021:2021. [PMID: 33532792 DOI: 10.1101/2021.01.22.21250054] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
19 Counoupas C, Johansen MD, Stella AO, Nguyen DH, Ferguson AL, Aggarwal A, Bhattacharyya ND, Grey A, Hutchings O, Patel K, Siddiquee R, Stewart EL, Feng CG, Hansbro NG, Palendira U, Steain MC, Saunders BM, Low JKK, Mackay JP, Kelleher AD, Britton WJ, Turville SG, Hansbro PM, Triccas JA. A single dose, BCG-adjuvanted COVID-19 vaccine provides sterilising immunity against SARS-CoV-2 infection. NPJ Vaccines 2021;6:143. [PMID: 34848711 DOI: 10.1038/s41541-021-00406-4] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Demaret J, Lefèvre G, Vuotto F, Trauet J, Duhamel A, Labreuche J, Varlet P, Dendooven A, Stabler S, Gachet B, Bauer J, Prevost B, Bocket L, Alidjinou EK, Lambert M, Yelnik C, Meresse B, Dubuquoy L, Launay D, Dubucquoi S, Montaigne D, Woitrain E, Maggiotto F, Bou Saleh M, Top I, Elsermans V, Jeanpierre E, Dupont A, Susen S, Brousseau T, Poissy J, Faure K, Labalette M; Lille Covid Research Network (LICORNE). Severe SARS-CoV-2 patients develop a higher specific T-cell response. Clin Transl Immunology 2020;9:e1217. [PMID: 33376594 DOI: 10.1002/cti2.1217] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
21 Sullivan K, Helgeson J, McGowan A. COVID-19 Associated Thyroid Storm: A Case Report. Clin Pract Cases Emerg Med 2021;5:412-4. [PMID: 34813431 DOI: 10.5811/cpcem.2021.5.52692] [Reference Citation Analysis]
22 De Biasi S, Meschiari M, Gibellini L, Bellinazzi C, Borella R, Fidanza L, Gozzi L, Iannone A, Lo Tartaro D, Mattioli M, Paolini A, Menozzi M, Milić J, Franceschi G, Fantini R, Tonelli R, Sita M, Sarti M, Trenti T, Brugioni L, Cicchetti L, Facchinetti F, Pietrangelo A, Clini E, Girardis M, Guaraldi G, Mussini C, Cossarizza A. Marked T cell activation, senescence, exhaustion and skewing towards TH17 in patients with COVID-19 pneumonia. Nat Commun 2020;11:3434. [PMID: 32632085 DOI: 10.1038/s41467-020-17292-4] [Cited by in Crossref: 239] [Cited by in F6Publishing: 234] [Article Influence: 119.5] [Reference Citation Analysis]
23 Pasquarelli-do-Nascimento G, Braz-de-Melo HA, Faria SS, Santos IO, Kobinger GP, Magalhães KG. Hypercoagulopathy and Adipose Tissue Exacerbated Inflammation May Explain Higher Mortality in COVID-19 Patients With Obesity. Front Endocrinol (Lausanne) 2020;11:530. [PMID: 32849309 DOI: 10.3389/fendo.2020.00530] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 10.0] [Reference Citation Analysis]
24 Rathi H, Burman V, Datta SK, Rana SV, Mirza AA, Saha S, Kumar R, Naithani M. Review on COVID-19 Etiopathogenesis, Clinical Presentation and Treatment Available with Emphasis on ACE2.Indian J Clin Biochem. 2021;1-20. [PMID: 33424145 DOI: 10.1007/s12291-020-00953-y] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
25 Bunders MJ, Altfeld M. Implications of Sex Differences in Immunity for SARS-CoV-2 Pathogenesis and Design of Therapeutic Interventions. Immunity 2020;53:487-95. [PMID: 32853545 DOI: 10.1016/j.immuni.2020.08.003] [Cited by in Crossref: 44] [Cited by in F6Publishing: 39] [Article Influence: 22.0] [Reference Citation Analysis]
26 Pothuri B, Alvarez Secord A, Armstrong DK, Chan J, Fader AN, Huh W, Kesterson J, Liu JF, Moore K, Westin SN, Naumann RW. Anti-cancer therapy and clinical trial considerations for gynecologic oncology patients during the COVID-19 pandemic crisis. Gynecol Oncol 2020;158:16-24. [PMID: 32386911 DOI: 10.1016/j.ygyno.2020.04.694] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 12.5] [Reference Citation Analysis]
27 Deschler S, Kager J, Erber J, Fricke L, Koyumdzhieva P, Georgieva A, Lahmer T, Wiessner JR, Voit F, Schneider J, Horstmann J, Iakoubov R, Treiber M, Winter C, Ruland J, Busch DH, Knolle PA, Protzer U, Spinner CD, Schmid RM, Quante M, Böttcher K. Mucosal-Associated Invariant T (MAIT) Cells Are Highly Activated and Functionally Impaired in COVID-19 Patients. Viruses 2021;13:241. [PMID: 33546489 DOI: 10.3390/v13020241] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
28 Sweet AN, André NM, Stout AE, Licitra BN, Whittaker GR. Clinical and Molecular Relationships between COVID-19 and Feline Infectious Peritonitis (FIP). Viruses 2022;14:481. [DOI: 10.3390/v14030481] [Reference Citation Analysis]
29 Knoll R, Schultze JL, Schulte-Schrepping J. Monocytes and Macrophages in COVID-19. Front Immunol 2021;12:720109. [PMID: 34367190 DOI: 10.3389/fimmu.2021.720109] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
30 Baresi G, Giacomelli M, Moratto D, Chiarini M, Conforti IC, Padoan R, Poli P, Timpano S, Caldarale F, Badolato R. Case Report: Analysis of Inflammatory Cytokines IL-6, CCL2/MCP1, CCL5/RANTES, CXCL9/MIG, and CXCL10/IP10 in a Cystic Fibrosis Patient Cohort During the First Wave of the COVID-19 Pandemic. Front Pediatr 2021;9:645063. [PMID: 34295857 DOI: 10.3389/fped.2021.645063] [Reference Citation Analysis]
31 Silva FAFD, Brito BB, Santos MLC, Marques HS, Silva Júnior RTD, Carvalho LS, Vieira ES, Oliveira MV, Melo FF. COVID-19 gastrointestinal manifestations: a systematic review. Rev Soc Bras Med Trop 2020;53:e20200714. [PMID: 33263693 DOI: 10.1590/0037-8682-0714-2020] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
32 Eskian M, Rezaei N. Clinical Manifestations of COVID-19. Adv Exp Med Biol 2021;1318:179-96. [PMID: 33973179 DOI: 10.1007/978-3-030-63761-3_11] [Reference Citation Analysis]
33 Collora JA, Liu R, Albrecht K, Ho YC. The single-cell landscape of immunological responses of CD4+ T cells in HIV versus severe acute respiratory syndrome coronavirus 2. Curr Opin HIV AIDS 2021;16:36-47. [PMID: 33165008 DOI: 10.1097/COH.0000000000000655] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
34 Calder PC. Foods to deliver immune-supporting nutrients. Curr Opin Food Sci 2022;43:136-45. [PMID: 34976746 DOI: 10.1016/j.cofs.2021.12.006] [Reference Citation Analysis]
35 Cyprian FS, Suleman M, Abdelhafez I, Doudin A, Masud Danjuma M, Mir FA, Parray A, Yousaf Z, Siddiqui MYA, Abdelmajid A, Mulhim M, Al-Shokri S, Abukhattab M, Shaheen R, Elkord E, Al-Khal AL, Elzouki AN, Girardi G. Complement C5a and Clinical Markers as Predictors of COVID-19 Disease Severity and Mortality in a Multi-Ethnic Population. Front Immunol 2021;12:707159. [PMID: 34966381 DOI: 10.3389/fimmu.2021.707159] [Reference Citation Analysis]
36 Li Z, Wang L, Huang LS, Zhang M, Cai X, Xu F, Wu F, Li H, Huang W, Zhou Q, Yao J, Liang Y, Liu G. Efficient management strategy of COVID-19 patients based on cluster analysis and clinical decision tree classification. Sci Rep 2021;11:9626. [PMID: 33953307 DOI: 10.1038/s41598-021-89187-3] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
37 Jayarangaiah A, Kariyanna PT, Chen X, Jayarangaiah A, Kumar A. COVID-19-Associated Coagulopathy: An Exacerbated Immunothrombosis Response. Clin Appl Thromb Hemost 2020;26:1076029620943293. [PMID: 32735131 DOI: 10.1177/1076029620943293] [Cited by in Crossref: 25] [Cited by in F6Publishing: 17] [Article Influence: 12.5] [Reference Citation Analysis]
38 Webb BJ, Peltan ID, Jensen P, Hoda D, Hunter B, Silver A, Starr N, Buckel W, Grisel N, Hummel E, Snow G, Morris D, Stenehjem E, Srivastava R, Brown SM. Clinical criteria for COVID-19-associated hyperinflammatory syndrome: a cohort study. Lancet Rheumatol 2020;2:e754-63. [PMID: 33015645 DOI: 10.1016/S2665-9913(20)30343-X] [Cited by in Crossref: 83] [Cited by in F6Publishing: 48] [Article Influence: 41.5] [Reference Citation Analysis]
39 Dęborska-Materkowska D, Kamińska D. The Immunology of SARS-CoV-2 Infection and Vaccines in Solid Organ Transplant Recipients. Viruses 2021;13:1879. [PMID: 34578460 DOI: 10.3390/v13091879] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
40 Dwivedi S, Choudhary P, Gupta A, Singh S. The cross-talk between mucormycosis, steroids and diabetes mellitus amidst the global contagion of COVID-19. Crit Rev Microbiol 2022;:1-16. [PMID: 35324372 DOI: 10.1080/1040841X.2022.2052795] [Reference Citation Analysis]
41 Kam YW, Ahmed MY, Amrun SN, Lee B, Refaie T, Elgizouli K, Fong SW, Renia L, Ng LF. Systematic analysis of disease-specific immunological signatures in patients with febrile illness from Saudi Arabia. Clin Transl Immunology 2020;9:e1163. [PMID: 32864128 DOI: 10.1002/cti2.1163] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
42 Gao F, Zheng KI, Yan HD, Sun QF, Pan KH, Wang TY, Chen YP, Targher G, Byrne CD, George J, Zheng MH. Association and Interaction Between Serum Interleukin-6 Levels and Metabolic Dysfunction-Associated Fatty Liver Disease in Patients With Severe Coronavirus Disease 2019. Front Endocrinol (Lausanne) 2021;12:604100. [PMID: 33763027 DOI: 10.3389/fendo.2021.604100] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
43 Bidar F, Hamada S, Gossez M, Coudereau R, Lopez J, Cazalis MA, Tardiveau C, Brengel-Pesce K, Mommert M, Buisson M, Conti F, Rimmelé T, Lukaszewicz AC, Argaud L, Cour M, Monneret G, Venet F; RICO Study Group. Recombinant human interleukin-7 reverses T cell exhaustion ex vivo in critically ill COVID-19 patients. Ann Intensive Care 2022;12:21. [PMID: 35246776 DOI: 10.1186/s13613-022-00982-1] [Reference Citation Analysis]
44 De Virgiliis F, Di Giovanni S. Lung innervation in the eye of a cytokine storm: neuroimmune interactions and COVID-19. Nat Rev Neurol 2020;16:645-52. [PMID: 32843733 DOI: 10.1038/s41582-020-0402-y] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 9.0] [Reference Citation Analysis]
45 Cheng L, Li H, Li L, Liu C, Yan S, Chen H, Li Y. Ferritin in the coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis. J Clin Lab Anal 2020;34:e23618. [PMID: 33078400 DOI: 10.1002/jcla.23618] [Cited by in Crossref: 39] [Cited by in F6Publishing: 43] [Article Influence: 19.5] [Reference Citation Analysis]
46 Du X, Shi L, Cao W, Zuo B, Zhou A. Add-on effect of Chinese herbal medicine in the treatment of mild to moderate COVID-19: A systematic review and meta-analysis. PLoS One 2021;16:e0256429. [PMID: 34415962 DOI: 10.1371/journal.pone.0256429] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
47 Zhang X, Yang X, Jiao H, Liu X. Coagulopathy in patients with COVID-19: a systematic review and meta-analysis. Aging (Albany NY) 2020;12:24535-51. [PMID: 33229625 DOI: 10.18632/aging.104138] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
48 Fouladseresht H, Ghamar Talepoor A, Eskandari N, Norouzian M, Ghezelbash B, Beyranvand MR, Nejadghaderi SA, Carson-chahhoud K, Kolahi A, Safiri S. Potential Immune Indicators for Predicting the Prognosis of COVID-19 and Trauma: Similarities and Disparities. Front Immunol 2022;12:785946. [DOI: 10.3389/fimmu.2021.785946] [Reference Citation Analysis]
49 Polverino F, Kheradmand F. COVID-19, COPD, and AECOPD: Immunological, Epidemiological, and Clinical Aspects. Front Med (Lausanne) 2020;7:627278. [PMID: 33537336 DOI: 10.3389/fmed.2020.627278] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
50 Morris EC, Neelapu SS, Giavridis T, Sadelain M. Cytokine release syndrome and associated neurotoxicity in cancer immunotherapy. Nat Rev Immunol 2021. [PMID: 34002066 DOI: 10.1038/s41577-021-00547-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
51 Barek MA, Aziz MA, Islam MS. Impact of age, sex, comorbidities and clinical symptoms on the severity of COVID-19 cases: A meta-analysis with 55 studies and 10014 cases. Heliyon 2020;6:e05684. [PMID: 33344791 DOI: 10.1016/j.heliyon.2020.e05684] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 9.5] [Reference Citation Analysis]
52 Szcześniak D, Gładka A, Misiak B, Cyran A, Rymaszewska J. The SARS-CoV-2 and mental health: From biological mechanisms to social consequences. Prog Neuropsychopharmacol Biol Psychiatry 2021;104:110046. [PMID: 32730915 DOI: 10.1016/j.pnpbp.2020.110046] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 11.5] [Reference Citation Analysis]
53 Cunha LL, Perazzio SF, Azzi J, Cravedi P, Riella LV. Remodeling of the Immune Response With Aging: Immunosenescence and Its Potential Impact on COVID-19 Immune Response. Front Immunol 2020;11:1748. [PMID: 32849623 DOI: 10.3389/fimmu.2020.01748] [Cited by in Crossref: 48] [Cited by in F6Publishing: 47] [Article Influence: 24.0] [Reference Citation Analysis]
54 Yuan Y, Wang QP, Sun D, Wu ZB, Peng H, Liu XW, Liu YL. Differences in Immune Responses between Children and Adults with COVID-19. Curr Med Sci 2021;41:58-61. [PMID: 33582906 DOI: 10.1007/s11596-021-2318-1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
55 Felsenstein S, Herbert JA, McNamara PS, Hedrich CM. COVID-19: Immunology and treatment options. Clin Immunol. 2020;215:108448. [PMID: 32353634 DOI: 10.1016/j.clim.2020.108448] [Cited by in Crossref: 254] [Cited by in F6Publishing: 222] [Article Influence: 127.0] [Reference Citation Analysis]
56 Chen R, Yu YL, Li W, Liu Y, Lu JX, Chen F, Zhou Q, Xia ZY, Gao L, Meng QT, Ma D. Gastrointestinal Symptoms Associated With Unfavorable Prognosis of COVID-19 Patients: A Retrospective Study. Front Med (Lausanne) 2020;7:608259. [PMID: 33262996 DOI: 10.3389/fmed.2020.608259] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
57 Kaspi H, Semo J, Abramov N, Dekel C, Lindborg S, Kern R, Lebovits C, Aricha R. MSC-NTF (NurOwn®) exosomes: a novel therapeutic modality in the mouse LPS-induced ARDS model. Stem Cell Res Ther 2021;12:72. [PMID: 33468250 DOI: 10.1186/s13287-021-02143-w] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
58 Yang L, Han Y, Jaffré F, Nilsson-Payant BE, Bram Y, Wang P, Zhu J, Zhang T, Redmond D, Houghton S, Uhl S, Borczuk A, Huang Y, Richardson C, Chandar V, Acklin JA, Lim JK, Chen Z, Xiang J, Ho DD, tenOever BR, Schwartz RE, Evans T, Chen S. An Immuno-Cardiac Model for Macrophage-Mediated Inflammation in COVID-19 Hearts. Circ Res 2021;129:33-46. [PMID: 33853355 DOI: 10.1161/CIRCRESAHA.121.319060] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
59 Liu D, Cui P, Zeng S, Wang S, Feng X, Xu S, Li R, Gao Y, Yu R, Wang Y, Yuan Y, Li H, Jiao X, Chi J, Liu J, Yu Y, Zheng X, Song C, Jin N, Gong W, Liu X, Cai G, Li C, Gao Q. Risk factors for developing into critical COVID-19 patients in Wuhan, China: A multicenter, retrospective, cohort study. EClinicalMedicine 2020;25:100471. [PMID: 32840491 DOI: 10.1016/j.eclinm.2020.100471] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 11.5] [Reference Citation Analysis]
60 Alberici F, Affatato S, Moratto D, Mescia F, Delbarba E, Guerini A, Tedesco M, Burbelo PD, Zani R, Castagna I, Gallico A, Tonoli M, Venturini M, Roccaro AM, Giacomelli M, Cohen JI, Giustini V, Dobbs K, Su HC, Fiorini C, Quaresima V, Viola FB, Vizzardi V, Gaggiotti M, Bossini N, Gaggia P, Badolato R, Notarangelo LD, Chiarini M, Scolari F. SARS-CoV-2 infection in dialysis and kidney transplant patients: immunological and serological response. J Nephrol. [DOI: 10.1007/s40620-021-01214-8] [Reference Citation Analysis]
61 Khalil BA, Elemam NM, Maghazachi AA. Chemokines and chemokine receptors during COVID-19 infection. Comput Struct Biotechnol J 2021;19:976-88. [PMID: 33558827 DOI: 10.1016/j.csbj.2021.01.034] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 12.0] [Reference Citation Analysis]
62 Delpino MV, Quarleri J. SARS-CoV-2 Pathogenesis: Imbalance in the Renin-Angiotensin System Favors Lung Fibrosis. Front Cell Infect Microbiol 2020;10:340. [PMID: 32596170 DOI: 10.3389/fcimb.2020.00340] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 10.0] [Reference Citation Analysis]
63 Zeng Q, Li YZ, Dong SY, Chen ZT, Gao XY, Zhang H, Huang G, Xu Y. Dynamic SARS-CoV-2-Specific Immunity in Critically Ill Patients With Hypertension. Front Immunol 2020;11:596684. [PMID: 33362779 DOI: 10.3389/fimmu.2020.596684] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
64 Pugliese L, Sbordone FP, Grimaldi F, Ricci F, DI Tosto F, Spiritigliozzi L, DI Donna C, Presicce M, DE Stasio V, Benelli L, D'Errico F, Pasqualetto M, Legramante JM, Materazzo M, Pellicciaro M, Buonomo OC, Vanni G, Rizza S, Bellia A, Floris R, Garaci F, Chiocchi M. Chest Computed Tomography Scoring in Patients With Novel Coronavirus-infected Pneumonia: Correlation With Clinical and Laboratory Features and Disease Outcome. In Vivo 2020;34:3735-46. [PMID: 33144492 DOI: 10.21873/invivo.12223] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
65 Soto JA, Díaz FE, Retamal-díaz A, Gálvez NMS, Melo-gonzález F, Piña-iturbe A, Ramírez MA, Bohmwald K, González PA, Bueno SM, Kalergis AM. BCG-Based Vaccines Elicit Antigen-Specific Adaptive and Trained Immunity against SARS-CoV-2 and Andes orthohantavirus. Vaccines 2022;10:721. [DOI: 10.3390/vaccines10050721] [Reference Citation Analysis]
66 Sethi SK, Rana A, Adnani H, McCulloch M, Alhasan K, Sultana A, Safadi R, Agrawal N, Raina R. Kidney involvement in multisystem inflammatory syndrome in children: a pediatric nephrologist's perspective. Clin Kidney J 2021;14:2000-11. [PMID: 34471522 DOI: 10.1093/ckj/sfab073] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
67 Fischer JC, Zänker K, van Griensven M, Schneider M, Kindgen-Milles D, Knoefel WT, Lichtenberg A, Tamaskovics B, Djiepmo-Njanang FJ, Budach W, Corradini S, Ganswindt U, Häussinger D, Feldt T, Schelzig H, Bojar H, Peiper M, Bölke E, Haussmann J, Matuschek C. The role of passive immunization in the age of SARS-CoV-2: an update. Eur J Med Res 2020;25:16. [PMID: 32404189 DOI: 10.1186/s40001-020-00414-5] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]
68 Dang D, Wang L, Zhang C, Li Z, Wu H. Potential effects of SARS-CoV-2 infection during pregnancy on fetuses and newborns are worthy of attention. J Obstet Gynaecol Res 2020;46:1951-7. [PMID: 32779309 DOI: 10.1111/jog.14406] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
69 Mulchandani R, Lyngdoh T, Kakkar AK. Deciphering the COVID-19 cytokine storm: Systematic review and meta-analysis. Eur J Clin Invest 2021;51:e13429. [PMID: 33058143 DOI: 10.1111/eci.13429] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 13.0] [Reference Citation Analysis]
70 Garcia-Pelagio KP, Hew-Butler T, Fahlman MM, Roche JA. Women's Lives Matter-The Critical Need for Women to Prioritize Optimal Physical Activity to Reduce COVID-19 Illness Risk and Severity. Int J Environ Res Public Health 2021;18:10271. [PMID: 34639569 DOI: 10.3390/ijerph181910271] [Reference Citation Analysis]
71 Kwak-Kim J, Ota K, Sung N, Huang C, Alsubki L, Lee S, Han JW, Han A, Yang X, Saab W, Derbala Y, Wang WJ, He Q, Liao A, Takahashi T, Cavalcante MB, Barini R, Bao S, Fukui A, Lédée N, Coulam C. COVID-19 and immunomodulation treatment for women with reproductive failures. J Reprod Immunol 2020;141:103168. [PMID: 32603991 DOI: 10.1016/j.jri.2020.103168] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
72 Devarakonda CKV, Meredith E, Ghosh M, Shapiro LH. Coronavirus Receptors as Immune Modulators. J Immunol 2021;206:923-9. [PMID: 33380494 DOI: 10.4049/jimmunol.2001062] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
73 Bost P, De Sanctis F, Canè S, Ugel S, Donadello K, Castellucci M, Eyal D, Fiore A, Anselmi C, Barouni RM, Trovato R, Caligola S, Lamolinara A, Iezzi M, Facciotti F, Mazzariol A, Gibellini D, De Nardo P, Tacconelli E, Gottin L, Polati E, Schwikowski B, Amit I, Bronte V. Deciphering the state of immune silence in fatal COVID-19 patients. Nat Commun 2021;12:1428. [PMID: 33674591 DOI: 10.1038/s41467-021-21702-6] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 10.0] [Reference Citation Analysis]
74 Chen J, He Z, Wang F. Evaluation of ferritin level in COVID-19 patients and its inflammatory response. Appl Nanosci. [DOI: 10.1007/s13204-021-02115-9] [Reference Citation Analysis]
75 Yu C, Littleton S, Giroux NS, Mathew R, Ding S, Kalnitsky J, Yang Y, Petzold E, Chung HA, Rivera GO, Rotstein T, Xi R, Ko ER, Tsalik EL, Sempowski GD, Denny TN, Burke TW, McClain MT, Woods CW, Shen X, Saban DR. Mucosal-associated invariant T cell responses differ by sex in COVID-19. Med (N Y) 2021;2:755-772.e5. [PMID: 33870241 DOI: 10.1016/j.medj.2021.04.008] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
76 Bossù P, Toppi E, Sterbini V, Spalletta G. Implication of Aging Related Chronic Neuroinflammation on COVID-19 Pandemic. J Pers Med 2020;10:E102. [PMID: 32858874 DOI: 10.3390/jpm10030102] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
77 Hyder Pottoo F, Abu-Izneid T, Mohammad Ibrahim A, Noushad Javed M, AlHajri N, Hamrouni AM. Immune system response during viral Infections: Immunomodulators, cytokine storm (CS) and Immunotherapeutics in COVID-19. Saudi Pharm J 2021;29:173-87. [PMID: 33519271 DOI: 10.1016/j.jsps.2020.12.018] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
78 Moreira AC, Teles MJ, Silva T, Bento CM, Alves IS, Pereira L, Guimarães JT, Porto G, Oliveira P, Gomes MS. Iron Related Biomarkers Predict Disease Severity in a Cohort of Portuguese Adult Patients during COVID-19 Acute Infection. Viruses 2021;13:2482. [PMID: 34960751 DOI: 10.3390/v13122482] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
79 Ray P, Wangzhou A, Ghneim N, Yousuf M, Paige C, Tavares-Ferreira D, Mwirigi J, Shiers S, Sankaranarayanan I, McFarland A, Neerukonda S, Davidson S, Dussor G, Burton M, Price T. A Pharmacological Interactome between COVID-19 Patient Samples and Human Sensory Neurons Reveals Potential Drivers of Neurogenic Pulmonary Dysfunction. SSRN 2020;:3581446. [PMID: 32714114 DOI: 10.2139/ssrn.3581446] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
80 Tian J, Yuan X, Xiao J, Zhong Q, Yang C, Liu B, Cai Y, Lu Z, Wang J, Wang Y, Liu S, Cheng B, Wang J, Zhang M, Wang L, Niu S, Yao Z, Deng X, Zhou F, Wei W, Li Q, Chen X, Chen W, Yang Q, Wu S, Fan J, Shu B, Hu Z, Wang S, Yang XP, Liu W, Miao X, Wang Z. Clinical characteristics and risk factors associated with COVID-19 disease severity in patients with cancer in Wuhan, China: a multicentre, retrospective, cohort study. Lancet Oncol 2020;21:893-903. [PMID: 32479790 DOI: 10.1016/S1470-2045(20)30309-0] [Cited by in Crossref: 174] [Cited by in F6Publishing: 133] [Article Influence: 87.0] [Reference Citation Analysis]
81 Cattelan AM, Di Meco E, Trevenzoli M, Frater A, Ferrari A, Villano M, Gomiero F, Carretta G, Sasset L. Clinical characteristics and laboratory biomarkers changes in COVID-19 patients requiring or not intensive or sub-intensive care: a comparative study. BMC Infect Dis 2020;20:934. [PMID: 33297986 DOI: 10.1186/s12879-020-05647-7] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
82 Carvalho T, Krammer F, Iwasaki A. The first 12 months of COVID-19: a timeline of immunological insights. Nat Rev Immunol 2021;21:245-56. [PMID: 33723416 DOI: 10.1038/s41577-021-00522-1] [Cited by in Crossref: 57] [Cited by in F6Publishing: 47] [Article Influence: 57.0] [Reference Citation Analysis]
83 Viurcos-Sanabria R, Escobedo G. Immunometabolic bases of type 2 diabetes in the severity of COVID-19. World J Diabetes 2021; 12(7): 1026-1041 [PMID: 34326952 DOI: 10.4239/wjd.v12.i7.1026] [Reference Citation Analysis]
84 Abdulla S, Hussain A, Azim D, Abduallah EH, Elawamy H, Nasim S, Kumar S, Naveed H. COVID-19-Induced Hepatic Injury: A Systematic Review and Meta-Analysis. Cureus 2020;12:e10923. [PMID: 33194489 DOI: 10.7759/cureus.10923] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
85 Jamal M, Bangash HI, Habiba M, Lei Y, Xie T, Sun J, Wei Z, Hong Z, Shao L, Zhang Q. Immune dysregulation and system pathology in COVID-19. Virulence 2021;12:918-36. [PMID: 33757410 DOI: 10.1080/21505594.2021.1898790] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
86 Saha A, Saha B. Novel coronavirus SARS-CoV-2 (Covid-19) dynamics inside the human body. Rev Med Virol 2020;30:e2140. [PMID: 32686248 DOI: 10.1002/rmv.2140] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
87 D'Marco L, Puchades MJ, Romero-Parra M, Gimenez-Civera E, Soler MJ, Ortiz A, Gorriz JL. Coronavirus disease 2019 in chronic kidney disease. Clin Kidney J 2020;13:297-306. [PMID: 32699615 DOI: 10.1093/ckj/sfaa104] [Cited by in Crossref: 8] [Cited by in F6Publishing: 17] [Article Influence: 4.0] [Reference Citation Analysis]
88 Veenhuis RT, Zeiss CJ. Animal Models of COVID-19 II. Comparative Immunology. ILAR J 2021:ilab010. [PMID: 33914873 DOI: 10.1093/ilar/ilab010] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
89 Ernst E, Wolfe P, Stahura C, Edwards KA. Technical considerations to development of serological tests for SARS-CoV-2. Talanta 2021;224:121883. [PMID: 33379092 DOI: 10.1016/j.talanta.2020.121883] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
90 Zhu A, Chen Z, Wang Y, Zeng Q, Sun J, Zhuang Z, Li F, Zhao J, Zhao J, Zhong N. Immune responses to SARS-CoV-2 infection in Humans and ACE2 humanized mice. Fundamental Research 2021;1:124-30. [DOI: 10.1016/j.fmre.2021.03.001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
91 Huang I, Pranata R, Lim MA, Oehadian A, Alisjahbana B. C-reactive protein, procalcitonin, D-dimer, and ferritin in severe coronavirus disease-2019: a meta-analysis. Ther Adv Respir Dis 2020;14:1753466620937175. [PMID: 32615866 DOI: 10.1177/1753466620937175] [Cited by in Crossref: 110] [Cited by in F6Publishing: 107] [Article Influence: 55.0] [Reference Citation Analysis]
92 Yasmin H, Saha S, Butt MT, Modi RK, George AJT, Kishore U. SARS-CoV-2: Pathogenic Mechanisms and Host Immune Response. Adv Exp Med Biol 2021;1313:99-134. [PMID: 34661893 DOI: 10.1007/978-3-030-67452-6_6] [Reference Citation Analysis]
93 Alsayb MA, Alsamiri ADD, Makhdoom HQ, Alwasaidi T, Osman HM, Mahallawi WH. Prolonged humoral and cellular immunity in COVID-19-recovered patients. Saudi J Biol Sci 2021;28:4010-5. [PMID: 33867805 DOI: 10.1016/j.sjbs.2021.04.008] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
94 Chen H, Qin L, Wu S, Xu W, Gao R, Zhang X. Clinical characteristics and laboratory features of COVID-19 in high altitude areas: A retrospective cohort study. PLoS One 2021;16:e0249964. [PMID: 34003821 DOI: 10.1371/journal.pone.0249964] [Reference Citation Analysis]
95 Zhang J, Rao X, Li Y, Zhu Y, Liu F, Guo G, Luo G, Meng Z, De Backer D, Xiang H, Peng Z. Pilot trial of high-dose vitamin C in critically ill COVID-19 patients. Ann Intensive Care 2021;11:5. [PMID: 33420963 DOI: 10.1186/s13613-020-00792-3] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 28.0] [Reference Citation Analysis]
96 Zhao N, Di B, Xu LL. The NLRP3 inflammasome and COVID-19: Activation, pathogenesis and therapeutic strategies. Cytokine Growth Factor Rev 2021:S1359-6101(21)00054-X. [PMID: 34183243 DOI: 10.1016/j.cytogfr.2021.06.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
97 Omarjee L, Perrot F, Meilhac O, Mahe G, Bousquet G, Janin A. Immunometabolism at the cornerstone of inflammaging, immunosenescence, and autoimmunity in COVID-19. Aging (Albany NY). 2020;12:26263-26278. [PMID: 33361522 DOI: 10.18632/aging.202422] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
98 Kuroda D, Tsumoto K. Microsecond molecular dynamics suggest that a non-synonymous mutation, frequently observed in patients with mild symptoms in Tokyo, alters dynamics of the SARS-CoV-2 main protease. Biophys Physicobiol 2021;18:215-22. [PMID: 34631338 DOI: 10.2142/biophysico.bppb-v18.022] [Reference Citation Analysis]
99 Alonso-Matielo H, da Silva Oliveira VR, de Oliveira VT, Dale CS. Pain in Covid Era. Front Physiol 2021;12:624154. [PMID: 33603679 DOI: 10.3389/fphys.2021.624154] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
100 Hikichi T, Sakamoto M, Harada M, Saito M, Yamane Y, Tokumura K, Nakamura Y. Identification of cytotoxic T cells and their T cell receptor sequences targeting COVID-19 using MHC class I-binding peptides. J Hum Genet 2022. [PMID: 35110673 DOI: 10.1038/s10038-022-01013-4] [Reference Citation Analysis]
101 Trottein F, Sokol H. Potential Causes and Consequences of Gastrointestinal Disorders during a SARS-CoV-2 Infection. Cell Rep 2020;32:107915. [PMID: 32649864 DOI: 10.1016/j.celrep.2020.107915] [Cited by in Crossref: 55] [Cited by in F6Publishing: 39] [Article Influence: 27.5] [Reference Citation Analysis]
102 Hazeldine J, Lord JM. Immunesenescence: A Predisposing Risk Factor for the Development of COVID-19? Front Immunol 2020;11:573662. [PMID: 33123152 DOI: 10.3389/fimmu.2020.573662] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 8.0] [Reference Citation Analysis]
103 Asghar MS, Haider Kazmi SJ, Khan NA, Akram M, Hassan M, Rasheed U, Ahmed Khan S. Poor Prognostic Biochemical Markers Predicting Fatalities Caused by COVID-19: A Retrospective Observational Study From a Developing Country. Cureus 2020;12:e9575. [PMID: 32913691 DOI: 10.7759/cureus.9575] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
104 Yonal-Hindilerden I, Hindilerden F, Mastanzade M, Tiryaki TO, Tasan-Yenigun S, Bilen Y, Aksoz S, Cagatay AA, Nalcaci M. Case Report: Severe COVID-19 Pneumonia in a Patient With Relapsed/Refractory Hodgkin's Lymphoma. Front Oncol 2021;11:601709. [PMID: 33816231 DOI: 10.3389/fonc.2021.601709] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
105 Kumar V. Understanding the complexities of SARS-CoV2 infection and its immunology: A road to immune-based therapeutics. Int Immunopharmacol 2020;88:106980. [PMID: 33182073 DOI: 10.1016/j.intimp.2020.106980] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
106 Lingappan K, Karmouty-Quintana H, Davies J, Akkanti B, Harting MT. Understanding the age divide in COVID-19: why are children overwhelmingly spared? Am J Physiol Lung Cell Mol Physiol. 2020;319:L39-L44. [PMID: 32491949 DOI: 10.1152/ajplung.00183.2020] [Cited by in Crossref: 35] [Cited by in F6Publishing: 37] [Article Influence: 17.5] [Reference Citation Analysis]
107 Chidambaram V, Tun NL, Haque WZ, Majella MG, Sivakumar RK, Kumar A, Hsu AT, Ishak IA, Nur AA, Ayeh SK, Salia EL, Zil-E-Ali A, Saeed MA, Sarena APB, Seth B, Ahmadzada M, Haque EF, Neupane P, Wang KH, Pu TM, Ali SMH, Arshad MA, Wang L, Baksh S, Karakousis PC, Galiatsatos P. Factors associated with disease severity and mortality among patients with COVID-19: A systematic review and meta-analysis.PLoS One. 2020;15:e0241541. [PMID: 33206661 DOI: 10.1371/journal.pone.0241541] [Cited by in Crossref: 27] [Cited by in F6Publishing: 31] [Article Influence: 13.5] [Reference Citation Analysis]
108 Reiss AB, De Leon J, Dapkins IP, Shahin G, Peltier MR, Goldberg ER. A Telemedicine Approach to Covid-19 Assessment and Triage. Medicina (Kaunas) 2020;56:E461. [PMID: 32927589 DOI: 10.3390/medicina56090461] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
109 Aviv A. Telomeres and COVID-19. FASEB J 2020;34:7247-52. [PMID: 32427393 DOI: 10.1096/fj.202001025] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 13.0] [Reference Citation Analysis]
110 Neidleman J, Luo X, McGregor M, Xie G, Murray V, Greene WC, Lee SA, Roan NR. mRNA vaccine-induced T cells respond identically to SARS-CoV-2 variants of concern but differ in longevity and homing properties depending on prior infection status. bioRxiv 2021:2021. [PMID: 34013277 DOI: 10.1101/2021.05.12.443888] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
111 Perikleous E, Tsalkidis A, Bush A, Paraskakis E. Coronavirus global pandemic: An overview of current findings among pediatric patients. Pediatr Pulmonol 2020;55:3252-67. [PMID: 32965785 DOI: 10.1002/ppul.25087] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
112 Bakowski D, Wood AJ, Parekh AB. Sequi Ad Maius Bonum; Targeting Ion Channels in the Lung. Function (Oxf) 2021;2:zqaa045. [PMID: 34223171 DOI: 10.1093/function/zqaa045] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
113 Castelli V, Cimini A, Ferri C. Cytokine Storm in COVID-19: "When You Come Out of the Storm, You Won't Be the Same Person Who Walked in". Front Immunol. 2020;11:2132. [PMID: 32983172 DOI: 10.3389/fimmu.2020.02132] [Cited by in Crossref: 34] [Cited by in F6Publishing: 32] [Article Influence: 17.0] [Reference Citation Analysis]
114 Di Micco P, Di Micco G, Russo V, Poggiano MR, Salzano C, Bosevski M, Imparato M, Fontanella L, Fontanella A. Blood Targets of Adjuvant Drugs Against COVID19. J Blood Med 2020;11:237-41. [PMID: 32694923 DOI: 10.2147/JBM.S256121] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
115 Mudatsir M, Fajar JK, Wulandari L, Soegiarto G, Ilmawan M, Purnamasari Y, Mahdi BA, Jayanto GD, Suhendra S, Setianingsih YA, Hamdani R, Suseno DA, Agustina K, Naim HY, Muchlas M, Alluza HHD, Rosida NA, Mayasari M, Mustofa M, Hartono A, Aditya R, Prastiwi F, Meku FX, Sitio M, Azmy A, Santoso AS, Nugroho RA, Gersom C, Rabaan AA, Masyeni S, Nainu F, Wagner AL, Dhama K, Harapan H. Predictors of COVID-19 severity: a systematic review and meta-analysis. F1000Res 2020;9:1107. [PMID: 33163160 DOI: 10.12688/f1000research.26186.2] [Cited by in Crossref: 32] [Cited by in F6Publishing: 12] [Article Influence: 16.0] [Reference Citation Analysis]
116 Tseng HT, Wu XC, Huang CY, Shih CM, Lin YW, Lin FY. The Impact of SARS-CoV-2 Infection, and Application of Immunosuppressive Agents in Kidney Transplant Recipients Suffering from COVID-19. Pharmaceuticals (Basel) 2021;14:1054. [PMID: 34681278 DOI: 10.3390/ph14101054] [Reference Citation Analysis]
117 Kakavas S, Karayiannis D, Mastora Z. The Complex Interplay between Immunonutrition, Mast Cells, and Histamine Signaling in COVID-19. Nutrients 2021;13:3458. [PMID: 34684460 DOI: 10.3390/nu13103458] [Reference Citation Analysis]
118 Chen B, Raja K, Pierre-Louis F, Patel M, Patel R, Kang S, Daniel N, Attalla M, Philips M. Intravenous N-Acetylcysteine in Management of COVID-19: A Case Series. J Pharm Pract 2022;:8971900221080283. [PMID: 35331045 DOI: 10.1177/08971900221080283] [Reference Citation Analysis]
119 Kaltoum ABO. Mutations and polymorphisms in genes involved in the infections by covid 19: a review. Gene Rep 2021;23:101062. [PMID: 33655087 DOI: 10.1016/j.genrep.2021.101062] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
120 Lalueza A, Lora-Tamayo J, Maestro-de la Calle G, Folgueira D, Arrieta E, de Miguel-Campo B, Díaz-Simón R, Lora D, de la Calle C, Mancheño-Losa M, Marchán-López Á, García-Reyne A, Fernández-Ruiz M, Sayas-Catalán J, Serrano A, Cueto-Felgueroso C, San Juan R, García-García R, Catalán M, Villena V, Aguado JM, Lumbreras C; COVID+12 group. A predictive score at admission for respiratory failure among hospitalized patients with confirmed 2019 Coronavirus Disease: a simple tool for a complex problem. Intern Emerg Med 2021. [PMID: 33914228 DOI: 10.1007/s11739-021-02748-2] [Reference Citation Analysis]
121 Baeten P, Van Zeebroeck L, Kleinewietfeld M, Hellings N, Broux B. Improving the Efficacy of Regulatory T Cell Therapy. Clin Rev Allergy Immunol 2021. [PMID: 34224053 DOI: 10.1007/s12016-021-08866-1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
122 Rajaram S, Canaday LM, Ochayon DE, Rangel KM, Ali A, Gyurova IE, Krishnamurthy D, Fletcher JS, Reighard SD, Cox A, Weirauch MT, Kottyan LC, Deshmukh H, Zacharias WJ, Borchers MT, Waggoner SN. The Promise and Peril of Natural Killer Cell Therapies in Pulmonary Infection. Immunity 2020;52:887-9. [PMID: 32405233 DOI: 10.1016/j.immuni.2020.04.018] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
123 Gangneux JP, Bougnoux ME, Dannaoui E, Cornet M, Zahar JR. Invasive fungal diseases during COVID-19: We should be prepared. J Mycol Med 2020;30:100971. [PMID: 32307254 DOI: 10.1016/j.mycmed.2020.100971] [Cited by in Crossref: 80] [Cited by in F6Publishing: 66] [Article Influence: 40.0] [Reference Citation Analysis]
124 Chen X, Guo H, Qiu L, Zhang C, Deng Q, Leng Q. Immunomodulatory and Antiviral Activity of Metformin and Its Potential Implications in Treating Coronavirus Disease 2019 and Lung Injury. Front Immunol 2020;11:2056. [PMID: 32973814 DOI: 10.3389/fimmu.2020.02056] [Cited by in Crossref: 18] [Cited by in F6Publishing: 11] [Article Influence: 9.0] [Reference Citation Analysis]
125 Cappello F, Gammazza AM, Dieli F, de Macario, Macario AJ. Does SARS-CoV-2 Trigger Stress-InducedAutoimmunity by Molecular Mimicry? A Hypothesis. J Clin Med 2020;9:E2038. [PMID: 32610587 DOI: 10.3390/jcm9072038] [Cited by in Crossref: 21] [Cited by in F6Publishing: 15] [Article Influence: 10.5] [Reference Citation Analysis]
126 Sobral MFF, Roazzi A, da Penha Sobral AIG, de Oliveira BRB, Duarte GB, da Silva JF, Nogueira RMTBL. A retrospective cohort study of 238,000 COVID-19 hospitalizations and deaths in Brazil. Sci Rep 2022;12. [DOI: 10.1038/s41598-022-07538-0] [Reference Citation Analysis]
127 Zhou X, Ye Q. Cellular Immune Response to COVID-19 and Potential Immune Modulators. Front Immunol 2021;12:646333. [PMID: 33995364 DOI: 10.3389/fimmu.2021.646333] [Reference Citation Analysis]
128 Li S, Zhang Y, Guan Z, Li H, Ye M, Chen X, Shen J, Zhou Y, Shi ZL, Zhou P, Peng K. SARS-CoV-2 triggers inflammatory responses and cell death through caspase-8 activation. Signal Transduct Target Ther 2020;5:235. [PMID: 33037188 DOI: 10.1038/s41392-020-00334-0] [Cited by in Crossref: 53] [Cited by in F6Publishing: 52] [Article Influence: 26.5] [Reference Citation Analysis]
129 Hajimohammadebrahim-Ketabforoush M, Shahmohammadi MR, Zali A, Vahdat Shariatpanahi Z. COVID-19-associated stroke risk: Could nutrition and dietary patterns have a contributing role? World J Meta-Anal 2020; 8(6): 435-446 [DOI: 10.13105/wjma.v8.i6.435] [Reference Citation Analysis]
130 Tamayo-Velasco Á, Peñarrubia Ponce MJ, Álvarez FJ, Gonzalo-Benito H, de la Fuente I, Pérez-González S, Rico L, Jiménez García MT, Sánchez Rodríguez A, Hijas Villaizan M, Martín-Fernández M, Dueñas C, Gómez-Sánchez E, Heredia-Rodríguez M, Gorgojo-Galindo Ó, Fernández I, Del Río L, Carnicero-Frutos I, Muñoz-Moreno MF, Tamayo E, Bernardo D, Martínez-Paz P. Can the Cytokine Profile According to ABO Blood Groups Be Related to Worse Outcome in COVID-19 Patients? Yes, They Can. Front Immunol 2021;12:726283. [PMID: 34721388 DOI: 10.3389/fimmu.2021.726283] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
131 García-Pérez BE, González-Rojas JA, Salazar MI, Torres-Torres C, Castrejón-Jiménez NS. Taming the Autophagy as a Strategy for Treating COVID-19. Cells 2020;9:E2679. [PMID: 33322168 DOI: 10.3390/cells9122679] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
132 Das SK. The Pathophysiology, Diagnosis and Treatment of Corona Virus Disease 2019 (COVID-19). Indian J Clin Biochem 2020;:1-12. [PMID: 32837036 DOI: 10.1007/s12291-020-00919-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
133 Barbalho SM, Matias JN, Flato UAP, Pilon JPG, Bitelli P, Pagani Junior MA, de Carvalho ACA, Haber JFDS, Reis CHB, Goulart RA. What Do Influenza and COVID-19 Represent for Patients With Inflammatory Bowel Disease? Gastroenterology Res 2021;14:1-12. [PMID: 33737994 DOI: 10.14740/gr1358] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
134 Alizadeh LS, Albrecht MH, Booz C. Radiographic case report of a heart transplanted patient suffering from COVID-19. Heliyon 2021;7:e06688. [PMID: 33842708 DOI: 10.1016/j.heliyon.2021.e06688] [Reference Citation Analysis]
135 Tebas P, Yang S, Boyer JD, Reuschel EL, Patel A, Christensen-Quick A, Andrade VM, Morrow MP, Kraynyak K, Agnes J, Purwar M, Sylvester A, Pawlicki J, Gillespie E, Maricic I, Zaidi FI, Kim KY, Dia Y, Frase D, Pezzoli P, Schultheis K, Smith TRF, Ramos SJ, McMullan T, Buttigieg K, Carroll MW, Ervin J, Diehl MC, Blackwood E, Mammen MP, Lee J, Dallas MJ, Brown AS, Shea JE, Kim JJ, Weiner DB, Broderick KE, Humeau LM. Safety and immunogenicity of INO-4800 DNA vaccine against SARS-CoV-2: A preliminary report of an open-label, Phase 1 clinical trial. EClinicalMedicine 2021;31:100689. [PMID: 33392485 DOI: 10.1016/j.eclinm.2020.100689] [Cited by in Crossref: 52] [Cited by in F6Publishing: 49] [Article Influence: 26.0] [Reference Citation Analysis]
136 Cohen CA, Li AP, Hachim A, Hui DS, Kwan MY, Tsang OT, Chiu SS, Chan WH, Yau YS, Kavian N, Ma FN, Lau EH, Cheng SM, Poon LL, Peiris JM, Valkenburg SA. SARS-CoV-2 specific T cell responses are lower in children and increase with age and time after infection. medRxiv 2021:2021. [PMID: 33564773 DOI: 10.1101/2021.02.02.21250988] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
137 Shenoy A, Ismaily M, Bajaj M. Diabetes and covid-19: a global health challenge. BMJ Open Diabetes Res Care 2020;8:e001450. [PMID: 32345580 DOI: 10.1136/bmjdrc-2020-001450] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 8.5] [Reference Citation Analysis]
138 Metcalfe RD, Putoczki TL, Griffin MDW. Structural Understanding of Interleukin 6 Family Cytokine Signaling and Targeted Therapies: Focus on Interleukin 11. Front Immunol 2020;11:1424. [PMID: 32765502 DOI: 10.3389/fimmu.2020.01424] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
139 Onoyama T, Koda H, Hamamoto W, Kawahara S, Sakamoto Y, Yamashita T, Kurumi H, Kawata S, Takeda Y, Matsumoto K, Isomoto H. Review on acute pancreatitis attributed to COVID-19 infection. World J Gastroenterol 2022; 28(19): 2034-2056 [DOI: 10.3748/wjg.v28.i19.2034] [Reference Citation Analysis]
140 Vanderbeke L, Van Mol P, Van Herck Y, De Smet F, Humblet-Baron S, Martinod K, Antoranz A, Arijs I, Boeckx B, Bosisio FM, Casaer M, Dauwe D, De Wever W, Dooms C, Dreesen E, Emmaneel A, Filtjens J, Gouwy M, Gunst J, Hermans G, Jansen S, Lagrou K, Liston A, Lorent N, Meersseman P, Mercier T, Neyts J, Odent J, Panovska D, Penttila PA, Pollet E, Proost P, Qian J, Quintelier K, Raes J, Rex S, Saeys Y, Sprooten J, Tejpar S, Testelmans D, Thevissen K, Van Buyten T, Vandenhaute J, Van Gassen S, Velásquez Pereira LC, Vos R, Weynand B, Wilmer A, Yserbyt J, Garg AD, Matthys P, Wouters C, Lambrechts D, Wauters E, Wauters J. Monocyte-driven atypical cytokine storm and aberrant neutrophil activation as key mediators of COVID-19 disease severity. Nat Commun 2021;12:4117. [PMID: 34226537 DOI: 10.1038/s41467-021-24360-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
141 Zellweger RM, Wartel TA, Marks F, Song M, Kim JH. Vaccination against SARS-CoV-2 and disease enhancement - knowns and unknowns. Expert Rev Vaccines 2020;19:691-8. [PMID: 32838605 DOI: 10.1080/14760584.2020.1800463] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
142 Shafqat A, Shafqat S, Salameh SA, Kashir J, Alkattan K, Yaqinuddin A. Mechanistic Insights Into the Immune Pathophysiology of COVID-19; An In-Depth Review. Front Immunol 2022;13:835104. [DOI: 10.3389/fimmu.2022.835104] [Reference Citation Analysis]
143 Dorjee K, Kim H, Bonomo E, Dolma R. Prevalence and predictors of death and severe disease in patients hospitalized due to COVID-19: A comprehensive systematic review and meta-analysis of 77 studies and 38,000 patients. PLoS One 2020;15:e0243191. [PMID: 33284825 DOI: 10.1371/journal.pone.0243191] [Cited by in Crossref: 30] [Cited by in F6Publishing: 37] [Article Influence: 15.0] [Reference Citation Analysis]
144 Yates JL, Ehrbar DJ, Hunt DT, Girardin RC, Dupuis AP 2nd, Payne AF, Sowizral M, Varney S, Kulas KE, Demarest VL, Howard KM, Carson K, Hales M, Ejemel M, Li Q, Wang Y, Peredo-Wende R, Ramani A, Singh G, Strle K, Mantis NJ, McDonough KA, Lee WT. Serological analysis reveals an imbalanced IgG subclass composition associated with COVID-19 disease severity. Cell Rep Med 2021;2:100329. [PMID: 34151306 DOI: 10.1016/j.xcrm.2021.100329] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
145 Zhou YJ, Zheng KI, Wang XB, Yan HD, Sun QF, Pan KH, Wang TY, Ma HL, Chen YP, George J, Zheng MH. Younger patients with MAFLD are at increased risk of severe COVID-19 illness: A multicenter preliminary analysis. J Hepatol. 2020;73:719-721. [PMID: 32348790 DOI: 10.1016/j.jhep.2020.04.027] [Cited by in Crossref: 51] [Cited by in F6Publishing: 53] [Article Influence: 25.5] [Reference Citation Analysis]
146 Cheung EW, Zachariah P, Gorelik M, Boneparth A, Kernie SG, Orange JS, Milner JD. Multisystem Inflammatory Syndrome Related to COVID-19 in Previously Healthy Children and Adolescents in New York City. JAMA. 2020;324:294-296. [PMID: 32511676 DOI: 10.1001/jama.2020.10374] [Cited by in Crossref: 260] [Cited by in F6Publishing: 224] [Article Influence: 130.0] [Reference Citation Analysis]
147 Encinar JA, Menendez JA. Potential Drugs Targeting Early Innate Immune Evasion of SARS-Coronavirus 2 via 2'-O-Methylation of Viral RNA. Viruses 2020;12:E525. [PMID: 32397643 DOI: 10.3390/v12050525] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 15.5] [Reference Citation Analysis]
148 Patnaik MM, Lasho T, Padron E, McCullough K, Al-Kali A, Tefferi A, Zeidan AM, Gangat N, Savona M, Steensma DP, Solary E. Special considerations in the management of patients with myelodysplastic myndrome / myeloproliferative neoplasm overlap syndromes during the SARS-CoV-2 pandemic. Am J Hematol 2020;95:E203-8. [PMID: 32356322 DOI: 10.1002/ajh.25853] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
149 Ribeiro DE, Oliveira-Giacomelli Á, Glaser T, Arnaud-Sampaio VF, Andrejew R, Dieckmann L, Baranova J, Lameu C, Ratajczak MZ, Ulrich H. Hyperactivation of P2X7 receptors as a culprit of COVID-19 neuropathology. Mol Psychiatry 2021;26:1044-59. [PMID: 33328588 DOI: 10.1038/s41380-020-00965-3] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 5.5] [Reference Citation Analysis]
150 Falasca L, Nardacci R, Colombo D, Lalle E, Di Caro A, Nicastri E, Antinori A, Petrosillo N, Marchioni L, Biava G, D'Offizi G, Palmieri F, Goletti D, Zumla A, Ippolito G, Piacentini M, Del Nonno F. Postmortem Findings in Italian Patients With COVID-19: A Descriptive Full Autopsy Study of Cases With and Without Comorbidities.J Infect Dis. 2020;222:1807-1815. [PMID: 32914853 DOI: 10.1093/infdis/jiaa578] [Cited by in Crossref: 54] [Cited by in F6Publishing: 53] [Article Influence: 27.0] [Reference Citation Analysis]
151 Cai J, Deng H, Luo L, You L, Liao H, Zheng Y. Decreased expression of JAK1 associated with immune infiltration and poor prognosis in lung adenocarcinoma. Aging (Albany NY) 2020;13:2073-88. [PMID: 33323549 DOI: 10.18632/aging.202205] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
152 Lee JS, Park S, Jeong HW, Ahn JY, Choi SJ, Lee H, Choi B, Nam SK, Sa M, Kwon JS, Jeong SJ, Lee HK, Park SH, Choi JY, Kim SH, Jung I, Shin EC. Immunophenotyping of COVID-19 and influenza highlights the role of type I interferons in development of severe COVID-19. Sci Immunol. 2020;5. [PMID: 32651212 DOI: 10.1126/sciimmunol.abd1554] [Cited by in Crossref: 255] [Cited by in F6Publishing: 227] [Article Influence: 127.5] [Reference Citation Analysis]
153 Theoharides TC, Antonopoulou S, Demopoulos CA. Coronavirus 2019, Microthromboses, and Platelet Activating Factor. Clin Ther 2020;42:1850-2. [PMID: 32883529 DOI: 10.1016/j.clinthera.2020.08.006] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
154 Greco M, Suppressa S, Lazzari RA, Sicuro F, Catanese C, Lobreglio G. sFlt-1 and CA 15.3 are indicators of endothelial damage and pulmonary fibrosis in SARS-CoV-2 infection. Sci Rep 2021;11:19979. [PMID: 34620968 DOI: 10.1038/s41598-021-99470-y] [Reference Citation Analysis]
155 Lisco G, De Tullio A, Stragapede A, Solimando AG, Albanese F, Capobianco M, Giagulli VA, Guastamacchia E, De Pergola G, Vacca A, Racanelli V, Triggiani V. COVID-19 and the Endocrine System: A Comprehensive Review on the Theme. J Clin Med 2021;10:2920. [PMID: 34209964 DOI: 10.3390/jcm10132920] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
156 Schmidbauer ML, Ferse C, Salih F, Klingner C, Musleh R, Kunst S, Wittstock M, Neumann B, Schebesch K, Bösel J, Godau J, Lochner P, Adam EH, Jahnke K, Knier B, Schirotzek I, Müllges W, Notz Q, Dengl M, Güldner A, Onur OA, Garcia Borrega J, Dimitriadis K, Günther A; on behalf of the IGNITE Study Group. COVID-19 and Intracranial Hemorrhage: A Multicenter Case Series, Systematic Review and Pooled Analysis. JCM 2022;11:605. [DOI: 10.3390/jcm11030605] [Reference Citation Analysis]
157 Fratta Pasini AM, Stranieri C, Cominacini L, Mozzini C. Potential Role of Antioxidant and Anti-Inflammatory Therapies to Prevent Severe SARS-Cov-2 Complications. Antioxidants (Basel) 2021;10:272. [PMID: 33578849 DOI: 10.3390/antiox10020272] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 9.0] [Reference Citation Analysis]
158 Mussa BM, Srivastava A, Verberne AJM. COVID-19 and Neurological Impairment: Hypothalamic Circuits and Beyond. Viruses 2021;13:498. [PMID: 33802995 DOI: 10.3390/v13030498] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
159 Han J, Gatheral T, Williams C. Procalcitonin for patient stratification and identification of bacterial co-infection in COVID-19. Clin Med (Lond) 2020;20:e47. [PMID: 32414743 DOI: 10.7861/clinmed.Let.20.3.3] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
160 Pourabdollah Toutkaboni M, Askari E, Khalili N, Tabarsi P, Jamaati H, Velayati AA, Dorudinia A, Rezaei M, Nadji SA, Mohamadnia A, Khalili N. Demographics, laboratory parameters and outcomes of 1061 patients with coronavirus disease 2019: a report from Tehran, Iran. New Microbes New Infect 2020;38:100777. [PMID: 33042553 DOI: 10.1016/j.nmni.2020.100777] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
161 Song Y, Zhong H, Li L, Yin M, Yin Y, Guo X, Zhang B, Liu W. Dynamic monitoring of immune function indexes in COVID-19 patients. Aging (Albany NY) 2020;12:24596-603. [PMID: 33361525 DOI: 10.18632/aging.202362] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
162 Shabalin IG, Czub MP, Majorek KA, Brzezinski D, Grabowski M, Cooper DR, Panasiuk M, Chruszcz M, Minor W. Molecular determinants of vascular transport of dexamethasone in COVID-19 therapy. bioRxiv 2020:2020. [PMID: 32743572 DOI: 10.1101/2020.07.21.212704] [Reference Citation Analysis]
163 Clemente A, Alba-Patiño A, Santopolo G, Barón E, Rojo-Molinero E, Oliver A, Pérez-Bárcena J, Merino de Cos P, Aranda M, Del Castillo A, Socias A, Borges M, de la Rica R. Optimized detection of lung IL-6 via enzymatic liquefaction of low respiratory tract samples: application for managing ventilated patients. Analyst 2021;146:6537-46. [PMID: 34581315 DOI: 10.1039/d1an00763g] [Reference Citation Analysis]
164 Ong SWX, Tan WYT, Chan YH, Fong SW, Renia L, Ng LF, Leo YS, Lye DC, Young BE. Safety and potential efficacy of cyclooxygenase-2 inhibitors in coronavirus disease 2019. Clin Transl Immunology 2020;9:e1159. [PMID: 32728438 DOI: 10.1002/cti2.1159] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
165 Stoian A, Bajko Z, Maier S, Cioflinc RA, Grigorescu BL, Moțățăianu A, Bărcuțean L, Balașa R, Stoian M. High-dose intravenous immunoglobulins as a therapeutic option in critical illness polyneuropathy accompanying SARS-CoV-2 infection: A case-based review of the literature (Review). Exp Ther Med 2021;22:1182. [PMID: 34475972 DOI: 10.3892/etm.2021.10616] [Reference Citation Analysis]
166 Acar HC, Can G, Karaali R, Börekçi Ş, Balkan İİ, Gemicioğlu B, Konukoğlu D, Erginöz E, Erdoğan MS, Tabak F. An easy-to-use nomogram for predicting in-hospital mortality risk in COVID-19: a retrospective cohort study in a university hospital. BMC Infect Dis 2021;21:148. [PMID: 33546639 DOI: 10.1186/s12879-021-05845-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
167 Xie M, Yunis J, Yao Y, Shi J, Yang Y, Zhou P, Liang K, Wan Y, Mehdi A, Chen Z, Wang N, Xu S, Zhou M, Yu M, Wang K, Tao Y, Zhou Y, Li X, Liu X, Yu X, Wei Y, Liu Z, Sprent J, Yu D. High levels of soluble CD25 in COVID-19 severity suggest a divergence between anti-viral and pro-inflammatory T-cell responses. Clin Transl Immunology 2021;10:e1251. [PMID: 33614032 DOI: 10.1002/cti2.1251] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
168 Zahran AM, El-Badawy O, Ali WA, Mahran ZG, Mahran EEMO, Rayan A. Circulating microparticles and activated platelets as novel prognostic biomarkers in COVID-19; relation to cancer. PLoS One 2021;16:e0246806. [PMID: 33617530 DOI: 10.1371/journal.pone.0246806] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
169 Hasanvand A. COVID-19 and the role of cytokines in this disease. Inflammopharmacology 2022. [PMID: 35505267 DOI: 10.1007/s10787-022-00992-2] [Reference Citation Analysis]
170 Li J, Zaslavsky M, Su Y, Guo J, Sikora MJ, van Unen V, Christophersen A, Chiou SH, Chen L, Li J, Ji X, Wilhelmy J, McSween AM, Palanski BA, Mallajosyula VVA, Bracey NA, Dhondalay GKR, Bhamidipati K, Pai J, Kipp LB, Dunn JE, Hauser SL, Oksenberg JR, Satpathy AT, Robinson WH, Dekker CL, Steinmetz LM, Khosla C, Utz PJ, Sollid LM, Chien YH, Heath JR, Fernandez-Becker NQ, Nadeau KC, Saligrama N, Davis MM. KIR+CD8+ T cells suppress pathogenic T cells and are active in autoimmune diseases and COVID-19. Science 2022;:eabi9591. [PMID: 35258337 DOI: 10.1126/science.abi9591] [Reference Citation Analysis]
171 Chou CC, Hua KT, Chen MW, Wu CJ, Hsu CH, Wang JT, Hsiao M, Wei LH. Discovery and characterization of a monoclonal antibody targeting a conformational epitope of IL-6/IL-6Rα to inhibit IL-6/ IL-6Rα/gp130 hexameric signaling complex formation. MAbs 2022;14:2029675. [PMID: 35133941 DOI: 10.1080/19420862.2022.2029675] [Reference Citation Analysis]
172 Ni M, Tian FB, Xiang DD, Yu B. Characteristics of inflammatory factors and lymphocyte subsets in patients with severe COVID-19. J Med Virol 2020;92:2600-6. [PMID: 32470153 DOI: 10.1002/jmv.26070] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 8.5] [Reference Citation Analysis]
173 He Q, Mao Q, Peng X, He Z, Lu S, Zhang J, Gao F, Bian L, An C, Yu W, Yang F, Zhou Y, Yang Y, Li Y, Yuan Y, Yan X, Yang J, Wu X, Huang W, Li C, Wang J, Liang Z, Xu M. Immunogenicity and protective efficacy of a recombinant protein subunit vaccine and an inactivated vaccine against SARS-CoV-2 variants in non-human primates. Signal Transduct Target Ther 2022;7:69. [PMID: 35241645 DOI: 10.1038/s41392-022-00926-y] [Reference Citation Analysis]
174 Azaiz MB, Chatbri B, Sellami W, Romdhani C, Lamine K, Ghazouani E, Oueslati R, Gharsallah H, Ferjani M. Outcomes of treatment of severe COVID-19 pneumonia with tocilizumab: a report of two cases from Tunisia. Pan Afr Med J 2021;40:126. [PMID: 34909094 DOI: 10.11604/pamj.2021.40.126.28020] [Reference Citation Analysis]
175 Ferrarini MG, Lal A, Rebollo R, Gruber AJ, Guarracino A, Gonzalez IM, Floyd T, de Oliveira DS, Shanklin J, Beausoleil E, Pusa T, Pickett BE, Aguiar-Pulido V. Genome-wide bioinformatic analyses predict key host and viral factors in SARS-CoV-2 pathogenesis. Commun Biol 2021;4:590. [PMID: 34002013 DOI: 10.1038/s42003-021-02095-0] [Reference Citation Analysis]
176 Nizami S, Arunasalam K, Green J, Cook J, Lawrence CB, Zarganes-Tzitzikas T, Davis JB, Di Daniel E, Brough D. Inhibition of the NLRP3 inflammasome by HSP90 inhibitors. Immunology 2021;162:84-91. [PMID: 32954500 DOI: 10.1111/imm.13267] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
177 Van Zeebroeck L, Arroyo Hornero R, Côrte-Real BF, Hamad I, Meissner TB, Kleinewietfeld M. Fast and Efficient Genome Editing of Human FOXP3+ Regulatory T Cells. Front Immunol 2021;12:655122. [PMID: 34408743 DOI: 10.3389/fimmu.2021.655122] [Reference Citation Analysis]
178 Zheng S, Baak JP, Li S, Xiao W, Ren H, Yang H, Gan Y, Wen C. Network pharmacology analysis of the therapeutic mechanisms of the traditional Chinese herbal formula Lian Hua Qing Wen in Corona virus disease 2019 (COVID-19), gives fundamental support to the clinical use of LHQW. Phytomedicine 2020;79:153336. [PMID: 32949888 DOI: 10.1016/j.phymed.2020.153336] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 8.5] [Reference Citation Analysis]
179 Costagliola G, Spada E, Consolini R. Severe COVID-19 in pediatric age: an update on the role of the anti-rheumatic agents. Pediatr Rheumatol Online J 2021;19:68. [PMID: 33947420 DOI: 10.1186/s12969-021-00559-5] [Reference Citation Analysis]
180 Fleming N, Sacks LJ, Pham CT, Neoh SL, Ekinci EI. An overview of COVID-19 in people with diabetes: Pathophysiology and considerations in the inpatient setting. Diabet Med 2021;38:e14509. [PMID: 33377213 DOI: 10.1111/dme.14509] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
181 Khamis F, Al-Zakwani I, Al Hashmi S, Al Dowaiki S, Al Bahrani M, Pandak N, Al Khalili H, Memish Z. Therapeutic plasma exchange in adults with severe COVID-19 infection. Int J Infect Dis 2020;99:214-8. [PMID: 32585284 DOI: 10.1016/j.ijid.2020.06.064] [Cited by in Crossref: 40] [Cited by in F6Publishing: 38] [Article Influence: 20.0] [Reference Citation Analysis]
182 Shoumariyeh K, Biavasco F, Ihorst G, Rieg S, Nieters A, Kern WV, Miething C, Duyster J, Engelhardt M, Bertz H. Covid-19 in patients with hematological and solid cancers at a Comprehensive Cancer Center in Germany. Cancer Med 2020;9:8412-22. [PMID: 32931637 DOI: 10.1002/cam4.3460] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
183 Wang Y, Zheng J, Islam MS, Yang Y, Hu Y, Chen X. The role of CD4+FoxP3+ regulatory T cells in the immunopathogenesis of COVID-19: implications for treatment. Int J Biol Sci 2021;17:1507-20. [PMID: 33907514 DOI: 10.7150/ijbs.59534] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
184 Zarrilli G, Angerilli V, Businello G, Sbaraglia M, Traverso G, Fortarezza F, Rizzo S, De Gaspari M, Basso C, Calabrese F, Dei Tos AP, Fassan M. The Immunopathological and Histological Landscape of COVID-19-Mediated Lung Injury. Int J Mol Sci 2021;22:974. [PMID: 33478107 DOI: 10.3390/ijms22020974] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
185 Suvarna K, Biswas D, Pai MGJ, Acharjee A, Bankar R, Palanivel V, Salkar A, Verma A, Mukherjee A, Choudhury M, Ghantasala S, Ghosh S, Singh A, Banerjee A, Badaya A, Bihani S, Loya G, Mantri K, Burli A, Roy J, Srivastava A, Agrawal S, Shrivastav O, Shastri J, Srivastava S. Proteomics and Machine Learning Approaches Reveal a Set of Prognostic Markers for COVID-19 Severity With Drug Repurposing Potential. Front Physiol 2021;12:652799. [PMID: 33995121 DOI: 10.3389/fphys.2021.652799] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
186 Kroemer A, Khan K, Plassmeyer M, Alpan O, Haseeb MA, Gupta R, Fishbein TM. Inflammasome activation and pyroptosis in lymphopenic liver patients with COVID-19. J Hepatol 2020;73:1258-62. [PMID: 32645361 DOI: 10.1016/j.jhep.2020.06.034] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
187 Cremoni M, Ruetsch C, Zorzi K, Fernandez C, Boyer-Suavet S, Benzaken S, Demonchy E, Dellamonica J, Ichai C, Esnault V, Brglez V, Seitz-Polski B. Humoral and Cellular Response of Frontline Health Care Workers Infected by SARS-CoV-2 in Nice, France: A Prospective Single-Center Cohort Study. Front Med (Lausanne) 2020;7:608804. [PMID: 33585509 DOI: 10.3389/fmed.2020.608804] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
188 Schub D, Klemis V, Schneitler S, Mihm J, Lepper PM, Wilkens H, Bals R, Eichler H, Gärtner BC, Becker SL, Sester U, Sester M, Schmidt T. High levels of SARS-CoV-2-specific T cells with restricted functionality in severe courses of COVID-19. JCI Insight 2020;5:142167. [PMID: 32937615 DOI: 10.1172/jci.insight.142167] [Cited by in Crossref: 28] [Cited by in F6Publishing: 34] [Article Influence: 14.0] [Reference Citation Analysis]
189 Dalamaga M, Karampela I, Mantzoros CS. Commentary: Phosphodiesterase 4 inhibitors as potential adjunct treatment targeting the cytokine storm in COVID-19. Metabolism 2020;109:154282. [PMID: 32497535 DOI: 10.1016/j.metabol.2020.154282] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 11.5] [Reference Citation Analysis]
190 Gómez-Escobar LG, Hoffman KL, Choi JJ, Borczuk A, Salvatore S, Alvarez-Mulett SL, Galvan MD, Zhao Z, Racine-Brzostek SE, Yang HS, Stout-Delgado HW, Choi ME, Choi AMK, Cho SJ, Schenck EJ. Cytokine signatures of end organ injury in COVID-19. Sci Rep 2021;11:12606. [PMID: 34131192 DOI: 10.1038/s41598-021-91859-z] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
191 Junior AF, Azevedo E, Paes AT, Lima E, Campos Guerra JC, Ingham SJMN. Chronic diseases, chest computed tomography, and laboratory tests as predictors of severe respiratory failure and death in elderly Brazilian patients hospitalized with COVID-19: a prospective cohort study. BMC Geriatr 2022;22:132. [PMID: 35172759 DOI: 10.1186/s12877-022-02776-3] [Reference Citation Analysis]
192 Shakaib B, Zohra T, Ikram A, Shakaib MB, Ali A, Bashir A, Salman M, Khan MA, Ansari J. A comprehensive review on clinical and mechanistic pathophysiological aspects of COVID-19 Malady: How far have we come? Virol J 2021;18:120. [PMID: 34098986 DOI: 10.1186/s12985-021-01578-0] [Reference Citation Analysis]
193 Tzar MN, Meor Jamaludin WHB, Abdul Wahab A, Ding CH. Exophiala dermatitidis, ‘the real black fungus’ fungemia in a patient with COVID-19. IDCases 2022;27:e01428. [DOI: 10.1016/j.idcr.2022.e01428] [Reference Citation Analysis]
194 Bernstein CN, Singh H, Murthy SK, Nguyen GC, Benchimol EI, Bitton A, Kuenzig ME, Huang JG, Jones JL, Lee K, Targownik LE, Windsor JW, Mukhtar MS, Tandon P, Kaplan GG. Crohn's and Colitis Canada's 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: Seniors With IBD. J Can Assoc Gastroenterol 2021;4:S34-9. [PMID: 34755037 DOI: 10.1093/jcag/gwab025] [Reference Citation Analysis]
195 Guarnieri T. Hypothesis: Emerging Roles for Aryl Hydrocarbon Receptor in Orchestrating CoV-2-Related Inflammation. Cells 2022;11:648. [DOI: 10.3390/cells11040648] [Reference Citation Analysis]
196 Stervbo U, Rahmann S, Roch T, Westhoff TH, Babel N. Epitope similarity cannot explain the pre-formed T cell immunity towards structural SARS-CoV-2 proteins. Sci Rep 2020;10:18995. [PMID: 33149224 DOI: 10.1038/s41598-020-75972-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
197 Vallinoto ACR, da Silva Torres MK, Vallinoto MC, Cayres Vallinoto IMV. The challenges of COVID-19 in the Brazilian Amazonian communities and the importance of seroepidemiological surveillance studies. Int J Equity Health 2020;19:140. [PMID: 32799872 DOI: 10.1186/s12939-020-01256-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
198 Galassi G, Marchioni A. Myasthenia gravis at the crossroad of COVID-19: focus on immunological and respiratory interplay. Acta Neurol Belg 2021;121:633-42. [PMID: 33811309 DOI: 10.1007/s13760-021-01612-6] [Reference Citation Analysis]
199 Rea IM, Alexander HD. Triple jeopardy in ageing: COVID-19, co-morbidities and inflamm-ageing. Ageing Res Rev 2021;73:101494. [PMID: 34688926 DOI: 10.1016/j.arr.2021.101494] [Reference Citation Analysis]
200 Dugail I, Amri EZ, Vitale N. High prevalence for obesity in severe COVID-19: Possible links and perspectives towards patient stratification. Biochimie. 2020;179:257-265. [PMID: 32649962 DOI: 10.1016/j.biochi.2020.07.001] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
201 Schrijver B, Assmann JLJC, van Gammeren AJ, Vermeulen RCH, Portengen L, Heukels P, Langerak AW, Dik WA, van der Velden VHJ, Ermens TAAM. Extensive longitudinal immune profiling reveals sustained innate immune activation in COVID-19 patients with unfavorable outcome. Eur Cytokine Netw 2020;31:154-67. [PMID: 33648924 DOI: 10.1684/ecn.2020.0456] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
202 Boeckmans J, Rodrigues RM, Demuyser T, Piérard D, Vanhaecke T, Rogiers V. COVID-19 and drug-induced liver injury: a problem of plenty or a petty point? Arch Toxicol 2020;94:1367-9. [PMID: 32266419 DOI: 10.1007/s00204-020-02734-1] [Cited by in F6Publishing: 50] [Reference Citation Analysis]
203 Elahi S. Hematopoietic responses to SARS-CoV-2 infection. Cell Mol Life Sci 2022;79. [DOI: 10.1007/s00018-022-04220-6] [Reference Citation Analysis]
204 Lee KW, Yusof Khan AHK, Ching SM, Chia PK, Loh WC, Abdul Rashid AM, Baharin J, Inche Mat LN, Wan Sulaiman WA, Devaraj NK, Sivaratnam D, Basri H, Hoo FK. Stroke and Novel Coronavirus Infection in Humans: A Systematic Review and Meta-Analysis. Front Neurol 2020;11:579070. [PMID: 33123082 DOI: 10.3389/fneur.2020.579070] [Cited by in Crossref: 16] [Cited by in F6Publishing: 9] [Article Influence: 8.0] [Reference Citation Analysis]
205 Biscetti F, Rando MM, Nardella E, Cecchini AL, Bruno P, Landolfi R, Flex A. Cardiovascular Disease and SARS-CoV-2: the Role of Host Immune Response Versus Direct Viral Injury. Int J Mol Sci 2020;21:E8141. [PMID: 33143371 DOI: 10.3390/ijms21218141] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
206 Lara PC, Nguyen NP, Macias-Verde D, Burgos-Burgos J, Arenas M, Zamagni A, Vinh-Hung V, Baumert BG, Motta M, Myint AS, Bonet M, Popescu T, Vuong T, Appalanaido GK, Trigo L, Karlsson U, Thariat J. Whole-lung Low Dose Irradiation for SARS-Cov2 Induced Pneumonia in the Geriatric Population: An Old Effective Treatment for a New Disease? Recommendation of the International Geriatric Radiotherapy Group. Aging Dis 2020;11:489-93. [PMID: 32489696 DOI: 10.14336/AD.2020.0506] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
207 Li G, Xu Y, Yang YT, Liu PF. Prevalence of acute liver injury and hypertransaminemia in patients with COVID-19: a protocol for a systematic review. BMJ Open 2020;10:e040517. [PMID: 32641369 DOI: 10.1136/bmjopen-2020-040517] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
208 Hanan N, Doud RL Jr, Park IW, Jones HP, Mathew SO. The Many Faces of Innate Immunity in SARS-CoV-2 Infection. Vaccines (Basel) 2021;9:596. [PMID: 34199761 DOI: 10.3390/vaccines9060596] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
209 Leija-Martínez JJ, Huang F, Del-Río-Navarro BE, Sanchéz-Muñoz F, Muñoz-Hernández O, Giacoman-Martínez A, Hall-Mondragon MS, Espinosa-Velazquez D. IL-17A and TNF-α as potential biomarkers for acute respiratory distress syndrome and mortality in patients with obesity and COVID-19. Med Hypotheses 2020;144:109935. [PMID: 32795834 DOI: 10.1016/j.mehy.2020.109935] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 5.5] [Reference Citation Analysis]
210 Buerke M, Sheriff A, Garlichs CD. [CRP apheresis in acute myocardial infarction and COVID-19]. Med Klin Intensivmed Notfmed 2022. [PMID: 35333926 DOI: 10.1007/s00063-022-00911-x] [Reference Citation Analysis]
211 Burian E, Jungmann F, Kaissis GA, Lohöfer FK, Spinner CD, Lahmer T, Treiber M, Dommasch M, Schneider G, Geisler F, Huber W, Protzer U, Schmid RM, Schwaiger M, Makowski MR, Braren RF. Intensive Care Risk Estimation in COVID-19 Pneumonia Based on Clinical and Imaging Parameters: Experiences from the Munich Cohort. J Clin Med 2020;9:E1514. [PMID: 32443442 DOI: 10.3390/jcm9051514] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 12.0] [Reference Citation Analysis]
212 Abdullah M, Pawitan JA, Irawan C, - R, Aditianingsih D, Liem IK, Sinto R, Susilo A, Yulianti M, Handayani RRD, Pratomo IP, Burhan E, Damayanti T, Wibowo H, Dilogo IH. Effectiveness and safety profile of mesenchymal stem cell secretome as a treatment for severe cases of COVID-19: a randomized controlled trial. F1000Res 2022;11:143. [DOI: 10.12688/f1000research.75580.1] [Reference Citation Analysis]
213 Samsami M, Fatemi A, Jalili Khoshnoud R, Kohansal K, Hussen BM, Soghala S, Taheri M, Ghafouri-Fard S. Abnormal Transcript Levels of Cytokines Among Iranian COVID-19 Patients. J Mol Neurosci 2021. [PMID: 34855144 DOI: 10.1007/s12031-021-01941-4] [Reference Citation Analysis]
214 Yoshida Y, Gillet SA, Brown MI, Zu Y, Wilson SM, Ahmed SJ, Tirumalasetty S, Lovre D, Krousel-Wood M, Denson JL, Mauvais-Jarvis F. Clinical characteristics and outcomes in women and men hospitalized for coronavirus disease 2019 in New Orleans. Biol Sex Differ 2021;12:20. [PMID: 33546750 DOI: 10.1186/s13293-021-00359-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
215 Theoharides TC, Cholevas C, Polyzoidis K, Politis A. Long-COVID syndrome-associated brain fog and chemofog: Luteolin to the rescue. Biofactors 2021;47:232-41. [PMID: 33847020 DOI: 10.1002/biof.1726] [Cited by in Crossref: 4] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
216 Tiwari NR, Khatib KI, Dixit SB, Rathore PK, Melinkeri S, Ganapule A, Borawake KS, Mhatre U. Anticoagulation in COVID - 19: An Update. J Crit Care Med (Targu Mures) 2020;6:217-23. [PMID: 33200092 DOI: 10.2478/jccm-2020-0033] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 3.5] [Reference Citation Analysis]
217 Zhao Y, Zhang R, Zhong Y, Wang J, Weng Z, Luo H, Chen C. Statistical Analysis and Machine Learning Prediction of Disease Outcomes for COVID-19 and Pneumonia Patients. Front Cell Infect Microbiol 2022;12:838749. [DOI: 10.3389/fcimb.2022.838749] [Reference Citation Analysis]
218 Gubbi S, Nazari MA, Taieb D, Klubo-Gwiezdzinska J, Pacak K. Catecholamine physiology and its implications in patients with COVID-19. Lancet Diabetes Endocrinol 2020;8:978-86. [PMID: 33128872 DOI: 10.1016/S2213-8587(20)30342-9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 3.5] [Reference Citation Analysis]
219 Katulanda P, Dissanayake HA, Ranathunga I, Ratnasamy V, Wijewickrama PSA, Yogendranathan N, Gamage KKK, de Silva NL, Sumanatilleke M, Somasundaram NP, Matthews DR. Prevention and management of COVID-19 among patients with diabetes: an appraisal of the literature. Diabetologia 2020;63:1440-52. [PMID: 32405783 DOI: 10.1007/s00125-020-05164-x] [Cited by in Crossref: 55] [Cited by in F6Publishing: 48] [Article Influence: 27.5] [Reference Citation Analysis]
220 Pérez-Gómez A, Vitallé J, Gasca-Capote C, Gutierrez-Valencia A, Trujillo-Rodriguez M, Serna-Gallego A, Muñoz-Muela E, Jiménez-Leon MLR, Rafii-El-Idrissi Benhnia M, Rivas-Jeremias I, Sotomayor C, Roca-Oporto C, Espinosa N, Infante-Domínguez C, Crespo-Rivas JC, Fernández-Villar A, Pérez-González A, López-Cortés LF, Poveda E, Ruiz-Mateos E; Virgen del Rocío Hospital COVID-19 Working Team. Dendritic cell deficiencies persist seven months after SARS-CoV-2 infection. Cell Mol Immunol 2021. [PMID: 34290398 DOI: 10.1038/s41423-021-00728-2] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
221 Garg R, Bharangar S, Gupta S, Bhardwaj S. Post Covid-19 Infection Presenting as Rhino-Orbital Mycosis. Indian J Otolaryngol Head Neck Surg 2021;:1-8. [PMID: 34307112 DOI: 10.1007/s12070-021-02722-6] [Reference Citation Analysis]
222 Trougakos IP, Terpos E, Zirou C, Sklirou AD, Apostolakou F, Gumeni S, Charitaki I, Papanagnou ED, Bagratuni T, Liacos CI, Scorilas A, Korompoki E, Papassotiriou I, Kastritis E, Dimopoulos MA. Comparative kinetics of SARS-CoV-2 anti-spike protein RBD IgGs and neutralizing antibodies in convalescent and naïve recipients of the BNT162b2 mRNA vaccine versus COVID-19 patients. BMC Med 2021;19:208. [PMID: 34420521 DOI: 10.1186/s12916-021-02090-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
223 Kroemer M, Spehner L, Vettoretti L, Bouard A, Eberst G, Pili Floury S, Capellier G, Lepiller Q, Orillard E, Mansi L, Clairet AL, Westeel V, Limat S, Dubois M, Malinowski L, Bohard L, Borg C, Chirouze C, Bouiller K. COVID-19 patients display distinct SARS-CoV-2 specific T-cell responses according to disease severity. J Infect 2021;82:282-327. [PMID: 32853599 DOI: 10.1016/j.jinf.2020.08.036] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 6.0] [Reference Citation Analysis]
224 Mauvais-Jarvis F. Aging, Male Sex, Obesity, and Metabolic Inflammation Create the Perfect Storm for COVID-19. Diabetes 2020;69:1857-63. [PMID: 32669390 DOI: 10.2337/dbi19-0023] [Cited by in Crossref: 66] [Cited by in F6Publishing: 62] [Article Influence: 33.0] [Reference Citation Analysis]
225 Gadotti AC, de Castro Deus M, Telles JP, Wind R, Goes M, Garcia Charello Ossoski R, de Padua AM, de Noronha L, Moreno-Amaral A, Baena CP, Tuon FF. IFN-γ is an independent risk factor associated with mortality in patients with moderate and severe COVID-19 infection. Virus Res 2020;289:198171. [PMID: 32979474 DOI: 10.1016/j.virusres.2020.198171] [Cited by in Crossref: 19] [Cited by in F6Publishing: 23] [Article Influence: 9.5] [Reference Citation Analysis]
226 Pfister F, Vonbrunn E, Ries T, Jäck HM, Überla K, Lochnit G, Sheriff A, Herrmann M, Büttner-Herold M, Amann K, Daniel C. Complement Activation in Kidneys of Patients With COVID-19. Front Immunol 2020;11:594849. [PMID: 33584662 DOI: 10.3389/fimmu.2020.594849] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 10.0] [Reference Citation Analysis]
227 Konig MF, Powell M, Staedtke V, Bai RY, Thomas DL, Fischer N, Huq S, Khalafallah AM, Koenecke A, Xiong R, Mensh B, Papadopoulos N, Kinzler KW, Vogelstein B, Vogelstein JT, Athey S, Zhou S, Bettegowda C. Preventing cytokine storm syndrome in COVID-19 using α-1 adrenergic receptor antagonists. J Clin Invest 2020;130:3345-7. [PMID: 32352407 DOI: 10.1172/JCI139642] [Cited by in Crossref: 43] [Cited by in F6Publishing: 35] [Article Influence: 21.5] [Reference Citation Analysis]
228 Costa TJ, Potje SR, Fraga-Silva TFC, da Silva-Neto JA, Barros PR, Rodrigues D, Machado MR, Martins RB, Santos-Eichler RA, Benatti MN, de Sá KSG, Almado CEL, Castro ÍA, Pontelli MC, Serra L, Carneiro FS, Becari C, Louzada-Junior P, Oliveira RDR, Zamboni DS, Arruda E, Auxiliadora-Martins M, Giachini FRC, Bonato VLD, Zachara NE, Bomfim GF, Tostes RC. Mitochondrial DNA and TLR9 activation contribute to SARS-CoV-2-induced endothelial cell damage. Vascul Pharmacol 2021;142:106946. [PMID: 34838735 DOI: 10.1016/j.vph.2021.106946] [Reference Citation Analysis]
229 Hu S, Jiang S, Qi X, Bai R, Ye XY, Xie T. Races of small molecule clinical trials for the treatment of COVID-19: An up-to-date comprehensive review. Drug Dev Res 2021. [PMID: 34762760 DOI: 10.1002/ddr.21895] [Reference Citation Analysis]
230 Li Q, Zhang J, Ling Y, Li W, Zhang X, Lu H, Chen L. A simple algorithm helps early identification of SARS-CoV-2 infection patients with severe progression tendency. Infection 2020;48:577-84. [PMID: 32440918 DOI: 10.1007/s15010-020-01446-z] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 7.0] [Reference Citation Analysis]
231 Carnero Contentti E, Correa J. Immunosuppression during the COVID-19 pandemic in neuromyelitis optica spectrum disorders patients: A new challenge. Mult Scler Relat Disord 2020;41:102097. [PMID: 32278860 DOI: 10.1016/j.msard.2020.102097] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 8.0] [Reference Citation Analysis]
232 Sigalov AB. SARS-CoV-2 may affect the immune response via direct inhibition of T cell receptor: Mechanistic hypothesis and rationale. Biochimie 2021:S0300-9084(21)00259-5. [PMID: 34793886 DOI: 10.1016/j.biochi.2021.11.005] [Reference Citation Analysis]
233 Shi K, Liu Y, Zhang Q, Ran CP, Hou J, Zhang Y, Wang XB. Severe Type of COVID-19: Pathogenesis, Warning Indicators and Treatment. Chin J Integr Med 2022;28:3-11. [PMID: 34962616 DOI: 10.1007/s11655-021-3313-x] [Reference Citation Analysis]
234 Xiong L, Zang X, Feng G, Zhao F, Wang S, Zeng W, Yu K, Zhai Y. Clinical characteristics and peripheral immunocyte subsets alteration of 85 COVID-19 deaths. Aging (Albany NY) 2021;13:6289-97. [PMID: 33711813 DOI: 10.18632/aging.202819] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
235 Triggle CR, Bansal D, Ding H, Islam MM, Farag EABA, Hadi HA, Sultan AA. A Comprehensive Review of Viral Characteristics, Transmission, Pathophysiology, Immune Response, and Management of SARS-CoV-2 and COVID-19 as a Basis for Controlling the Pandemic. Front Immunol 2021;12:631139. [PMID: 33717166 DOI: 10.3389/fimmu.2021.631139] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 9.0] [Reference Citation Analysis]
236 Kyriazopoulou E, Huet T, Cavalli G, Gori A, Kyprianou M, Pickkers P, Eugen-Olsen J, Clerici M, Veas F, Chatellier G, Kaplanski G, Netea MG, Pontali E, Gattorno M, Cauchois R, Kooistra E, Kox M, Bandera A, Beaussier H, Mangioni D, Dagna L, van der Meer JWM, Giamarellos-Bourboulis EJ, Hayem G; International Collaborative Group for Anakinra in COVID-19. Effect of anakinra on mortality in patients with COVID-19: a systematic review and patient-level meta-analysis. Lancet Rheumatol 2021. [PMID: 34396156 DOI: 10.1016/S2665-9913(21)00216-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
237 Ullah I, Sohail A, Shah MUFA, Khurshid M, Diwan MN, Qadir A, Irfan M. Central Retinal Vein Occlusion in patients with COVID-19 infection: A systematic review. Ann Med Surg (Lond) 2021;71:102898. [PMID: 34659743 DOI: 10.1016/j.amsu.2021.102898] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
238 Kim N, Lee JM, Oh EJ, Jekarl DW, Lee DG, Im KI, Cho SG. Off-the-Shelf Partial HLA Matching SARS-CoV-2 Antigen Specific T Cell Therapy: A New Possibility for COVID-19 Treatment. Front Immunol 2021;12:751869. [PMID: 35003063 DOI: 10.3389/fimmu.2021.751869] [Reference Citation Analysis]
239 La Sala L, Gandini S, Bruno A, Allevi R, Gallazzi M, Senesi P, Palano MT, Meregalli P, Longhi E, Sommese C, Luzi L, Trabucchi E. SARS-CoV-2 Immunization Orchestrates the Amplification of IFNγ-Producing T Cell and NK Cell Persistence. Front Immunol 2022;13:798813. [DOI: 10.3389/fimmu.2022.798813] [Reference Citation Analysis]
240 Navarro KM, Clark KA, Hardt DJ, Reid CE, Lahm PW, Domitrovich JW, Butler CR, Balmes JR. Wildland firefighter exposure to smoke and COVID-19: A new risk on the fire line. Sci Total Environ 2021;760:144296. [PMID: 33341613 DOI: 10.1016/j.scitotenv.2020.144296] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
241 Foley CE, Mulvey C, Boylan M, Reidy N, Reidy P, Moynan D, Worrall A, Curley G, Boland K, de Barra E, Ryan JD. Liver injury, hypoalbuminaemia and severe SARS-CoV-2 infection. Gut 2021:gutjnl-2021-324570. [PMID: 34083385 DOI: 10.1136/gutjnl-2021-324570] [Reference Citation Analysis]
242 Qiao W, Lau HE, Xie H, Poon VK, Chan CC, Chu H, Yuan S, Yuen TT, Chik KK, Tsang JO, Chan CC, Cai J, Luo C, Yuen K, Cheung KM, Chan JF, Yeung KW. SARS-CoV-2 infection induces inflammatory bone loss in golden Syrian hamsters. Nat Commun 2022;13. [DOI: 10.1038/s41467-022-30195-w] [Reference Citation Analysis]
243 Gubernatorova EO, Gorshkova EA, Polinova AI, Drutskaya MS. IL-6: Relevance for immunopathology of SARS-CoV-2.Cytokine Growth Factor Rev. 2020;53:13-24. [PMID: 32475759 DOI: 10.1016/j.cytogfr.2020.05.009] [Cited by in Crossref: 89] [Cited by in F6Publishing: 80] [Article Influence: 44.5] [Reference Citation Analysis]
244 Coperchini F, Chiovato L, Croce L, Magri F, Rotondi M. The cytokine storm in COVID-19: An overview of the involvement of the chemokine/chemokine-receptor system. Cytokine Growth Factor Rev 2020;53:25-32. [PMID: 32446778 DOI: 10.1016/j.cytogfr.2020.05.003] [Cited by in Crossref: 486] [Cited by in F6Publishing: 421] [Article Influence: 243.0] [Reference Citation Analysis]
245 Mistry P, Balwani M, Barbouth D, Burrow TA, Ginns EI, Goker-Alpan O, Grabowski GA, Kartha RV, Kishnani PS, Lau H, Lee CU, Lopez G, Maegawa G, Packman S, Prada C, Rosenbloom B, Lal TR, Schiffmann R, Weinreb N, Sidransky E. Gaucher disease and SARS-CoV-2 infection: Emerging management challenges. Mol Genet Metab 2020;130:164-9. [PMID: 32471800 DOI: 10.1016/j.ymgme.2020.05.002] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 5.5] [Reference Citation Analysis]
246 Montali F, Palmieri G, Casali L, Pagliai L, Costi R. Rapidly fatal outcome of Covid-19 after successful emergency surgery during pandemic outbreak in Northern Italy. Int J Surg Case Rep. 2020;73:9-12. [PMID: 32622186 DOI: 10.1016/j.ijscr.2020.06.073] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
247 Venditto VJ, Haydar D, Abdel-Latif A, Gensel JC, Anstead MI, Pitts MG, Creameans J, Kopper TJ, Peng C, Feola DJ. Immunomodulatory Effects of Azithromycin Revisited: Potential Applications to COVID-19. Front Immunol 2021;12:574425. [PMID: 33643308 DOI: 10.3389/fimmu.2021.574425] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
248 Abu-El-Rub E, Khasawneh RR, Almahasneh F, Altaany Z, Bataineh N, Zegallai H, Sekaran S. Mesenchymal stem cells and COVID-19: What they do and what they can do. World J Stem Cells 2021; 13(9): 1318-1337 [PMID: 34630865 DOI: 10.4252/wjsc.v13.i9.1318] [Reference Citation Analysis]
249 Paland N, Pechkovsky A, Aswad M, Hamza H, Popov T, Shahar E, Louria-Hayon I. The Immunopathology of COVID-19 and the Cannabis Paradigm. Front Immunol 2021;12:631233. [PMID: 33643316 DOI: 10.3389/fimmu.2021.631233] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
250 Váncsa S, Hegyi PJ, Zádori N, Szakó L, Vörhendi N, Ocskay K, Földi M, Dembrovszky F, Dömötör ZR, Jánosi K, Rakonczay Z Jr, Hartmann P, Horváth T, Erőss B, Kiss S, Szakács Z, Németh D, Hegyi P, Pár G. Pre-existing Liver Diseases and On-Admission Liver-Related Laboratory Tests in COVID-19: A Prognostic Accuracy Meta-Analysis With Systematic Review. Front Med (Lausanne) 2020;7:572115. [PMID: 33282888 DOI: 10.3389/fmed.2020.572115] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
251 Sohn KM, Lee SG, Kim HJ, Cheon S, Jeong H, Lee J, Kim IS, Silwal P, Kim YJ, Paik S, Chung C, Park C, Kim YS, Jo EK. COVID-19 Patients Upregulate Toll-like Receptor 4-mediated Inflammatory Signaling That Mimics Bacterial Sepsis. J Korean Med Sci 2020;35:e343. [PMID: 32989935 DOI: 10.3346/jkms.2020.35.e343] [Cited by in Crossref: 43] [Cited by in F6Publishing: 44] [Article Influence: 21.5] [Reference Citation Analysis]
252 Saheb Sharif-Askari N, Saheb Sharif-Askari F, Mdkhana B, Al Heialy S, Alsafar HS, Hamoudi R, Hamid Q, Halwani R. Enhanced expression of immune checkpoint receptors during SARS-CoV-2 viral infection. Mol Ther Methods Clin Dev 2021;20:109-21. [PMID: 33200082 DOI: 10.1016/j.omtm.2020.11.002] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
253 Elkahloun AG, Saavedra JM. Candesartan could ameliorate the COVID-19 cytokine storm. Biomed Pharmacother 2020;131:110653. [PMID: 32942152 DOI: 10.1016/j.biopha.2020.110653] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
254 Maleki A, Look-Why S, Manhapra A, Foster CS. COVID-19 Recombinant mRNA Vaccines and Serious Ocular Inflammatory Side Effects: Real or Coincidence? J Ophthalmic Vis Res 2021;16:490-501. [PMID: 34394876 DOI: 10.18502/jovr.v16i3.9443] [Reference Citation Analysis]
255 Semeraro N, Colucci M. The Prothrombotic State Associated with SARS-CoV-2 Infection: Pathophysiological Aspects. Mediterr J Hematol Infect Dis 2021;13:e2021045. [PMID: 34276914 DOI: 10.4084/MJHID.2021.045] [Reference Citation Analysis]
256 Bordallo B, Bellas M, Cortez AF, Vieira M, Pinheiro M. Severe COVID-19: what have we learned with the immunopathogenesis? Adv Rheumatol 2020;60:50. [PMID: 32962761 DOI: 10.1186/s42358-020-00151-7] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 7.0] [Reference Citation Analysis]
257 Harkin TJ, Rurak KM, Martins J, Eber C, Szporn AH, Beasley MB. Delayed diagnosis of COVID-19 in a 34-year-old man with atypical presentation. Lancet Respir Med 2020;8:644-6. [PMID: 32437648 DOI: 10.1016/S2213-2600(20)30232-0] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
258 Hamdy SM, Abdel-Naseer M, Shehata HS, Shalaby NM, Hassan A, Elmazny A, Shaker E, Nada MAF, Ahmed SM, Hegazy MI, Mourad HS, Abdelalim A, Magdy R, Othman AS, Mekkawy DA, Kishk NA. Management Strategies of Patients with Neuromyelitis Optica Spectrum Disorder During the COVID-19 Pandemic Era. Ther Clin Risk Manag 2020;16:759-67. [PMID: 32884277 DOI: 10.2147/TCRM.S261753] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
259 Tan EH, Sena AG, Prats-Uribe A, You SC, Ahmed WU, Kostka K, Reich C, Duvall SL, Lynch KE, Matheny ME, Duarte-Salles T, Bertolin SF, Hripcsak G, Natarajan K, Falconer T, Spotnitz M, Ostropolets A, Blacketer C, Alshammari TM, Alghoul H, Alser O, Lane JCE, Dawoud DM, Shah K, Yang Y, Zhang L, Areia C, Golozar A, Relcade M, Casajust P, Jonnagaddala J, Subbian V, Vizcaya D, Lai LY, Nyberg F, Morales DR, Posada JD, Shah NH, Gong M, Vivekanantham A, Abend A, Minty EP, Suchard M, Rijnbeek P, Ryan PB, Prieto-Alhambra D. Characteristics, outcomes, and mortality amongst 133,589 patients with prevalent autoimmune diseases diagnosed with, and 48,418 hospitalised for COVID-19: a multinational distributed network cohort analysis. medRxiv 2020:2020. [PMID: 33269355 DOI: 10.1101/2020.11.24.20236802] [Reference Citation Analysis]
260 Jarineshin H, Saljoughi F, Estabraghnia Babaki H, Hassaniazad M, Kheirandish M, Ghanbarnejad A, Sohrabipour S. Clinical features of 50 cases of 2019 novel coronavirus in Bandar Abbas, Iran. Med J Islam Repub Iran 2021;35:7. [PMID: 33996658 DOI: 10.47176/mjiri.35.7] [Reference Citation Analysis]
261 Santos AF, Póvoa P, Paixão P, Mendonça A, Taborda-Barata L. Changes in Glycolytic Pathway in SARS-COV 2 Infection and Their Importance in Understanding the Severity of COVID-19. Front Chem 2021;9:685196. [PMID: 34568275 DOI: 10.3389/fchem.2021.685196] [Reference Citation Analysis]
262 Cihakova D, Streiff MB, Menez SP, Chen TK, Gilotra NA, Michos ED, Marr KA, Karaba AH, Robinson ML, Blair PW, Dioverti MV, Post WS, Cox AL, R Antar AA. High-value laboratory testing for hospitalized COVID-19 patients: a review. Future Virol 2021. [PMID: 34567235 DOI: 10.2217/fvl-2020-0316] [Reference Citation Analysis]
263 Zheng C, Kar I, Chen CK, Sau C, Woodson S, Serra A, Abboud H. Multiple Sclerosis Disease-Modifying Therapy and the COVID-19 Pandemic: Implications on the Risk of Infection and Future Vaccination. CNS Drugs 2020;34:879-96. [PMID: 32780300 DOI: 10.1007/s40263-020-00756-y] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 15.5] [Reference Citation Analysis]
264 Ma Z, Yang KY, Huang Y, Lui KO. Endothelial contribution to COVID-19: an update on mechanisms and therapeutic implications. J Mol Cell Cardiol 2021;164:69-82. [PMID: 34838588 DOI: 10.1016/j.yjmcc.2021.11.010] [Reference Citation Analysis]
265 Mamdouh Elsayed M, Zeid MM, Fayed AM, Elreweny EM, Zakaria NH, Baess AI. Does therapeutic plasma exchange have a role in resistant cytokine storm state of COVID-19 infection? Alexandria Journal of Medicine 2021;57:235-9. [DOI: 10.1080/20905068.2021.1987111] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
266 Ferrari F, Martins VM, Fuchs FD, Stein R. Renin-Angiotensin-Aldosterone System Inhibitors in COVID-19: A Review. Clinics (Sao Paulo) 2021;76:e2342. [PMID: 33852652 DOI: 10.6061/clinics/2021/e2342] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
267 Nagant C, Ponthieux F, Smet J, Dauby N, Doyen V, Besse-Hammer T, De Bels D, Maillart E, Corazza F. A score combining early detection of cytokines accurately predicts COVID-19 severity and intensive care unit transfer. Int J Infect Dis 2020;101:342-5. [PMID: 33039609 DOI: 10.1016/j.ijid.2020.10.003] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 7.0] [Reference Citation Analysis]
268 Lam G, Zhou Y, Wang JX, Tsui YP. Targeting mesenchymal stem cell therapy for severe pneumonia patients. World J Stem Cells 2021; 13(2): 139-154 [PMID: 33708343 DOI: 10.4252/wjsc.v13.i2.139] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
269 Aziz M, Fatima R, Lee-Smith W, Assaly R. The association of low serum albumin level with severe COVID-19: a systematic review and meta-analysis. Crit Care. 2020;24:255. [PMID: 32456658 DOI: 10.1186/s13054-020-02995-3] [Cited by in Crossref: 58] [Cited by in F6Publishing: 42] [Article Influence: 29.0] [Reference Citation Analysis]
270 Cava C, Bertoli G, Castiglioni I. A protein interaction map identifies existing drugs targeting SARS-CoV-2. BMC Pharmacol Toxicol 2020;21:65. [PMID: 32883368 DOI: 10.1186/s40360-020-00444-z] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
271 Walczak P, Janowski M. The COVID-19 Menace. Glob Chall 2021;:2100004. [PMID: 34178377 DOI: 10.1002/gch2.202100004] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
272 Yamada T, Wakabayashi M, Yamaji T, Chopra N, Mikami T, Miyashita H, Miyashita S. Value of leukocytosis and elevated C-reactive protein in predicting severe coronavirus 2019 (COVID-19): A systematic review and meta-analysis. Clin Chim Acta 2020;509:235-43. [PMID: 32533986 DOI: 10.1016/j.cca.2020.06.008] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 9.0] [Reference Citation Analysis]
273 [DOI: 10.1101/2020.07.02.20143271] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
274 Hanff TC, Mohareb AM, Giri J, Cohen JB, Chirinos JA. Thrombosis in COVID-19. Am J Hematol 2020;95:1578-89. [PMID: 32857878 DOI: 10.1002/ajh.25982] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 12.5] [Reference Citation Analysis]
275 Karimzadeh S, Dong V, Hassan OG, Raut A, Fouda A, Parrill A, Eaton K, Huy NT. Covid-19-induced coagulopathy and observed benefits with anticoagulation. Transfus Apher Sci 2020;59:102906. [PMID: 32778522 DOI: 10.1016/j.transci.2020.102906] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
276 Rha MS, Kim AR, Shin EC. SARS-CoV-2-Specific T Cell Responses in Patients with COVID-19 and Unexposed Individuals. Immune Netw 2021;21:e2. [PMID: 33728095 DOI: 10.4110/in.2021.21.e2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
277 Ielapi N, Licastro N, Provenzano M, Andreucci M, Franciscis S, Serra R. Cardiovascular disease as a biomarker for an increased risk of COVID-19 infection and related poor prognosis. Biomark Med 2020;14:713-6. [PMID: 32426991 DOI: 10.2217/bmm-2020-0201] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 7.5] [Reference Citation Analysis]
278 Bottaccioli AG, Lazzari D, Bottaccioli F. Promoting the Resilience of the Italian Population Against SARS-CoV-2. Front Psychiatry 2020;11:560017. [PMID: 33664678 DOI: 10.3389/fpsyt.2020.560017] [Reference Citation Analysis]
279 De La Flor JC, Valga F, Marschall A, Monzon T, Albarracín C, Ruiz E, Rodeles M. Targeting Cytokine Storm in COVID-19: A Role of Online Hemodiafiltration with Asymmetric Cellulose Triacetate in Maintenance Hemodialysis Patients-A Report of 10 Cases. Case Rep Nephrol 2021;2021:5575928. [PMID: 33747583 DOI: 10.1155/2021/5575928] [Reference Citation Analysis]
280 Lee PY, Day-Lewis M, Henderson LA, Friedman KG, Lo J, Roberts JE, Lo MS, Platt CD, Chou J, Hoyt KJ, Baker AL, Banzon TM, Chang MH, Cohen E, de Ferranti SD, Dionne A, Habiballah S, Halyabar O, Hausmann JS, Hazen MM, Janssen E, Meidan E, Nelson RW, Nguyen AA, Sundel RP, Dedeoglu F, Nigrovic PA, Newburger JW, Son MBF. Distinct clinical and immunological features of SARS-CoV-2-induced multisystem inflammatory syndrome in children. J Clin Invest 2020;130:5942-50. [PMID: 32701511 DOI: 10.1172/JCI141113] [Cited by in Crossref: 100] [Cited by in F6Publishing: 64] [Article Influence: 50.0] [Reference Citation Analysis]
281 Parimoo A, Biswas A, Baitha U, Gupta G, Pandey S, Ranjan P, Gupta V, Barman Roy D, Prakash B, Wig N. Dynamics of Inflammatory Markers in Predicting Mortality in COVID-19. Cureus 2021;13:e19080. [PMID: 34868744 DOI: 10.7759/cureus.19080] [Reference Citation Analysis]
282 Huang CG, Dutta A, Huang CT, Chang PY, Hsiao MJ, Hsieh YC, Lin SM, Shih SR, Tsao KC, Yang CT. Relative COVID-19 Viral Persistence and Antibody Kinetics. Pathogens 2021;10:752. [PMID: 34199240 DOI: 10.3390/pathogens10060752] [Reference Citation Analysis]
283 Addeo A, Friedlaender A. Cancer and COVID-19: Unmasking their ties. Cancer Treat Rev 2020;88:102041. [PMID: 32516704 DOI: 10.1016/j.ctrv.2020.102041] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 11.5] [Reference Citation Analysis]
284 Vadasz Z, Brenner B, Toubi E. Immune-Mediated Coagulopathy in COVID-19 Infection. Semin Thromb Hemost 2020;46:838-40. [PMID: 32877959 DOI: 10.1055/s-0040-1714272] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
285 Cutler T, Scales D, Levine W, Schluger N, O'Donnell M. A Novel Viral Epidemic Collides with an Ancient Scourge: COVID-19 Associated with Tuberculosis. Am J Respir Crit Care Med 2020;202:748-9. [PMID: 32609542 DOI: 10.1164/rccm.202003-0828IM] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
286 Al-Bahrani SY, Al-Shammari AS, Al-Otaibi MJ, Ahmed ZR. Outcome of early short-course corticosteroids in hospitalized patients with coronavirus disease-2019 (COVID-19): A report from a Saudi Arabian hospital. J Family Community Med 2021;28:125-8. [PMID: 34194277 DOI: 10.4103/jfcm.jfcm_69_21] [Reference Citation Analysis]
287 Swenson KE, Swenson ER. Pathophysiology of Acute Respiratory Distress Syndrome and COVID-19 Lung Injury. Crit Care Clin 2021;37:749-76. [PMID: 34548132 DOI: 10.1016/j.ccc.2021.05.003] [Reference Citation Analysis]
288 Radbel J, Narayanan N, Bhatt PJ. Use of Tocilizumab for COVID-19-Induced Cytokine Release Syndrome: A Cautionary Case Report. Chest 2020;158:e15-9. [PMID: 32343968 DOI: 10.1016/j.chest.2020.04.024] [Cited by in Crossref: 95] [Cited by in F6Publishing: 88] [Article Influence: 47.5] [Reference Citation Analysis]
289 Filgueira TO, Castoldi A, Santos LER, de Amorim GJ, de Sousa Fernandes MS, Anastácio WLDN, Campos EZ, Santos TM, Souto FO. The Relevance of a Physical Active Lifestyle and Physical Fitness on Immune Defense: Mitigating Disease Burden, With Focus on COVID-19 Consequences. Front Immunol 2021;12:587146. [PMID: 33613573 DOI: 10.3389/fimmu.2021.587146] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 13.0] [Reference Citation Analysis]
290 Zhang Y, Shi F, Wang Y, Meng Y, Zhang Q, Wang K, Zeng P, Diao H. Comparative Analysis of Long Non-Coding RNA Expression and Immune Response in Mild and Severe COVID-19. Front Mol Biosci 2022;9:835590. [DOI: 10.3389/fmolb.2022.835590] [Reference Citation Analysis]
291 Chandarana H, Pisuchpen N, Krieger R, Dane B, Mikheev A, Feng Y, Kambadakone A, Rusinek H. Association of body composition parameters measured on CT with risk of hospitalization in patients with Covid-19. Eur J Radiol 2021;145:110031. [PMID: 34801878 DOI: 10.1016/j.ejrad.2021.110031] [Reference Citation Analysis]
292 Hasan ZT, Atrakji DMQYMAA, Mehuaiden DAK. The Effect of Melatonin on Thrombosis, Sepsis and Mortality Rate in COVID-19 Patients. Int J Infect Dis 2022;114:79-84. [PMID: 34653660 DOI: 10.1016/j.ijid.2021.10.012] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
293 Picchianti Diamanti A, Rosado MM, Pioli C, Sesti G, Laganà B. Cytokine Release Syndrome in COVID-19 Patients, A New Scenario for an Old Concern: The Fragile Balance between Infections and Autoimmunity. Int J Mol Sci 2020;21:E3330. [PMID: 32397174 DOI: 10.3390/ijms21093330] [Cited by in Crossref: 45] [Cited by in F6Publishing: 44] [Article Influence: 22.5] [Reference Citation Analysis]
294 Yoo JS, Sasaki M, Cho SX, Kasuga Y, Zhu B, Ouda R, Orba Y, de Figueiredo P, Sawa H, Kobayashi KS. SARS-CoV-2 inhibits induction of the MHC class I pathway by targeting the STAT1-IRF1-NLRC5 axis. Nat Commun 2021;12:6602. [PMID: 34782627 DOI: 10.1038/s41467-021-26910-8] [Reference Citation Analysis]
295 Torres Acosta MA, Singer BD. Pathogenesis of COVID-19-induced ARDS: implications for an ageing population. Eur Respir J 2020;56:2002049. [PMID: 32747391 DOI: 10.1183/13993003.02049-2020] [Cited by in Crossref: 41] [Cited by in F6Publishing: 40] [Article Influence: 20.5] [Reference Citation Analysis]
296 Shinde T, Hansbro PM, Sohal SS, Dingle P, Eri R, Stanley R. Microbiota Modulating Nutritional Approaches to Countering the Effects of Viral Respiratory Infections Including SARS-CoV-2 through Promoting Metabolic and Immune Fitness with Probiotics and Plant Bioactives. Microorganisms 2020;8:E921. [PMID: 32570850 DOI: 10.3390/microorganisms8060921] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 11.0] [Reference Citation Analysis]
297 Torres T, Puig L. Managing Cutaneous Immune-Mediated Diseases During the COVID-19 Pandemic. Am J Clin Dermatol 2020;21:307-11. [PMID: 32277351 DOI: 10.1007/s40257-020-00514-2] [Cited by in Crossref: 34] [Cited by in F6Publishing: 35] [Article Influence: 17.0] [Reference Citation Analysis]
298 Paliogiannis P, Mangoni AA, Dettori P, Nasrallah GK, Pintus G, Zinellu A. D-Dimer Concentrations and COVID-19 Severity: A Systematic Review and Meta-Analysis. Front Public Health 2020;8:432. [PMID: 32903841 DOI: 10.3389/fpubh.2020.00432] [Cited by in Crossref: 22] [Cited by in F6Publishing: 27] [Article Influence: 11.0] [Reference Citation Analysis]
299 Bai B, Xu Z, Hu Y, Qu M, Cheng J, Luo S, Yao Z, Gao H, Ma Y, Gao R, Hou J, Xin S, Mao P. Patient hematology during hospitalization for viral pneumonia caused by SARS-CoV-2 and non-SARS-CoV-2 agents: a retrospective study. Eur J Med Res 2021;26:45. [PMID: 33990223 DOI: 10.1186/s40001-021-00515-9] [Reference Citation Analysis]
300 Candel FJ, Viñuela-Prieto JM, González Del Castillo J, Barreiro García P, Fragiel Saavedra M, Hernández Píriz A, Jiménez Virumbrales D, Canora Lebrato J, García de Casasola G, Gil Prieto R, San-Román Montero J, Ortega Anselmi J, Barba Martín R, Prados Roa F, Marco Martínez J, Zapatero Gaviria A. Utility of lateral flow tests in SARS-CoV-2 infection monitorization. Rev Esp Quimioter 2020;33:258-66. [PMID: 32492991 DOI: 10.37201/req/052.2020] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 7.5] [Reference Citation Analysis]
301 Zhou X, Wang G, Chen L, Meng F, Huang L, Huang L, Wang N, Li T, Cao Y, Zhou J. Clinical characteristics of hematological patients concomitant with COVID-19. Cancer Sci 2020;111:3379-85. [PMID: 32619034 DOI: 10.1111/cas.14544] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
302 Valdez-Cruz NA, García-Hernández E, Espitia C, Cobos-Marín L, Altamirano C, Bando-Campos CG, Cofas-Vargas LF, Coronado-Aceves EW, González-Hernández RA, Hernández-Peralta P, Juárez-López D, Ortega-Portilla PA, Restrepo-Pineda S, Zelada-Cordero P, Trujillo-Roldán MA. Integrative overview of antibodies against SARS-CoV-2 and their possible applications in COVID-19 prophylaxis and treatment. Microb Cell Fact 2021;20:88. [PMID: 33888152 DOI: 10.1186/s12934-021-01576-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
303 de la Rica R, Borges M, Aranda M, Del Castillo A, Socias A, Payeras A, Rialp G, Socias L, Masmiquel L, Gonzalez-Freire M. Low Albumin Levels Are Associated with Poorer Outcomes in a Case Series of COVID-19 Patients in Spain: A Retrospective Cohort Study. Microorganisms. 2020;8. [PMID: 32722020 DOI: 10.3390/microorganisms8081106] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 12.5] [Reference Citation Analysis]
304 Hernandez-Cedeño M, Venegas-Rodriguez R, Peña-Ruiz R, Bequet-Romero M, Santana-Sanchez R, Penton-Arias E, Martinez-Donato G, Guillén-Nieto G, Dominguez-Horta MDC. CIGB-258, a peptide derived from human heat-shock protein 60, decreases hyperinflammation in COVID-19 patients. Cell Stress Chaperones 2021;26:515-25. [PMID: 33629254 DOI: 10.1007/s12192-021-01197-2] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
305 Sherwood KR, Nicholl DDM, Fenninger F, Wu V, Wong P, Benedicto V, Cina DP, Wang M, Pobran TD, De Marco ML, Márquez AC, Jassem AN, Sekirov I, Morshed MG, Bardi M, Sekhon M, Keown P, Kadatz M, Lan JH. Comprehensive Immune Profiling of a Kidney Transplant Recipient With Peri-Operative SARS-CoV-2 Infection: A Case Report. Front Immunol 2021;12:753558. [PMID: 34630432 DOI: 10.3389/fimmu.2021.753558] [Reference Citation Analysis]
306 Wang H, Yan D, Li Y, Gong Y, Mai Y, Li B, Zhu X, Wan X, Xie L, Jiang H, Zhang M, Sun M, Yao Y, Zhu Y. Clinical and antibody characteristics reveal diverse signatures of severe and non-severe SARS-CoV-2 patients. Infect Dis Poverty 2022;11:15. [PMID: 35109926 DOI: 10.1186/s40249-022-00940-w] [Reference Citation Analysis]
307 Shi W, Lv J, Lin L. Coagulopathy in COVID-19: Focus on vascular thrombotic events. J Mol Cell Cardiol 2020;146:32-40. [PMID: 32681845 DOI: 10.1016/j.yjmcc.2020.07.003] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 10.0] [Reference Citation Analysis]
308 Cory TJ, Emmons RS, Yarbro JR, Davis KL, Pence BD. Metformin Suppresses Monocyte Immunometabolic Activation by SARS-CoV-2 Spike Protein Subunit 1. Front Immunol 2021;12:733921. [PMID: 34858397 DOI: 10.3389/fimmu.2021.733921] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
309 Wood TR, Jóhannsson GF. Metabolic health and lifestyle medicine should be a cornerstone of future pandemic preparedness. Lifestyle Medicine 2020;1. [DOI: 10.1002/lim2.2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
310 Hasan A, Al-Ozairi E, Al-Baqsumi Z, Ahmad R, Al-Mulla F. Cellular and Humoral Immune Responses in Covid-19 and Immunotherapeutic Approaches. Immunotargets Ther 2021;10:63-85. [PMID: 33728277 DOI: 10.2147/ITT.S280706] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
311 Majolo F, Silva GLD, Vieira L, Anli C, Timmers LFSM, Laufer S, Goettert MI. Neuropsychiatric Disorders and COVID-19: What We Know So Far. Pharmaceuticals (Basel) 2021;14:933. [PMID: 34577633 DOI: 10.3390/ph14090933] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
312 Guo Y, Li T, Xia X, Su B, Li H, Feng Y, Han J, Wang X, Jia L, Bao Z, Li J, Liu Y, Li L. Different Profiles of Antibodies and Cytokines Were Found Between Severe and Moderate COVID-19 Patients. Front Immunol 2021;12:723585. [PMID: 34489974 DOI: 10.3389/fimmu.2021.723585] [Reference Citation Analysis]
313 Cherneva Z, Cherneva R. COVID-19 Associated Coagulopathy and Implications for its Treatment. Acta Medica Bulgarica 2020;47:48-52. [DOI: 10.2478/amb-2020-0035] [Reference Citation Analysis]
314 Kong M, Zhang H, Cao X, Mao X, Lu Z. Higher level of neutrophil-to-lymphocyte is associated with severe COVID-19. Epidemiol Infect 2020;148:e139. [PMID: 32641174 DOI: 10.1017/S0950268820001557] [Cited by in Crossref: 50] [Cited by in F6Publishing: 27] [Article Influence: 25.0] [Reference Citation Analysis]
315 Wu B, Ramaiah A, Garcia G, Gwack Y, Arumugaswami V, Srikanth S. ORAI1 establishes resistance to SARS-CoV-2 infection by regulating tonic type I interferon signaling. bioRxiv 2021:2021. [PMID: 33972946 DOI: 10.1101/2021.05.04.442548] [Reference Citation Analysis]
316 Durhan G, Ardalı Düzgün S, Başaran Demirkazık F, Irmak İ, İdilman İ, Gülsün Akpınar M, Akpınar E, Öcal S, Telli G, Topeli A, Arıyürek OM. Visual and software-based quantitative chest CT assessment of COVID-19: correlation with clinical findings. Diagn Interv Radiol 2020;26:557-64. [PMID: 32876569 DOI: 10.5152/dir.2020.20407] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
317 Mackman N, Antoniak S, Wolberg AS, Kasthuri R, Key NS. Coagulation Abnormalities and Thrombosis in Patients Infected With SARS-CoV-2 and Other Pandemic Viruses. Arterioscler Thromb Vasc Biol 2020;40:2033-44. [PMID: 32657623 DOI: 10.1161/ATVBAHA.120.314514] [Cited by in Crossref: 47] [Cited by in F6Publishing: 34] [Article Influence: 23.5] [Reference Citation Analysis]
318 Goldstein EJC, Tillotson G, Redell M. Antimicrobial Management of Respiratory Infections in Severe Acute Respiratory Syndrome Coronavirus 2 Patients: Clinical and Antimicrobial Stewardship Programs Conundrums. Open Forum Infect Dis 2020;7:ofaa517. [PMID: 33263070 DOI: 10.1093/ofid/ofaa517] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
319 Mutinelli-Szymanski P, Hude I, Merle E, Lombardi Y, Seris P, Abtahi M, Azeroual L, Bourgain C, Ensergueix G, Katerinis I, Kolko A, Kolta A, Maheas C, Mehrbanian S, Morel P, Ossman R, de Préneuf H, Roux A, Saltiel C, Vendé F, Verhoeven AS, Viron B, Laplanche S, Le Monnier A, Ridel C, Ureña-Torres P, Touzot M. Neutrophil:lymphocyte ratio predicts short-term outcome of COVID-19 in haemodialysis patients. Clin Kidney J 2021;14:124-31. [PMID: 33558835 DOI: 10.1093/ckj/sfaa194] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
320 Zhou X, Hou H, Yang L, Ding G, Wei T, Li C, Heng Y, Liu R, Ma M, Hu Z, Huang L, Xu X, Hu Q, Zhao Y, Xing W, Zhao Z. Arbidol is associated with increased in-hospital mortality among 109 patients with severe COVID-19: A multicenter, retrospective study. J Glob Health 2021;11:05017. [PMID: 34326998 DOI: 10.7189/jogh.11.05017] [Reference Citation Analysis]
321 Kong Q, Wu Y, Gu Y, Lv Q, Qi F, Gong S, Chen X. Analysis of the molecular mechanism of Pudilan (PDL) treatment for COVID-19 by network pharmacology tools. Biomed Pharmacother 2020;128:110316. [PMID: 32505821 DOI: 10.1016/j.biopha.2020.110316] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 6.5] [Reference Citation Analysis]
322 Tian Y, Carpp LN, Miller HER, Zager M, Newell EW, Gottardo R. Single-cell immunology of SARS-CoV-2 infection. Nat Biotechnol 2021. [PMID: 34931002 DOI: 10.1038/s41587-021-01131-y] [Reference Citation Analysis]
323 Jiang N, Li Z, Yang B, Jin M, Sun Y, He Y, Liu Y, Wang Y, Si D, Ma P, Zhang J, Liu T, Yu Q. Peripheral Inflammatory Cytokines and Lymphocyte Subset Features of Deceased COVID-19 Patients. Biomed Res Int 2021;2021:9101082. [PMID: 33542929 DOI: 10.1155/2021/9101082] [Reference Citation Analysis]
324 Huang A, Bange E, Han N, Wileyto EP, Kim J, Gouma S, Robinson J, Greenplate A, Porterfield F, Owoyemi O, Naik K, Zheng C, Galantino M, Weisman A, Ittner C, Kugler E, Baxter A, Weirick M, McAllister C, Babady NE, Kumar A, Widman A, Dewolf S, Boutemine S, Roberts C, Budzik K, Tollett S, Wright C, Perloff T, Sun L, Mathew D, Giles J, Oldridge D, Wu J, Alanio C, Adamski S, Vella L, Kerr S, Cohen J, Oyer R, Massa R, Maillard I, Maxwell K, Maslak P, Vonderheide R, Wolchok JD, Hensley S, Wherry E, Meyer N, DeMichele A, Vardhana S, Mamtani R, Oniyide O, Agyekum R, Dunn T, Jones T, Giannini H, Garfall A, Reilly J. CD8 T cells compensate for impaired humoral immunity in COVID-19 patients with hematologic cancer. Res Sq 2021:rs. [PMID: 33564756 DOI: 10.21203/rs.3.rs-162289/v1] [Cited by in Crossref: 9] [Article Influence: 9.0] [Reference Citation Analysis]
325 Khurana P, Varshney R, Gupta A. A Network-Biology led Computational Drug repurposing Strategy to prioritize therapeutic options for COVID-19. Heliyon 2022. [DOI: 10.1016/j.heliyon.2022.e09387] [Reference Citation Analysis]
326 Gąsecka A, Borovac JA, Guerreiro RA, Giustozzi M, Parker W, Caldeira D, Chiva-Blanch G. Thrombotic Complications in Patients with COVID-19: Pathophysiological Mechanisms, Diagnosis, and Treatment. Cardiovasc Drugs Ther 2021;35:215-29. [PMID: 33074525 DOI: 10.1007/s10557-020-07084-9] [Cited by in Crossref: 33] [Cited by in F6Publishing: 26] [Article Influence: 16.5] [Reference Citation Analysis]
327 Otifi HM, Adiga BK. Endothelial Dysfunction in Covid-19. The American Journal of the Medical Sciences 2022. [DOI: 10.1016/j.amjms.2021.12.010] [Reference Citation Analysis]
328 Huang H, Chen S, Li H, Zhou XL, Dai Y, Wu J, Zhang J, Shao L, Yan R, Wang M, Wang J, Tu Y, Ge M. The association between markers of liver injury and clinical outcomes in patients with COVID-19 in Wuhan. Aliment Pharmacol Ther. 2020;52:1051-1059. [PMID: 32697870 DOI: 10.1111/apt.15962] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
329 Chandra A, Johri A. A Peek into Pandora’s Box: COVID-19 and Neurodegeneration. Brain Sciences 2022;12:190. [DOI: 10.3390/brainsci12020190] [Reference Citation Analysis]
330 Martha JW, Wibowo A, Pranata R. Prognostic value of elevated lactate dehydrogenase in patients with COVID-19: a systematic review and meta-analysis. Postgrad Med J 2021:postgradmedj-2020-139542. [PMID: 33452143 DOI: 10.1136/postgradmedj-2020-139542] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
331 Dravid A, Kashiva R, Khan Z, Memon D, Kodre A, Potdar P, Mane M, Borse R, Pawar V, Patil D, Banerjee D, Bhoite K, Pharande R, Kalyani S, Raut P, Bapte M, Mehta A, Reddy MS, Bhayani K, Laxmi SS, Vishnu PD, Srivastava S, Khandelwal S, More S, Shinde R, Pawar M, Harshe A, Kadam S, Mahajan U, Joshi G, Mane D. Combination therapy of Tocilizumab and steroid for management of COVID-19 associated cytokine release syndrome: A single center experience from Pune, Western India. Medicine (Baltimore) 2021;100:e26705. [PMID: 34398044 DOI: 10.1097/MD.0000000000026705] [Reference Citation Analysis]
332 Shahjouei S, Naderi S, Li J, Khan A, Chaudhary D, Farahmand G, Male S, Griessenauer C, Sabra M, Mondello S, Cernigliaro A, Khodadadi F, Dev A, Goyal N, Ranji-Burachaloo S, Olulana O, Avula V, Ebrahimzadeh SA, Alizada O, Hancı MM, Ghorbani A, Vaghefi Far A, Ranta A, Punter M, Ramezani M, Ostadrahimi N, Tsivgoulis G, Fragkou PC, Nowrouzi-Sohrabi P, Karofylakis E, Tsiodras S, Neshin Aghayari Sheikh S, Saberi A, Niemelä M, Rezai Jahromi B, Mowla A, Mashayekhi M, Bavarsad Shahripour R, Sajedi SA, Ghorbani M, Kia A, Rahimian N, Abedi V, Zand R. Risk of stroke in hospitalized SARS-CoV-2 infected patients: A multinational study. EBioMedicine 2020;59:102939. [PMID: 32818804 DOI: 10.1016/j.ebiom.2020.102939] [Cited by in Crossref: 38] [Cited by in F6Publishing: 36] [Article Influence: 19.0] [Reference Citation Analysis]
333 Wang J, Lu Z, Jin M, Wang Y, Tian K, Xiao J, Cai Y, Wang Y, Zhang X, Chen T, Yao Z, Yang C, Deng R, Zhong Q, Deng X, Chen X, Yang XP, Wei G, Wang Z, Tian J, Chen XP. Clinical characteristics and risk factors of COVID-19 patients with chronic hepatitis B: a multi-center retrospective cohort study. Front Med 2021. [PMID: 34387851 DOI: 10.1007/s11684-021-0854-5] [Reference Citation Analysis]
334 An PJ, Zhu YZ, Yang LP. Biochemical indicators of coronavirus disease 2019 exacerbation and the clinical implications. Pharmacol Res 2020;159:104946. [PMID: 32450346 DOI: 10.1016/j.phrs.2020.104946] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 7.5] [Reference Citation Analysis]
335 Quarleri J, Delpino MV. SARS-CoV-2 interacts with renin-angiotensin system: impact on the central nervous system in elderly patients. Geroscience 2022. [PMID: 35157210 DOI: 10.1007/s11357-022-00528-0] [Reference Citation Analysis]
336 Rossi D, Shadman M, Condoluci A, Brown JR, Byrd JC, Gaidano G, Hallek M, Hillmen P, Mato A, Montserrat E, Ghia P. How We Manage Patients With Chronic Lymphocytic Leukemia During the SARS-CoV-2 Pandemic. Hemasphere 2020;4:e432. [PMID: 32803132 DOI: 10.1097/HS9.0000000000000432] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 5.5] [Reference Citation Analysis]
337 DiPiazza AT, Graham BS, Ruckwardt TJ. T cell immunity to SARS-CoV-2 following natural infection and vaccination. Biochem Biophys Res Commun 2021;538:211-7. [PMID: 33190827 DOI: 10.1016/j.bbrc.2020.10.060] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
338 Ruscitti P, Conforti A, Cipriani P, Giacomelli R, Tasso M, Costa L, Caso F. Pathogenic implications, incidence, and outcomes of COVID-19 in autoimmune inflammatory joint diseases and autoinflammatory disorders. Adv Rheumatol 2021;61:45. [PMID: 34238376 DOI: 10.1186/s42358-021-00204-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
339 Adrover-Jaume C, Alba-Patiño A, Clemente A, Santopolo G, Vaquer A, Russell SM, Barón E, González Del Campo MDM, Ferrer JM, Berman-Riu M, García-Gasalla M, Aranda M, Borges M, de la Rica R. Paper biosensors for detecting elevated IL-6 levels in blood and respiratory samples from COVID-19 patients. Sens Actuators B Chem 2021;330:129333. [PMID: 33519090 DOI: 10.1016/j.snb.2020.129333] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
340 Rydyznski Moderbacher C, Ramirez SI, Dan JM, Grifoni A, Hastie KM, Weiskopf D, Belanger S, Abbott RK, Kim C, Choi J, Kato Y, Crotty EG, Kim C, Rawlings SA, Mateus J, Tse LPV, Frazier A, Baric R, Peters B, Greenbaum J, Ollmann Saphire E, Smith DM, Sette A, Crotty S. Antigen-Specific Adaptive Immunity to SARS-CoV-2 in Acute COVID-19 and Associations with Age and Disease Severity. Cell 2020;183:996-1012.e19. [PMID: 33010815 DOI: 10.1016/j.cell.2020.09.038] [Cited by in Crossref: 358] [Cited by in F6Publishing: 361] [Article Influence: 179.0] [Reference Citation Analysis]
341 Premeaux TA, Yeung ST, Bukhari Z, Bowler S, Alpan O, Gupta R, Ndhlovu LC. Emerging Insights on Caspases in COVID-19 Pathogenesis, Sequelae, and Directed Therapies. Front Immunol 2022;13:842740. [DOI: 10.3389/fimmu.2022.842740] [Reference Citation Analysis]
342 Söderberg-Nauclér C. Does reactivation of cytomegalovirus contribute to severe COVID-19 disease? Immun Ageing 2021;18:12. [PMID: 33712035 DOI: 10.1186/s12979-021-00218-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
343 Asghar MS, Ahmed I, Alvi H, Iqbal S, Khan I, Alvi RS, Saeed Z, Irfan S, Akhtar M, Fatima I. Correlation of refractory hypoxemia with biochemical markers and clinical outcomes of COVID-19 patients in a developing country: A retrospective observational study: Running head: Predictors of hypoxemia in COVID-19. J Community Hosp Intern Med Perspect 2021;11:9-16. [PMID: 33552406 DOI: 10.1080/20009666.2020.1835214] [Reference Citation Analysis]
344 Triana S, Metz-Zumaran C, Ramirez C, Kee C, Doldan P, Shahraz M, Schraivogel D, Gschwind AR, Sharma AK, Steinmetz LM, Herrmann C, Alexandrov T, Boulant S, Stanifer ML. Single-cell analyses reveal SARS-CoV-2 interference with intrinsic immune response in the human gut. Mol Syst Biol 2021;17:e10232. [PMID: 33904651 DOI: 10.15252/msb.202110232] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 10.0] [Reference Citation Analysis]
345 Carlisle JW, Jansen CS, Bilen MA, Kissick H. Considerations for cancer immunotherapy biomarker research during COVID-19. Endocr Relat Cancer 2020;27:C1-8. [PMID: 32508308 DOI: 10.1530/ERC-20-0187] [Reference Citation Analysis]
346 Spoerl S, Kremer AN, Aigner M, Eisenhauer N, Koch P, Meretuk L, Löffler P, Tenbusch M, Maier C, Überla K, Heinzerling L, Frey B, Lutzny-Geier G, Winkler TH, Krönke G, Vetter M, Bruns H, Neurath MF, Mackensen A, Kremer AE, Völkl S. Upregulation of CCR4 in activated CD8+ T cells indicates enhanced lung homing in patients with severe acute SARS-CoV-2 infection. Eur J Immunol 2021;51:1436-48. [PMID: 33784417 DOI: 10.1002/eji.202049135] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
347 Al-nimer MS, Merza TA, Mohammed‎ ‎YMY, Mohammed ‎A. Blood Cells Indices are Determinants of the COVID-19 Outcome: A Cross-Sectional Study from ‎Kurdistan Region-Iraq. ELECTRON J GEN MED 2021;18:em304. [DOI: 10.29333/ejgm/11013] [Reference Citation Analysis]
348 Tian W, Zhang N, Jin R, Feng Y, Wang S, Gao S, Gao R, Wu G, Tian D, Tan W, Chen Y, Gao GF, Wong CCL. Immune suppression in the early stage of COVID-19 disease. Nat Commun 2020;11:5859. [PMID: 33203833 DOI: 10.1038/s41467-020-19706-9] [Cited by in Crossref: 35] [Cited by in F6Publishing: 32] [Article Influence: 17.5] [Reference Citation Analysis]
349 Ferreira AO, Polonini HC, Dijkers ECF. Postulated Adjuvant Therapeutic Strategies for COVID-19. J Pers Med 2020;10:E80. [PMID: 32764275 DOI: 10.3390/jpm10030080] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 6.5] [Reference Citation Analysis]
350 Anand G, Perry AM, Cummings CL, Raymond E, Clemens RA, Steed AL. Surface Proteins of SARS-CoV-2 Drive Airway Epithelial Cells to Induce IFN-Dependent Inflammation. J Immunol 2021:ji2001407. [PMID: 34078711 DOI: 10.4049/jimmunol.2001407] [Reference Citation Analysis]
351 Vabret N, Britton GJ, Gruber C, Hegde S, Kim J, Kuksin M, Levantovsky R, Malle L, Moreira A, Park MD, Pia L, Risson E, Saffern M, Salomé B, Esai Selvan M, Spindler MP, Tan J, van der Heide V, Gregory JK, Alexandropoulos K, Bhardwaj N, Brown BD, Greenbaum B, Gümüş ZH, Homann D, Horowitz A, Kamphorst AO, Curotto de Lafaille MA, Mehandru S, Merad M, Samstein RM; Sinai Immunology Review Project. Immunology of COVID-19: Current State of the Science. Immunity 2020;52:910-41. [PMID: 32505227 DOI: 10.1016/j.immuni.2020.05.002] [Cited by in Crossref: 731] [Cited by in F6Publishing: 635] [Article Influence: 365.5] [Reference Citation Analysis]
352 Kim SY, Yoo DM, Min C, Kim JH, Choi HG. Evaluation of Mortality and Morbidity According to Initial Symptoms in COVID-19 Patients Using Clinical Epidemiologic Data from the Korea Centers for Disease Control & Prevention. Medicina (Kaunas) 2021;57:688. [PMID: 34356969 DOI: 10.3390/medicina57070688] [Reference Citation Analysis]
353 Zhang N, Zhang H, Tang Y, Zhang H, Ma A, Xu F, Sun Y, Jiang L, Shan F. Risk factors for illness severity in patients with COVID-19 pneumonia: a prospective cohort study. Int J Med Sci 2021;18:921-8. [PMID: 33456349 DOI: 10.7150/ijms.51205] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
354 Coppock D, Zurlo CE, Meloni JM, Goss SL, Zurlo JJ, Pettengill MA. Interferon Gamma Release Assay Mitogen Responses in COVID-19. Infect Dis Clin Pract 2022;30. [DOI: 10.1097/ipc.0000000000001085] [Reference Citation Analysis]
355 Tomo S, Banerjee M, Sharma P, Garg M. Does dehydroepiandrosterone sulfate have a role in COVID-19 prognosis and treatment? Endocr Regul 2021;55:174-81. [PMID: 34523302 DOI: 10.2478/enr-2021-0019] [Reference Citation Analysis]
356 Zheng HY, He XY, Li W, Song TZ, Han JB, Yang X, Liu FL, Luo RH, Tian RR, Feng XL, Ma YH, Liu C, Li MH, Zheng YT. Pro-inflammatory microenvironment and systemic accumulation of CXCR3+ cell exacerbate lung pathology of old rhesus macaques infected with SARS-CoV-2. Signal Transduct Target Ther 2021;6:328. [PMID: 34471088 DOI: 10.1038/s41392-021-00734-w] [Reference Citation Analysis]
357 Huang H, Hu PF, Sun LL, Guo YB, Wang Q, Liu ZM, Yin JZ, Shi PM, Yuan ZL, Xie WF. Treatment of patients with Covid-19 with a high dose of ulinastatin. Exp Ther Med 2022;23:121. [PMID: 34970344 DOI: 10.3892/etm.2021.11044] [Reference Citation Analysis]
358 Terracciano D, Buonerba C, Scafuri L, De Berardinis P, Calin GA, Ferrajoli A, Fabbri M, Cimmino A. Perspective: Cancer Patient Management Challenges During the COVID-19 Pandemic. Front Oncol 2020;10:1556. [PMID: 32984015 DOI: 10.3389/fonc.2020.01556] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
359 Liu S, Luo H, Wang Y, Cuevas LE, Wang D, Ju S, Yang Y. Clinical characteristics and risk factors of patients with severe COVID-19 in Jiangsu province, China: a retrospective multicentre cohort study. BMC Infect Dis 2020;20:584. [PMID: 32762665 DOI: 10.1186/s12879-020-05314-x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 21] [Article Influence: 7.5] [Reference Citation Analysis]
360 Tan Q, He L, Meng X, Wang W, Pan H, Yin W, Zhu T, Huang X, Shan H. Macrophage biomimetic nanocarriers for anti-inflammation and targeted antiviral treatment in COVID-19. J Nanobiotechnology 2021;19:173. [PMID: 34112203 DOI: 10.1186/s12951-021-00926-0] [Reference Citation Analysis]
361 Minakshi R, Jan AT, Rahman S, Kim J. A Testimony of the Surgent SARS-CoV-2 in the Immunological Panorama of the Human Host. Front Cell Infect Microbiol 2020;10:575404. [PMID: 33262955 DOI: 10.3389/fcimb.2020.575404] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
362 Freeman TL, Swartz TH. Targeting the NLRP3 Inflammasome in Severe COVID-19. Front Immunol 2020;11:1518. [PMID: 32655582 DOI: 10.3389/fimmu.2020.01518] [Cited by in Crossref: 99] [Cited by in F6Publishing: 95] [Article Influence: 49.5] [Reference Citation Analysis]
363 Vogel-González M, Talló-Parra M, Herrera-Fernández V, Pérez-Vilaró G, Chillón M, Nogués X, Gómez-Zorrilla S, López-Montesinos I, Arnau-Barrés I, Sorli-Redó ML, Horcajada JP, García-Giralt N, Pascual J, Díez J, Vicente R, Güerri-Fernández R. Low Zinc Levels at Admission Associates with Poor Clinical Outcomes in SARS-CoV-2 Infection. Nutrients 2021;13:562. [PMID: 33572045 DOI: 10.3390/nu13020562] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 7.0] [Reference Citation Analysis]
364 Kalicińska E, Szymczak D, Andrasiak I, Bogucka-Fedorczuk A, Zińczuk A, Szymański W, Biernat M, Rymko M, Semeńczuk G, Jabłonowska P, Rybka J, Simon K, Wróbel T. Lymphocyte subsets in haematological patients with COVID-19: Multicentre prospective study. Transl Oncol 2021;14:100943. [PMID: 33204385 DOI: 10.1016/j.tranon.2020.100943] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
365 Apicella M, Campopiano MC, Mantuano M, Mazoni L, Coppelli A, Del Prato S. COVID-19 in people with diabetes: understanding the reasons for worse outcomes. Lancet Diabetes Endocrinol. 2020;8:782-792. [PMID: 32687793 DOI: 10.1016/s2213-8587(20)30238-2] [Cited by in Crossref: 263] [Cited by in F6Publishing: 170] [Article Influence: 131.5] [Reference Citation Analysis]
366 Palmas F, Clarke J, Colas RA, Gomez EA, Keogh A, Boylan M, McEvoy N, McElvaney OJ, McElvaney O, Alalqam R, McElvaney NG, Curley GF, Dalli J. Dysregulated plasma lipid mediator profiles in critically ill COVID-19 patients. PLoS One 2021;16:e0256226. [PMID: 34437568 DOI: 10.1371/journal.pone.0256226] [Reference Citation Analysis]
367 Xu J, Liu Z, Liu H, Luo Y, Kang K, Li X, Yang W, Fei D, Wang C, Yu K. Decreased T Cell Levels in Critically Ill Coronavirus Patients: Single-Center, Prospective and Observational Study. J Inflamm Res 2021;14:1331-40. [PMID: 33859488 DOI: 10.2147/JIR.S303117] [Reference Citation Analysis]
368 Shang Y, Liu T, Wei Y, Li J, Shao L, Liu M, Zhang Y, Zhao Z, Xu H, Peng Z, Zhou F, Wang X. Scoring systems for predicting mortality for severe patients with COVID-19. EClinicalMedicine 2020;24:100426. [PMID: 32766541 DOI: 10.1016/j.eclinm.2020.100426] [Cited by in Crossref: 41] [Cited by in F6Publishing: 39] [Article Influence: 20.5] [Reference Citation Analysis]
369 Khor WP, Olaoye O, D'Arcy N, Krockow EM, Elshenawy RA, Rutter V, Ashiru-Oredope D. The Need for Ongoing Antimicrobial Stewardship during the COVID-19 Pandemic and Actionable Recommendations. Antibiotics (Basel) 2020;9:E904. [PMID: 33327430 DOI: 10.3390/antibiotics9120904] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
370 Liu T, Liu S, Li T, Zhang J. Thymosin a1 use is not associated with reduced COVID-19 mortality. Am J Emerg Med 2021:S0735-6757(21)00329-6. [PMID: 33896653 DOI: 10.1016/j.ajem.2021.04.043] [Reference Citation Analysis]
371 Gujar S, Pol JG, Kim Y, Kroemer G. Repurposing CD8+ T cell immunity against SARS-CoV-2 for cancer immunotherapy: a positive aspect of the COVID-19 pandemic? Oncoimmunology 2020;9:1794424. [PMID: 32923158 DOI: 10.1080/2162402X.2020.1794424] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
372 Tanner T, Wahezi DM. Hyperinflammation and the utility of immunomodulatory medications in children with COVID-19. Paediatr Respir Rev. 2020;35:81-87. [PMID: 32792288 DOI: 10.1016/j.prrv.2020.07.003] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
373 Zhang Z, Ai G, Chen L, Liu S, Gong C, Zhu X, Zhang C, Qin H, Hu J, Huang J. Associations of immunological features with COVID-19 severity: a systematic review and meta-analysis. BMC Infect Dis 2021;21:738. [PMID: 34344353 DOI: 10.1186/s12879-021-06457-1] [Reference Citation Analysis]
374 Hussen J, Kandeel M, Hemida MG, Al-Mubarak AIA. Antibody-Based Immunotherapeutic Strategies for COVID-19. Pathogens. 2020;9. [PMID: 33167401 DOI: 10.3390/pathogens9110917] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
375 Ling KL, Hilmi I, Raja Ali RA, Leong RWL, Leung WK, Ng SC, Wu KC, Chen MH, Ran ZH, Hisamatsu T, Ahuja V, Makharia GK, Banerjee R, Wei SC, Wu DC, Pisespongsa P, Ye BD, Sollano J, Simadibrata M, Chuah SW, Ooi CJ. Asian Pacific Association of Gastroenterology (APAGE) Inflammatory Bowel Disease (IBD) Working Party guidelines on IBD management during the COVID-19 pandemic. JGH Open 2020;4:320-3. [PMID: 32514431 DOI: 10.1002/jgh3.12362] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
376 Cremoni M, Cuozzo S, Martinuzzi E, Barbosa S, Ben Hassen N, Massa F, Demonchy E, Durand M, Thaunat O, Esnault V, Le Quintrec M, Caillard S, Glaichenhaus N, Sicard A. Low T Cell Responsiveness in the Early Phase of COVID-19 Associates with Progression to Severe Pneumonia in Kidney Transplant Recipients. Viruses 2022;14:542. [DOI: 10.3390/v14030542] [Reference Citation Analysis]
377 Ascierto PA, Fu B, Wei H. IL-6 modulation for COVID-19: the right patients at the right time? J Immunother Cancer 2021;9:e002285. [PMID: 33837054 DOI: 10.1136/jitc-2020-002285] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
378 Moser D, Biere K, Han B, Hoerl M, Schelling G, Choukér A, Woehrle T. COVID-19 Impairs Immune Response to Candida albicans. Front Immunol 2021;12:640644. [PMID: 33717195 DOI: 10.3389/fimmu.2021.640644] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
379 Ingraham NE, Lotfi-Emran S, Thielen BK, Techar K, Morris RS, Holtan SG, Dudley RA, Tignanelli CJ. Immunomodulation in COVID-19. Lancet Respir Med. 2020;8:544-546. [PMID: 32380023 DOI: 10.1016/s2213-2600(20)30226-5] [Cited by in Crossref: 83] [Cited by in F6Publishing: 57] [Article Influence: 41.5] [Reference Citation Analysis]
380 McManus NM, Offman R, Oetman JD. Emergency Department Management of COVID-19: An Evidence-Based Approach. West J Emerg Med 2020;21:32-44. [PMID: 33052814 DOI: 10.5811/westjem.2020.8.48288] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
381 Wu D, Wu X, Huang J, Rao Q, Zhang Q, Zhang W. Lymphocyte subset alterations with disease severity, imaging manifestation, and delayed hospitalization in COVID-19 patients. BMC Infect Dis 2021;21:631. [PMID: 34210280 DOI: 10.1186/s12879-021-06354-7] [Reference Citation Analysis]
382 Caccuri F, Bugatti A, Zani A, De Palma A, Di Silvestre D, Manocha E, Filippini F, Messali S, Chiodelli P, Campisi G, Fiorentini S, Facchetti F, Mauri P, Caruso A. SARS-CoV-2 Infection Remodels the Phenotype and Promotes Angiogenesis of Primary Human Lung Endothelial Cells. Microorganisms 2021;9:1438. [PMID: 34361874 DOI: 10.3390/microorganisms9071438] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
383 Sun CY, Sun YL, Li XM. The role of Chinese medicine in COVID-19 pneumonia: A systematic review and meta-analysis. Am J Emerg Med 2020;38:2153-9. [PMID: 33071103 DOI: 10.1016/j.ajem.2020.06.069] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
384 Chinnici CM, Russelli G, Bulati M, Miceli V, Gallo A, Busà R, Tinnirello R, Conaldi PG, Iannolo G. Mesenchymal stromal cell secretome in liver failure: Perspectives on COVID-19 infection treatment. World J Gastroenterol 2021; 27(17): 1905-1919 [PMID: 34007129 DOI: 10.3748/wjg.v27.i17.1905] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
385 Thimmulappa RK, Mudnakudu-Nagaraju KK, Shivamallu C, Subramaniam KJT, Radhakrishnan A, Bhojraj S, Kuppusamy G. Antiviral and immunomodulatory activity of curcumin: A case for prophylactic therapy for COVID-19. Heliyon 2021;7:e06350. [PMID: 33655086 DOI: 10.1016/j.heliyon.2021.e06350] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 14.0] [Reference Citation Analysis]
386 Salvarani C, Dolci G, Massari M, Merlo DF, Cavuto S, Savoldi L, Bruzzi P, Boni F, Braglia L, Turrà C, Ballerini PF, Sciascia R, Zammarchi L, Para O, Scotton PG, Inojosa WO, Ravagnani V, Salerno ND, Sainaghi PP, Brignone A, Codeluppi M, Teopompi E, Milesi M, Bertomoro P, Claudio N, Salio M, Falcone M, Cenderello G, Donghi L, Del Bono V, Colombelli PL, Angheben A, Passaro A, Secondo G, Pascale R, Piazza I, Facciolongo N, Costantini M; RCT-TCZ-COVID-19 Study Group. Effect of Tocilizumab vs Standard Care on Clinical Worsening in Patients Hospitalized With COVID-19 Pneumonia: A Randomized Clinical Trial. JAMA Intern Med 2021;181:24-31. [PMID: 33080005 DOI: 10.1001/jamainternmed.2020.6615] [Cited by in Crossref: 207] [Cited by in F6Publishing: 220] [Article Influence: 207.0] [Reference Citation Analysis]
387 Zhao R, Sun Y, Zhang Y, Wang W, Wang S, Wang C, Liu J, Gao L, Hu Z, Fei J, Hou X, Zheng H, Chen L. Distinguishable Immunologic Characteristics of COVID-19 Patients with Comorbid Type 2 Diabetes Compared with Nondiabetic Individuals. Mediators Inflamm 2020;2020:6914878. [PMID: 33061829 DOI: 10.1155/2020/6914878] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
388 Hasan D, Shono A, van Kalken CK, van der Spek PJ, Krenning EP, Kotani T. A novel definition and treatment of hyperinflammation in COVID-19 based on purinergic signalling. Purinergic Signal 2021. [PMID: 34757513 DOI: 10.1007/s11302-021-09814-6] [Reference Citation Analysis]
389 Ahmed MH, Hassan A. Dexamethasone for the Treatment of Coronavirus Disease (COVID-19): a Review. SN Compr Clin Med. 2020;1-10. [PMID: 33163859 DOI: 10.1007/s42399-020-00610-8] [Cited by in Crossref: 21] [Cited by in F6Publishing: 26] [Article Influence: 10.5] [Reference Citation Analysis]
390 Palermo E, Di Carlo D, Sgarbanti M, Hiscott J. Type I Interferons in COVID-19 Pathogenesis. Biology (Basel) 2021;10:829. [PMID: 34571706 DOI: 10.3390/biology10090829] [Reference Citation Analysis]
391 Ricci D, Etna MP, Rizzo F, Sandini S, Severa M, Coccia EM. Innate Immune Response to SARS-CoV-2 Infection: From Cells to Soluble Mediators. Int J Mol Sci 2021;22:7017. [PMID: 34209845 DOI: 10.3390/ijms22137017] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
392 Kumar A, Sharma A, Tirpude NV, Sharma S, Padwad YS, Kumar S. Pharmaco-immunomodulatory interventions for averting cytokine storm-linked disease severity in SARS-CoV-2 infection. Inflammopharmacol. [DOI: 10.1007/s10787-021-00903-x] [Reference Citation Analysis]
393 Kiener M, Roldan N, Machahua C, Sengupta A, Geiser T, Guenat OT, Funke-Chambour M, Hobi N, Kruithof-de Julio M. Human-Based Advanced in vitro Approaches to Investigate Lung Fibrosis and Pulmonary Effects of COVID-19. Front Med (Lausanne) 2021;8:644678. [PMID: 34026781 DOI: 10.3389/fmed.2021.644678] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
394 Mazzoni A, Salvati L, Maggi L, Annunziato F, Cosmi L. Hallmarks of immune response in COVID-19: Exploring dysregulation and exhaustion. Semin Immunol 2021;:101508. [PMID: 34728121 DOI: 10.1016/j.smim.2021.101508] [Reference Citation Analysis]
395 Shoukry A, Kite TA. Large-vessel thrombotic stroke despite concurrent therapeutic anticoagulation in COVID-19-positive patient. Oxf Med Case Reports 2020;2020:omaa096. [PMID: 33269081 DOI: 10.1093/omcr/omaa096] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
396 Bonaventura A, Vecchié A, Dagna L, Tangianu F, Abbate A, Dentali F. Colchicine for COVID-19: targeting NLRP3 inflammasome to blunt hyperinflammation. Inflamm Res 2022. [PMID: 35113170 DOI: 10.1007/s00011-022-01540-y] [Reference Citation Analysis]
397 Luo W, Huang L, Wang X, Ma Y, Xiao J, Song X, Liu P, Wang Y, Wang Y, Ren Z. SARS-CoV-2 infection activates a subset of intrinsic pathways to inhibit type I interferons in vitro and in vivo. Int J Med Sci 2021;18:2561-9. [PMID: 34104087 DOI: 10.7150/ijms.56630] [Reference Citation Analysis]
398 Gorgojo-Galindo Ó, Martín-Fernández M, Peñarrubia-Ponce MJ, Álvarez FJ, Ortega-Loubon C, Gonzalo-Benito H, Martínez-Paz P, Miramontes-González JP, Gómez-Sánchez E, Poves-Álvarez R, Jorge-Monjas P, Tamayo E, Heredia-Rodríguez M, Tamayo-Velasco Á. Predictive Modeling of Poor Outcome in Severe COVID-19: A Single-Center Observational Study Based on Clinical, Cytokine and Laboratory Profiles. J Clin Med 2021;10:5431. [PMID: 34830714 DOI: 10.3390/jcm10225431] [Reference Citation Analysis]
399 Goudouris ES. Laboratory diagnosis of COVID-19. J Pediatr (Rio J) 2021;97:7-12. [PMID: 32882235 DOI: 10.1016/j.jped.2020.08.001] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 6.5] [Reference Citation Analysis]
400 Varikasuvu SR, Dutt N, Thangappazham B, Varshney S. Diabetes and COVID-19: A pooled analysis related to disease severity and mortality. Prim Care Diabetes 2021;15:24-7. [PMID: 32891525 DOI: 10.1016/j.pcd.2020.08.015] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
401 Larionova R, Byvaltsev K, Kravtsova О, Takha E, Petrov S, Kazarian G, Valeeva A, Shuralev E, Mukminov M, Renaudineau Y, Arleevskaya M. SARS-Cov2 acute and post-active infection in the context of autoimmune and chronic inflammatory diseases. Journal of Translational Autoimmunity 2022;5:100154. [DOI: 10.1016/j.jtauto.2022.100154] [Reference Citation Analysis]
402 Seidu S, Gillies C, Zaccardi F, Kunutsor SK, Hartmann-Boyce J, Yates T, Singh AK, Davies MJ, Khunti K. The impact of obesity on severe disease and mortality in people with SARS-CoV-2: A systematic review and meta-analysis. Endocrinol Diabetes Metab 2020;:e00176. [PMID: 32904932 DOI: 10.1002/edm2.176] [Cited by in Crossref: 19] [Cited by in F6Publishing: 24] [Article Influence: 9.5] [Reference Citation Analysis]
403 Pryzdial ELG, Sutherland MR, Lin BH, Horwitz M. Antiviral anticoagulation. Res Pract Thromb Haemost 2020;4:774-88. [PMID: 32685886 DOI: 10.1002/rth2.12406] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
404 Ghaith MM, Albanghali MA, Aldairi AF, Iqbal MS, Almaimani RA, AlQuthami K, Alqasmi MH, Almaimani W, El-Readi MZ, Alghamdi A, Almasmoum HA. Potential Predictors of Poor Prognosis among Severe COVID-19 Patients: A Single-Center Study. Can J Infect Dis Med Microbiol 2021;2021:6656092. [PMID: 33884042 DOI: 10.1155/2021/6656092] [Reference Citation Analysis]
405 Admou B. [Relevant immunologic markers in COVID-19]. Pan Afr Med J 2021;39:40. [PMID: 34422163 DOI: 10.11604/pamj.2021.39.40.23481] [Reference Citation Analysis]
406 Karijo E, Wamugi S, Lemanyishoe S, Njuki J, Boit F, Kibui V, Karanja S, Abuya T. Knowledge, attitudes, practices, and the effects of COVID-19 among the youth in Kenya. BMC Public Health 2021;21:1020. [PMID: 34053442 DOI: 10.1186/s12889-021-11067-2] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
407 Yang R, Zhao Q, Rao J, Zeng F, Yuan S, Ji M, Sun X, Li J, Yang J, Cui J, Jin Z, Liu L, Liu Z. SARS-CoV-2 Accessory Protein ORF7b Mediates Tumor Necrosis Factor-α-Induced Apoptosis in Cells. Front Microbiol 2021;12:654709. [PMID: 34484133 DOI: 10.3389/fmicb.2021.654709] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
408 Tanwar V, Adelstein JM, Wold LE. Double trouble: combined cardiovascular effects of particulate matter exposure and coronavirus disease 2019. Cardiovasc Res 2021;117:85-95. [PMID: 33084879 DOI: 10.1093/cvr/cvaa293] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
409 Shukla AK, Misra S. An overview of post COVID sequelae. J Basic Clin Physiol Pharmacol 2022. [PMID: 35428040 DOI: 10.1515/jbcpp-2022-0057] [Reference Citation Analysis]
410 Wilson JC, Kealy D, James SR, Plowman T, Newling K, Jagger C, Filbey K, Mann ER, Konkel JE, Menon M, Knight SB, Simpson A, Prihartadi A, Forshaw G, Todd N, Yates DR, Grainger JR, Hussell T, Kaye PM, Signoret N, Lagos D. Integrated miRNA/cytokine/chemokine profiling reveals severity-associated step changes and principal correlates of fatality in COVID-19. iScience 2022;25:103672. [DOI: 10.1016/j.isci.2021.103672] [Reference Citation Analysis]
411 Bordallo B, Bellas M, Cortez AF, Vieira M, Pinheiro M. Severe COVID-19: what have we learned with the immunopathogenesis? Adv Rheumatol 2020;60:50. [PMID: 32962761 DOI: 10.1186/s42358-020-00151-7] [Cited by in Crossref: 23] [Cited by in F6Publishing: 1] [Article Influence: 11.5] [Reference Citation Analysis]
412 Masterson CH, Ceccato A, Artigas A, Dos Santos C, Rocco PR, Rolandsson Enes S, Weiss DJ, McAuley D, Matthay MA, English K, Curley GF, Laffey JG. Mesenchymal stem/stromal cell-based therapies for severe viral pneumonia: therapeutic potential and challenges. Intensive Care Med Exp 2021;9:61. [PMID: 34970706 DOI: 10.1186/s40635-021-00424-5] [Reference Citation Analysis]
413 Salamanna F, Maglio M, Sartori M, Landini MP, Fini M. Vitamin D and Platelets: A Menacing Duo in COVID-19 and Potential Relation to Bone Remodeling. Int J Mol Sci 2021;22:10010. [PMID: 34576172 DOI: 10.3390/ijms221810010] [Reference Citation Analysis]
414 Ryu G, Shin HW. SARS-CoV-2 Infection of Airway Epithelial Cells. Immune Netw 2021;21:e3. [PMID: 33728096 DOI: 10.4110/in.2021.21.e3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
415 Lafon E, Diem G, Witting C, Zaderer V, Bellmann-Weiler RM, Reindl M, Bauer A, Griesmacher A, Fux V, Hoermann G, Miller C, Zabernigg A, Wöll E, Wilflingseder D, Lass-Flörl C, Posch W. Potent SARS-CoV-2-Specific T Cell Immunity and Low Anaphylatoxin Levels Correlate With Mild Disease Progression in COVID-19 Patients. Front Immunol 2021;12:684014. [PMID: 34194438 DOI: 10.3389/fimmu.2021.684014] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
416 Shrivastava R, Shrivastava R, Johansen B, Allain T. Anti-Inflammatory and Antiviral Osmotic Polymeric Film to Treat Covid-19 Early-Stage Infection. J Inflamm Res 2021;14:1195-206. [PMID: 33833542 DOI: 10.2147/JIR.S306434] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
417 Daoud A, Alqassieh A, Alkhader D, Posadas Salas MA, Rao V, Fülöp T, Soliman KM. Immunosuppression in kidney transplant recipients with COVID-19 infection - where do we stand and where are we heading? Ren Fail 2021;43:273-80. [PMID: 33491531 DOI: 10.1080/0886022X.2021.1876730] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
418 Gamage AM, Tan KS, Chan WOY, Liu J, Tan CW, Ong YK, Thong M, Andiappan AK, Anderson DE, Wang Y, Wang LF. Infection of human Nasal Epithelial Cells with SARS-CoV-2 and a 382-nt deletion isolate lacking ORF8 reveals similar viral kinetics and host transcriptional profiles. PLoS Pathog 2020;16:e1009130. [PMID: 33284849 DOI: 10.1371/journal.ppat.1009130] [Cited by in Crossref: 29] [Cited by in F6Publishing: 20] [Article Influence: 14.5] [Reference Citation Analysis]
419 Weiskopf D, Schmitz KS, Raadsen MP, Grifoni A, Okba NMA, Endeman H, van den Akker JPC, Molenkamp R, Koopmans MPG, van Gorp ECM, Haagmans BL, de Swart RL, Sette A, de Vries RD. Phenotype and kinetics of SARS-CoV-2-specific T cells in COVID-19 patients with acute respiratory distress syndrome. Sci Immunol 2020;5:eabd2071. [PMID: 32591408 DOI: 10.1126/sciimmunol.abd2071] [Cited by in Crossref: 391] [Cited by in F6Publishing: 363] [Article Influence: 195.5] [Reference Citation Analysis]
420 Jaiswal V, Sarfraz Z, Sarfraz A, Mukherjee D, Batra N, Hitawala G, Yaqoob S, Patel A, Agarwala P, Ruchika, Sarfraz M, Bano S, Azeem N, Naz S, Jaiswal A, Sharma P, Chaudhary G. COVID-19 Infection and Myocarditis: A State-of-the-Art Systematic Review. J Prim Care Community Health 2021;12:21501327211056800. [PMID: 34854348 DOI: 10.1177/21501327211056800] [Reference Citation Analysis]
421 Wang M, Yan W, Qi W, Wu D, Zhu L, Li W, Wang X, Ma K, Ni M, Xu D, Wang H, Chen G, Yu H, Ding H, Xing M, Han M, Luo X, Chen T, Guo W, Xi D, Ning Q. Clinical characteristics and risk factors of liver injury in COVID-19: a retrospective cohort study from Wuhan, China. Hepatol Int. 2020;14:723-732. [PMID: 33026573 DOI: 10.1007/s12072-020-10075-5] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]
422 Liou TG, Adler FR, Cahill BC, Cox DR, Cox JE, Grant GJ, Hanson KE, Hartsell SC, Hatton ND, Helms MN, Jensen JL, Kartsonaki C, Li Y, Leung DT, Marvin JE, Middleton EA, Osburn-Staker SM, Packer KA, Shakir SM, Sturrock AB, Tardif KD, Warren KJ, Waddoups LJ, Weaver LJ, Zimmerman E, Paine R 3rd. SARS-CoV-2 innate effector associations and viral load in early nasopharyngeal infection. Physiol Rep 2021;9:e14761. [PMID: 33625796 DOI: 10.14814/phy2.14761] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
423 Mann ER, Menon M, Knight SB, Konkel JE, Jagger C, Shaw TN, Krishnan S, Rattray M, Ustianowski A, Bakerly ND, Dark P, Lord G, Simpson A, Felton T, Ho LP, Feldmann M, Grainger JR, Hussell T; NIHR Respiratory TRC,., CIRCO,. Longitudinal immune profiling reveals key myeloid signatures associated with COVID-19. Sci Immunol 2020;5:eabd6197. [PMID: 32943497 DOI: 10.1126/sciimmunol.abd6197] [Cited by in Crossref: 71] [Cited by in F6Publishing: 60] [Article Influence: 35.5] [Reference Citation Analysis]
424 Grigoryan L, Pulendran B. The immunology of SARS-CoV-2 infections and vaccines. Semin Immunol 2020;50:101422. [PMID: 33262067 DOI: 10.1016/j.smim.2020.101422] [Cited by in Crossref: 25] [Cited by in F6Publishing: 18] [Article Influence: 12.5] [Reference Citation Analysis]
425 Duarte-Millán MA, Mesa-Plaza N, Guerrero-Santillán M, Morales-Ortega A, Bernal-Bello D, Farfán-Sedano AI, García de Viedma-García V, Velázquez-Ríos L, Frutos-Pérez B, De Ancos-Aracil CL, Soria Fernández-Llamazares G, Toledano-Macías M, Cristóbal-Bilbao R, Luquín-Ciuro N, Marrero-Francés J, Piedrabuena-García SI, Satué-Bartolomé JA, Gonzalo-Pascua S, Rivilla-Jiménez M, Carpintero-García L, Ayala-Larrañaga I, García-Bermúdez V, Lara-Montes C, Llerena-Riofrío ÁR, RIvas-Prado L, Walter S, Escriba-Barcena A, San Martín López JV, Ruíz-Giardín JM. Prognostic factors and combined use of tocilizumab and corticosteroids in a Spanish cohort of elderly COVID-19 patients. J Med Virol 2021. [PMID: 34845754 DOI: 10.1002/jmv.27488] [Reference Citation Analysis]
426 Guadarrama-Ortiz P, Choreño-Parra JA, Sánchez-Martínez CM, Pacheco-Sánchez FJ, Rodríguez-Nava AI, García-Quintero G. Neurological Aspects of SARS-CoV-2 Infection: Mechanisms and Manifestations. Front Neurol 2020;11:1039. [PMID: 33013675 DOI: 10.3389/fneur.2020.01039] [Cited by in Crossref: 27] [Cited by in F6Publishing: 21] [Article Influence: 13.5] [Reference Citation Analysis]
427 Synowiec A, Szczepański A, Barreto-Duran E, Lie LK, Pyrc K. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): a Systemic Infection. Clin Microbiol Rev 2021;34:e00133-20. [PMID: 33441314 DOI: 10.1128/CMR.00133-20] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 13.0] [Reference Citation Analysis]
428 Liu D, Zhang T, Wang Y, Xia L. Tocilizumab: The Key to Stop Coronavirus Disease 2019 (COVID-19)-Induced Cytokine Release Syndrome (CRS)? Front Med (Lausanne) 2020;7:571597. [PMID: 33195318 DOI: 10.3389/fmed.2020.571597] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
429 Zeng L, Zhang H, He Y, Lai B, Huang Z, Lin L, Zhong Z, Guo X. A severe COVID-19 case with schizophrenia as well as other chronic diseases. Braz J Med Biol Res 2021;54:e10426. [PMID: 33470392 DOI: 10.1590/1414-431X202010426] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
430 Guirao JJ, Cabrera CM, Jiménez N, Rincón L, Urra JM. High serum IL-6 values increase the risk of mortality and the severity of pneumonia in patients diagnosed with COVID-19. Mol Immunol 2020;128:64-8. [PMID: 33075636 DOI: 10.1016/j.molimm.2020.10.006] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
431 [DOI: 10.1101/2020.04.12.20062869] [Cited by in Crossref: 10] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
432 Krysko O, Kondakova E, Vershinina O, Galova E, Blagonravova A, Gorshkova E, Bachert C, Ivanchenko M, Krysko DV, Vedunova M. Artificial Intelligence Predicts Severity of COVID-19 Based on Correlation of Exaggerated Monocyte Activation, Excessive Organ Damage and Hyperinflammatory Syndrome: A Prospective Clinical Study. Front Immunol 2021;12:715072. [PMID: 34539644 DOI: 10.3389/fimmu.2021.715072] [Reference Citation Analysis]
433 Moradian N, Gouravani M, Salehi MA, Heidari A, Shafeghat M, Hamblin MR, Rezaei N. Cytokine release syndrome: inhibition of pro-inflammatory cytokines as a solution for reducing COVID-19 mortality. Eur Cytokine Netw 2020;31:81-93. [PMID: 33361013 DOI: 10.1684/ecn.2020.0451] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 5.5] [Reference Citation Analysis]
434 Farzi R, Aghbash PS, Eslami N, Azadi A, Shamekh A, Hemmat N, Entezari-Maleki T, Baghi HB. The role of antigen-presenting cells in the pathogenesis of COVID-19. Pathol Res Pract 2022;233:153848. [PMID: 35338971 DOI: 10.1016/j.prp.2022.153848] [Reference Citation Analysis]
435 Colantuoni A, Martini R, Caprari P, Ballestri M, Capecchi PL, Gnasso A, Lo Presti R, Marcoccia A, Rossi M, Caimi G. COVID-19 Sepsis and Microcirculation Dysfunction. Front Physiol 2020;11:747. [PMID: 32676039 DOI: 10.3389/fphys.2020.00747] [Cited by in Crossref: 34] [Cited by in F6Publishing: 32] [Article Influence: 17.0] [Reference Citation Analysis]
436 Belaid B, Lamara Mahammad L, Mihi B, Rahali SY, Djidjeli A, Larab Z, Berkani L, Berkane I, Sayah W, Merah F, Lazli NZ, Kheddouci L, Kadi A, Ouali M, Khellafi R, Mekideche D, Kheliouen A, Ayoub S, Hamidi RM, Derrar F, Gharnaout M, Allam I, Djidjik R. T cell counts and IL-6 concentration in blood of North African COVID-19 patients are two independent prognostic factors for severe disease and death. J Leukoc Biol 2021. [PMID: 33527487 DOI: 10.1002/JLB.4COVA1020-703R] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
437 Calabrò L, Rossi G, Covre A, Morra A, Maio M. COVID and Lung Cancer. Curr Oncol Rep 2021;23:134. [PMID: 34677721 DOI: 10.1007/s11912-021-01125-8] [Reference Citation Analysis]
438 Zhang J, Xu J, Zhou S, Wang C, Wang X, Zhang W, Ning K, Pan Y, Liu T, Zhao J, Dong L. The characteristics of 527 discharged COVID-19 patients undergoing long-term follow-up in China. Int J Infect Dis 2021;104:685-92. [PMID: 33540129 DOI: 10.1016/j.ijid.2021.01.064] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
439 Rejeki MS, Sarnadi N, Wihastuti R, Fazharyasti V, Samin WY, Yudhaputri FA, Johar E, Nurainy N, Bachtiar NS, Muljono DH. Convalescent plasma therapy in patients with moderate-to-severe COVID-19: A study from Indonesia for clinical research in low- and middle-income countries. EClinicalMedicine 2021;36:100931. [PMID: 34104878 DOI: 10.1016/j.eclinm.2021.100931] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
440 Liu Y, Tan W, Chen H, Zhu Y, Wan L, Jiang K, Guo Y, Tang K, Xie C, Yi H, Kuang Y, Luo Y. Dynamic changes in lymphocyte subsets and parallel cytokine levels in patients with severe and critical COVID-19. BMC Infect Dis 2021;21:79. [PMID: 33461503 DOI: 10.1186/s12879-021-05792-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
441 Cong W, Poudel AN, Alhusein N, Wang H, Yao G, Lambert H. Antimicrobial Use in COVID-19 Patients in the First Phase of the SARS-CoV-2 Pandemic: A Scoping Review. Antibiotics (Basel) 2021;10:745. [PMID: 34205440 DOI: 10.3390/antibiotics10060745] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
442 Aziz M, Fatima R, Assaly R. Elevated interleukin-6 and severe COVID-19: A meta-analysis. J Med Virol 2020;92:2283-5. [PMID: 32343429 DOI: 10.1002/jmv.25948] [Cited by in Crossref: 199] [Cited by in F6Publishing: 186] [Article Influence: 99.5] [Reference Citation Analysis]
443 Du J, Wei L, Li G, Hua M, Sun Y, Wang D, Han K, Yan Y, Song C, Song R, Zhang H, Han J, Liu J, Kong Y. Persistent High Percentage of HLA-DR+CD38high CD8+ T Cells Associated With Immune Disorder and Disease Severity of COVID-19. Front Immunol 2021;12:735125. [PMID: 34567001 DOI: 10.3389/fimmu.2021.735125] [Reference Citation Analysis]
444 Zhao XN, You Y, Cui XM, Gao HX, Wang GL, Zhang SB, Yao L, Duan LJ, Zhu KL, Wang YL, Li L, Lu JH, Wang HB, Fan JF, Zheng HW, Dai EH, Tian LY, Ma MJ. Single-cell immune profiling reveals distinct immune response in asymptomatic COVID-19 patients. Signal Transduct Target Ther 2021;6:342. [PMID: 34531370 DOI: 10.1038/s41392-021-00753-7] [Reference Citation Analysis]
445 Anft M, Paniskaki K, Blazquez-Navarro A, Doevelaar A, Seibert FS, Hölzer B, Skrzypczyk S, Kohut E, Kurek J, Zapka J, Wehler P, Kaliszczyk S, Bajda S, Thieme CJ, Roch T, Konik MJ, Berger MM, Brenner T, Kölsch U, Meister TL, Pfaender S, Steinmann E, Tempfer C, Watzl C, Dolff S, Dittmer U, Abou-El-Enein M, Westhoff TH, Witzke O, Stervbo U, Babel N. COVID-19-Induced ARDS Is Associated with Decreased Frequency of Activated Memory/Effector T Cells Expressing CD11a+. Mol Ther 2020;28:2691-702. [PMID: 33186542 DOI: 10.1016/j.ymthe.2020.10.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
446 Turilli ES, Lualdi M, Fasano M. Looking at COVID-19 from a Systems Biology Perspective. Biomolecules 2022;12:188. [DOI: 10.3390/biom12020188] [Reference Citation Analysis]
447 Dejani NN, Elshabrawy HA, Bezerra Filho CDSM, de Sousa DP. Anticoronavirus and Immunomodulatory Phenolic Compounds: Opportunities and Pharmacotherapeutic Perspectives. Biomolecules 2021;11:1254. [PMID: 34439920 DOI: 10.3390/biom11081254] [Reference Citation Analysis]
448 Rajaiah R, Abhilasha KV, Shekar MA, Vogel SN, Vishwanath BS. Evaluation of mechanisms of action of re-purposed drugs for treatment of COVID-19. Cell Immunol 2020;358:104240. [PMID: 33137649 DOI: 10.1016/j.cellimm.2020.104240] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
449 Mauvais-Jarvis F, Klein SL, Levin ER. Estradiol, Progesterone, Immunomodulation, and COVID-19 Outcomes. Endocrinology 2020;161:bqaa127. [PMID: 32730568 DOI: 10.1210/endocr/bqaa127] [Cited by in Crossref: 49] [Cited by in F6Publishing: 42] [Article Influence: 24.5] [Reference Citation Analysis]
450 Lombardi A, Duiella S, Li Piani L, Comelli A, Ceriotti F, Oggioni M, Muscatello A, Bandera A, Gori A, Ferrazzi E. Inflammatory biomarkers in pregnant women with COVID-19: a retrospective cohort study. Sci Rep 2021;11:13350. [PMID: 34172816 DOI: 10.1038/s41598-021-92885-7] [Reference Citation Analysis]
451 Wu ZH, Yang DL. A meta-analysis of the impact of COVID-19 on liver dysfunction. Eur J Med Res. 2020;25:54. [PMID: 33148326 DOI: 10.1186/s40001-020-00454-x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]
452 Lovre D, Bateman K, Sherman M, Fonseca VA, Lefante J, Mauvais-Jarvis F. Acute estradiol and progesterone therapy in hospitalised adults to reduce COVID-19 severity: a randomised control trial. BMJ Open 2021;11:e053684. [PMID: 34848523 DOI: 10.1136/bmjopen-2021-053684] [Reference Citation Analysis]
453 Li C, Cheng G. Will Hydroxychloroquine Still Be a Game-Changer for COVID-19 by Combining Azithromycin? Front Immunol 2020;11:1969. [PMID: 32849658 DOI: 10.3389/fimmu.2020.01969] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
454 Jin H, Bi R, Hu J, Xu D, Su Y, Huang M, Peng Q, Li Z, Chen S, Hu B. Elevated Serum Lactate Dehydrogenase Predicts Unfavorable Outcomes After rt-PA Thrombolysis in Ischemic Stroke Patients. Front Neurol 2022;13:816216. [DOI: 10.3389/fneur.2022.816216] [Reference Citation Analysis]
455 Payen D, Cravat M, Maadadi H, Didelot C, Prosic L, Dupuis C, Losser MR, De Carvalho Bittencourt M. A Longitudinal Study of Immune Cells in Severe COVID-19 Patients. Front Immunol 2020;11:580250. [PMID: 33178207 DOI: 10.3389/fimmu.2020.580250] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
456 Ni Y, Alu A, Lei H, Wang Y, Wu M, Wei X. Immunological perspectives on the pathogenesis, diagnosis, prevention and treatment of COVID-19. Mol Biomed 2021;2:1. [PMID: 34766001 DOI: 10.1186/s43556-020-00015-y] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
457 García-García JA, Pérez-Quintana M, Ramos-Giráldez C, Cebrián-González I, Martín-Ponce ML, Del Valle-Villagrán J, Navarro-Puerto MA, Sánchez-Villegas J, Gómez-Herreros R, Manoja-Bustos I, León-Martí D, Serrano-Rodríguez L, de Miguel-Albarreal A, Velasco-Romero MJ, Mula-Falcón F, Fernández-Pérez P, Melguizo-Moya I, Pérez-Quintana MJ, Romero-Molina G, Vergara-López S, Marenco-de la Fuente JL, Marín-Martín J, Mira-Escarti JA. Anakinra versus Baricitinib: Different Strategies for Patients Hospitalized with COVID-19. J Clin Med 2021;10:4019. [PMID: 34501467 DOI: 10.3390/jcm10174019] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
458 Napoli C, Tritto I, Mansueto G, Coscioni E, Ambrosio G. Immunosenescence exacerbates the COVID-19. Arch Gerontol Geriatr 2020;90:104174. [PMID: 32653765 DOI: 10.1016/j.archger.2020.104174] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 9.0] [Reference Citation Analysis]
459 Aslam M, Zehri MT, Mandoklel H, Kamal R, Din M. Lower mortality rate in health workers and their families infected with COVID-19 associated pneumonia in Quetta, Baluchistan. Pak J Med Sci 2021;37:1747-52. [PMID: 34912389 DOI: 10.12669/pjms.37.7.4060] [Reference Citation Analysis]
460 Kumar PN, Hernández-Sánchez J, Nagel S, Feng Y, Cai F, Rabin J, Morse CG, Nadig NR, Ashraf O, Gotur DB, McComsey GA, Gafoor K, Perin P, Thornton SC, Stubbings W, Lin CJF, Tsai L. Safety and Efficacy of Tocilizumab 4 or 8 mg/kg in Hospitalized Patients With Moderate to Severe Coronavirus Disease 2019 Pneumonia: A Randomized Clinical Trial. Open Forum Infect Dis 2022;9:ofab608. [PMID: 35024375 DOI: 10.1093/ofid/ofab608] [Reference Citation Analysis]
461 Zhao W, Chen W, Li J, Chen M, Li Q, Lv M, Zhou S, Bai S, Wang Y, Zhang L, Zhang P, Wang J, Zheng Q, Wu J. Status of Humoral and Cellular Immune Responses within 12 Months following CoronaVac Vaccination against COVID-19. mBio 2022;:e0018122. [PMID: 35475648 DOI: 10.1128/mbio.00181-22] [Reference Citation Analysis]
462 Funk CD, Laferrière C, Ardakani A. Target Product Profile Analysis of COVID-19 Vaccines in Phase III Clinical Trials and Beyond: An Early 2021 Perspective. Viruses 2021;13:418. [PMID: 33807839 DOI: 10.3390/v13030418] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 10.0] [Reference Citation Analysis]
463 Gillot C, Favresse J, Mullier F, Lecompte T, Dogné JM, Douxfils J. NETosis and the Immune System in COVID-19: Mechanisms and Potential Treatments. Front Pharmacol 2021;12:708302. [PMID: 34421600 DOI: 10.3389/fphar.2021.708302] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
464 Jugler C, Sun H, Chen Q. SARS-CoV-2 Spike Protein-Induced Interleukin 6 Signaling Is Blocked by a Plant-Produced Anti-Interleukin 6 Receptor Monoclonal Antibody. Vaccines (Basel) 2021;9:1365. [PMID: 34835296 DOI: 10.3390/vaccines9111365] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
465 Delorey TM, Ziegler CGK, Heimberg G, Normand R, Yang Y, Segerstolpe A, Abbondanza D, Fleming SJ, Subramanian A, Montoro DT, Jagadeesh KA, Dey KK, Sen P, Slyper M, Pita-Juárez YH, Phillips D, Bloom-Ackerman Z, Barkas N, Ganna A, Gomez J, Normandin E, Naderi P, Popov YV, Raju SS, Niezen S, Tsai LT, Siddle KJ, Sud M, Tran VM, Vellarikkal SK, Amir-Zilberstein L, Atri DS, Beechem J, Brook OR, Chen J, Divakar P, Dorceus P, Engreitz JM, Essene A, Fitzgerald DM, Fropf R, Gazal S, Gould J, Grzyb J, Harvey T, Hecht J, Hether T, Jane-Valbuena J, Leney-Greene M, Ma H, McCabe C, McLoughlin DE, Miller EM, Muus C, Niemi M, Padera R, Pan L, Pant D, Pe'er C, Pfiffner-Borges J, Pinto CJ, Plaisted J, Reeves J, Ross M, Rudy M, Rueckert EH, Siciliano M, Sturm A, Todres E, Waghray A, Warren S, Zhang S, Zollinger DR, Cosimi L, Gupta RM, Hacohen N, Hide W, Price AL, Rajagopal J, Tata PR, Riedel S, Szabo G, Tickle TL, Hung D, Sabeti PC, Novak R, Rogers R, Ingber DE, Gordon Jiang Z, Juric D, Babadi M, Farhi SL, Stone JR, Vlachos IS, Solomon IH, Ashenberg O, Porter CBM, Li B, Shalek AK, Villani AC, Rozenblatt-Rosen O, Regev A. A single-cell and spatial atlas of autopsy tissues reveals pathology and cellular targets of SARS-CoV-2. bioRxiv 2021:2021. [PMID: 33655247 DOI: 10.1101/2021.02.25.430130] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 8.0] [Reference Citation Analysis]
466 Batra N, De Souza C, Batra J, Raetz AG, Yu AM. The HMOX1 Pathway as a Promising Target for the Treatment and Prevention of SARS-CoV-2 of 2019 (COVID-19). Int J Mol Sci 2020;21:E6412. [PMID: 32899231 DOI: 10.3390/ijms21176412] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
467 Sattui SE, Crow MK, Navarro-Millán I. The role of immunomodulatory medications in the treatment of COVID-19. Curr Opin Rheumatol 2021;33:431-45. [PMID: 34397605 DOI: 10.1097/BOR.0000000000000817] [Reference Citation Analysis]
468 Skevaki C, Fragkou PC, Cheng C, Xie M, Renz H. Laboratory characteristics of patients infected with the novel SARS-CoV-2 virus. J Infect 2020;81:205-12. [PMID: 32579986 DOI: 10.1016/j.jinf.2020.06.039] [Cited by in Crossref: 33] [Cited by in F6Publishing: 29] [Article Influence: 16.5] [Reference Citation Analysis]
469 Hong X, He J, Li P, Chen J, Zou B, Li Z, Jia Y, Liu Y, Yang L, Li J. Evidence of SARS-CoV-2 infection in gallbladder and aggravating cholecystitis to septic shock: a case report. Ann Transl Med 2021;9:1631. [PMID: 34926675 DOI: 10.21037/atm-21-4778] [Reference Citation Analysis]
470 Lüke F, Orsó E, Kirsten J, Poeck H, Grube M, Wolff D, Burkhardt R, Lunz D, Lubnow M, Schmidt B, Hitzenbichler F, Hanses F, Salzberger B, Evert M, Herr W, Brochhausen C, Pukrop T, Reichle A, Heudobler D. Coronavirus disease 2019 induces multi-lineage, morphologic changes in peripheral blood cells. EJHaem 2020. [PMID: 32838398 DOI: 10.1002/jha2.44] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
471 Abramson HN. Immunotherapy of Multiple Myeloma: Promise and Challenges. Immunotargets Ther 2021;10:343-71. [PMID: 34527606 DOI: 10.2147/ITT.S306103] [Reference Citation Analysis]
472 Verma HK, Bhaskar L. SARS-CoV-2 infection in people with pre-existing liver disease: Further research is warranted. World J Gastroenterol 2021; 27(45): 7855-7858 [PMID: 34963747 DOI: 10.3748/wjg.v27.i45.7855] [Reference Citation Analysis]
473 Mei Z, Wu X, Zhang X, Zheng X, Li W, Fan R, Yu H, Zhang S, Gu Y, Wang X, Xia Y, Meng G, Shen J, Niu K. The occurrence and risk factors associated with post‐traumatic stress disorder among discharged COVID‐19 patients in Tianjin, China. Brain and Behavior. [DOI: 10.1002/brb3.2492] [Reference Citation Analysis]
474 Jandial A, Gupta A, Malviya A, Agastam S, Kumar D. Coagulation abnormalities & thromboprophylaxis in COVID-19. Indian J Med Res 2021;153:606-18. [PMID: 34643567 DOI: 10.4103/ijmr.IJMR_3841_20] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
475 Fidecicchi T, Fruzzetti F, Lete Lasa LI, Calaf J. COVID-19, gender and estroprogestins, what do we know? Eur J Contracept Reprod Health Care 2021;:1-8. [PMID: 34842025 DOI: 10.1080/13625187.2021.2000959] [Reference Citation Analysis]
476 Fakharian A, Barati S, Mohamadi M, Dastan F. Successful Management of COVID-19 With Adalimumab in a Post-Coronary Artery Bypass Graft Surgery Patient. J Cardiothorac Vasc Anesth 2021:S1053-0770(20)31370-7. [PMID: 33423911 DOI: 10.1053/j.jvca.2020.12.023] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
477 Boregowda U, Perisetti A, Nanjappa A, Gajendran M, Kutti Sridharan G, Goyal H. Addition of Tocilizumab to the Standard of Care Reduces Mortality in Severe COVID-19: A Systematic Review and Meta-Analysis. Front Med (Lausanne). 2020;7:586221. [PMID: 33123544 DOI: 10.3389/fmed.2020.586221] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 10.0] [Reference Citation Analysis]
478 Alberca RW, Pereira NZ, Oliveira LMDS, Gozzi-Silva SC, Sato MN. Pregnancy, Viral Infection, and COVID-19. Front Immunol. 2020;11:1672. [PMID: 32733490 DOI: 10.3389/fimmu.2020.01672] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 10.0] [Reference Citation Analysis]
479 Duan YQ, Xia MH, Ren L, Zhang YF, Ao QL, Xu SP, Kuang D, Liu Q, Yan B, Zhou YW, Chu Q, Liu L, Yang XP, Wang GP. Deficiency of Tfh Cells and Germinal Center in Deceased COVID-19 Patients. Curr Med Sci 2020;40:618-24. [PMID: 32767259 DOI: 10.1007/s11596-020-2225-x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
480 Mello MT, Silva A, Guerreiro RC, da-Silva FR, Esteves AM, Poyares D, Piovezan R, Treptow E, Starling M, Rosa DS, Pires GN, Andersen ML, Tufik S. Sleep and COVID-19: considerations about immunity, pathophysiology, and treatment. Sleep Sci 2020;13:199-209. [PMID: 33381288 DOI: 10.5935/1984-0063.20200062] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
481 Chen F, Sun W, Sun S, Li Z, Wang Z, Yu L. Clinical characteristics and risk factors for mortality among inpatients with COVID-19 in Wuhan, China. Clin Transl Med 2020;10:e40. [PMID: 32508024 DOI: 10.1002/ctm2.40] [Cited by in Crossref: 21] [Cited by in F6Publishing: 26] [Article Influence: 10.5] [Reference Citation Analysis]
482 Sozio E, Tascini C, Fabris M, D'Aurizio F, De Carlo C, Graziano E, Bassi F, Sbrana F, Ripoli A, Pagotto A, Giacinta A, Gerussi V, Visentini D, De Stefanis P, Merelli M, Saeed K, Curcio F. MR-proADM as prognostic factor of outcome in COVID-19 patients. Sci Rep 2021;11:5121. [PMID: 33664308 DOI: 10.1038/s41598-021-84478-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
483 Al-Baadani A, Eltayeb N, Alsufyani E, Albahrani S, Basheri S, Albayat H, Batubara E, Ballool S, Al Assiri A, Faqihi F, Musa AB, Robert AA, Alsherbeeni N, Elzein F. Efficacy of tocilizumab in patients with severe COVID-19: Survival and clinical outcomes. J Infect Public Health 2021;14:1021-7. [PMID: 34153727 DOI: 10.1016/j.jiph.2021.05.015] [Reference Citation Analysis]
484 Port JR, Adney DR, Schwarz B, Schulz JE, Sturdevant DE, Smith BJ, Avanzato VA, Holbrook MG, Purushotham JN, Stromberg KA, Leighton I, Bosio CM, Shaia C, Munster VJ. Western diet increases COVID-19 disease severity in the Syrian hamster. bioRxiv 2021:2021. [PMID: 34159329 DOI: 10.1101/2021.06.17.448814] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
485 Kumar R, Rathi H, Haq A, Wimalawansa SJ, Sharma A. Putative roles of vitamin D in modulating immune response and immunopathology associated with COVID-19. Virus Res 2021;292:198235. [PMID: 33232783 DOI: 10.1016/j.virusres.2020.198235] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 8.5] [Reference Citation Analysis]
486 Ventura-Díaz S, Quintana-Pérez JV, Gil-Boronat A, Herrero-Huertas M, Gorospe-Sarasúa L, Montilla J, Acosta-Batlle J, Blázquez-Sánchez J, Vicente-Bártulos A. A higher D-dimer threshold for predicting pulmonary embolism in patients with COVID-19: a retrospective study. Emerg Radiol 2020;27:679-89. [PMID: 33025219 DOI: 10.1007/s10140-020-01859-1] [Cited by in Crossref: 17] [Cited by in F6Publishing: 10] [Article Influence: 8.5] [Reference Citation Analysis]
487 Budhwar S, Sethi K, Chakraborty M. A Rapid Advice Guideline for the Prevention of Novel Coronavirus Through Nutritional Intervention.Curr Nutr Rep. 2020;9:119-128. [PMID: 32578027 DOI: 10.1007/s13668-020-00325-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
488 Chen LD, Zhang ZY, Wei XJ, Cai YQ, Yao WZ, Wang MH, Huang QF, Zhang XB. Association between cytokine profiles and lung injury in COVID-19 pneumonia. Respir Res 2020;21:201. [PMID: 32727465 DOI: 10.1186/s12931-020-01465-2] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 11.0] [Reference Citation Analysis]
489 Price LC, McCabe C, Garfield B, Wort SJ. Thrombosis and COVID-19 pneumonia: the clot thickens! Eur Respir J. 2020;56. [PMID: 32554532 DOI: 10.1183/13993003.01608-2020] [Cited by in Crossref: 63] [Cited by in F6Publishing: 59] [Article Influence: 31.5] [Reference Citation Analysis]
490 Chu CF, Sabath F, Fibi-Smetana S, Sun S, Öllinger R, Noeßner E, Chao YY, Rinke L, Winheim E, Rad R, Krug AB, Taher L, Zielinski CE. Convalescent COVID-19 Patients Without Comorbidities Display Similar Immunophenotypes Over Time Despite Divergent Disease Severities. Front Immunol 2021;12:601080. [PMID: 34867933 DOI: 10.3389/fimmu.2021.601080] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
491 Ravindra NG, Alfajaro MM, Gasque V, Huston NC, Wan H, Szigeti-Buck K, Yasumoto Y, Greaney AM, Habet V, Chow RD, Chen JS, Wei J, Filler RB, Wang B, Wang G, Niklason LE, Montgomery RR, Eisenbarth SC, Chen S, Williams A, Iwasaki A, Horvath TL, Foxman EF, Pierce RW, Pyle AM, van Dijk D, Wilen CB. Single-cell longitudinal analysis of SARS-CoV-2 infection in human airway epithelium identifies target cells, alterations in gene expression, and cell state changes. PLoS Biol 2021;19:e3001143. [PMID: 33730024 DOI: 10.1371/journal.pbio.3001143] [Cited by in Crossref: 16] [Cited by in F6Publishing: 32] [Article Influence: 16.0] [Reference Citation Analysis]
492 Danilenko V, Devyatkin A, Marsova M, Shibilova M, Ilyasov R, Shmyrev V. Common Inflammatory Mechanisms in COVID-19 and Parkinson's Diseases: The Role of Microbiome, Pharmabiotics and Postbiotics in Their Prevention. J Inflamm Res 2021;14:6349-81. [PMID: 34876830 DOI: 10.2147/JIR.S333887] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
493 Thompson EA, Cascino K, Ordonez AA, Zhou W, Vaghasia A, Hamacher-Brady A, Brady NR, Sun IH, Wang R, Rosenberg AZ, Delannoy M, Rothman R, Fenstermacher K, Sauer L, Shaw-Saliba K, Bloch EM, Redd AD, Tobian AAR, Horton M, Smith K, Pekosz A, D'Alessio FR, Yegnasubramanian S, Ji H, Cox AL, Powell JD. Metabolic programs define dysfunctional immune responses in severe COVID-19 patients. Cell Rep 2021;34:108863. [PMID: 33691089 DOI: 10.1016/j.celrep.2021.108863] [Cited by in Crossref: 9] [Cited by in F6Publishing: 13] [Article Influence: 9.0] [Reference Citation Analysis]
494 Magusali N, Graham AC, Piers TM, Panichnantakul P, Yaman U, Shoai M, Reynolds RH, Botia JA, Brookes KJ, Guetta-Baranes T, Bellou E, Bayram S, Sokolova D, Ryten M, Sala Frigerio C, Escott-Price V, Morgan K, Pocock JM, Hardy J, Salih DA. A genetic link between risk for Alzheimer's disease and severe COVID-19 outcomes via the OAS1 gene. Brain 2021:awab337. [PMID: 34619763 DOI: 10.1093/brain/awab337] [Reference Citation Analysis]
495 Sureshchandra S, Zulu MZ, Doratt B, Jankeel A, Tifrea D, Edwards R, Rincon M, Marshall NE, Messaoudi I. Deep immune profiling of the maternal-fetal interface with mild SARS-CoV-2 infection. bioRxiv 2021:2021. [PMID: 34462741 DOI: 10.1101/2021.08.23.457408] [Reference Citation Analysis]
496 Quatrini L, Ugolini S. New insights into the cell- and tissue-specificity of glucocorticoid actions. Cell Mol Immunol 2021;18:269-78. [PMID: 32868909 DOI: 10.1038/s41423-020-00526-2] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 9.0] [Reference Citation Analysis]
497 Aralova NI; V. M. Glushkov Institute of Cybernetics of National Academy of Sciences of Ukraine, Kyiv. MATHEMATICAL MODEL FOR THE INVESTIGATION OF HYPOXIC STATES IN THE HEART MUSCLE AT VIRAL DAMAGE. Biotechnol acta 2021;14:38-52. [DOI: 10.15407/biotech14.04.038] [Reference Citation Analysis]
498 Li S, Jiang L, Li X, Lin F, Wang Y, Li B, Jiang T, An W, Liu S, Liu H, Xu P, Zhao L, Zhang L, Mu J, Wang H, Kang J, Li Y, Huang L, Zhu C, Zhao S, Lu J, Ji J, Zhao J. Clinical and pathological investigation of patients with severe COVID-19. JCI Insight 2020;5:138070. [PMID: 32427582 DOI: 10.1172/jci.insight.138070] [Cited by in Crossref: 94] [Cited by in F6Publishing: 91] [Article Influence: 47.0] [Reference Citation Analysis]
499 Zhang JY, Wang XM, Xing X, Xu Z, Zhang C, Song JW, Fan X, Xia P, Fu JL, Wang SY, Xu RN, Dai XP, Shi L, Huang L, Jiang TJ, Shi M, Zhang Y, Zumla A, Maeurer M, Bai F, Wang FS. Single-cell landscape of immunological responses in patients with COVID-19. Nat Immunol. 2020;21:1107-1118. [PMID: 32788748 DOI: 10.1038/s41590-020-0762-x] [Cited by in Crossref: 155] [Cited by in F6Publishing: 135] [Article Influence: 77.5] [Reference Citation Analysis]
500 Feng X, Li P, Ma L, Liang H, Lei J, Li W, Wang K, Song Y, Li S, Yang W, Yang C. Clinical Characteristics and Short-Term Outcomes of Severe Patients With COVID-19 in Wuhan, China. Front Med (Lausanne) 2020;7:491. [PMID: 32850926 DOI: 10.3389/fmed.2020.00491] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 8.0] [Reference Citation Analysis]
501 Morenikeji OB, Bernard K, Strutton E, Wallace M, Thomas BN. Evolutionarily Conserved Long Non-coding RNA Regulates Gene Expression in Cytokine Storm During COVID-19. Front Bioeng Biotechnol 2020;8:582953. [PMID: 33520952 DOI: 10.3389/fbioe.2020.582953] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
502 Hou X, Zhang X, Wu X, Lu M, Wang D, Xu M, Wang H, Liang T, Dai J, Duan H, Xu Y, Yu X, Li Y. Serum Protein Profiling Reveals a Landscape of Inflammation and Immune Signaling in Early-stage COVID-19 Infection. Mol Cell Proteomics 2020;19:1749-59. [PMID: 32788344 DOI: 10.1074/mcp.RP120.002128] [Cited by in Crossref: 16] [Cited by in F6Publishing: 6] [Article Influence: 8.0] [Reference Citation Analysis]
503 Sariol A, Perlman S. Lessons for COVID-19 Immunity from Other Coronavirus Infections. Immunity 2020;53:248-63. [PMID: 32717182 DOI: 10.1016/j.immuni.2020.07.005] [Cited by in Crossref: 126] [Cited by in F6Publishing: 110] [Article Influence: 63.0] [Reference Citation Analysis]
504 Yıldız E. Comparison of pure tone audiometry thresholds and transient evoked otoacoustic emissions (TEOAE) of patients with and without Covid-19 pneumonia. American Journal of Otolaryngology 2022. [DOI: 10.1016/j.amjoto.2022.103377] [Reference Citation Analysis]
505 Kinnare N, Hook JS, Patel PA, Monson NL, Moreland JG. Neutrophil Extracellular Trap Formation Potential Correlates with Lung Disease Severity in COVID-19 Patients. Inflammation 2021. [PMID: 34718927 DOI: 10.1007/s10753-021-01585-x] [Reference Citation Analysis]
506 Wang X, Gui J. Cell-mediated immunity to SARS-CoV-2. Pediatr Investig 2020;4:281-91. [PMID: 33376956 DOI: 10.1002/ped4.12228] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
507 Alonso-Lana S, Marquié M, Ruiz A, Boada M. Cognitive and Neuropsychiatric Manifestations of COVID-19 and Effects on Elderly Individuals With Dementia. Front Aging Neurosci 2020;12:588872. [PMID: 33192483 DOI: 10.3389/fnagi.2020.588872] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 13.0] [Reference Citation Analysis]
508 Rex DAB, Dagamajalu S, Kandasamy RK, Raju R, Prasad TSK. SARS-CoV-2 signaling pathway map: A functional landscape of molecular mechanisms in COVID-19. J Cell Commun Signal 2021. [PMID: 34181169 DOI: 10.1007/s12079-021-00632-4] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
509 Ferrari F, Martins VM, Teixeira M, Santos RD, Stein R. COVID-19 and Thromboinflammation: Is There a Role for Statins? Clinics (Sao Paulo) 2021;76:e2518. [PMID: 33787678 DOI: 10.6061/clinics/2021/e2518] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
510 Coloretti I, Berlot G, Busani S, De Rosa FG, Donati A, Forfori F, Grasselli G, Mirabella L, Tascini C, Viale P, Girardis M. Rationale for Polyclonal Intravenous Immunoglobulin Adjunctive Therapy in COVID-19 Patients: Report of a Structured Multidisciplinary Consensus. J Clin Med 2021;10:3500. [PMID: 34441796 DOI: 10.3390/jcm10163500] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
511 Combadière B, Adam L, Guillou N, Quentric P, Rosenbaum P, Dorgham K, Bonduelle O, Parizot C, Sauce D, Mayaux J, Luyt CE, Boissonnas A, Amoura Z, Pourcher V, Miyara M, Gorochov G, Guihot A, Combadière C. LOX-1-Expressing Immature Neutrophils Identify Critically-Ill COVID-19 Patients at Risk of Thrombotic Complications. Front Immunol 2021;12:752612. [PMID: 34616409 DOI: 10.3389/fimmu.2021.752612] [Reference Citation Analysis]
512 Fernández-Lázaro D, Fernandez-Lazaro CI, Mielgo-Ayuso J, Adams DP, García Hernández JL, González-Bernal J, González-Gross M. Glycophosphopeptical AM3 Food Supplement: A Potential Adjuvant in the Treatment and Vaccination of SARS-CoV-2. Front Immunol 2021;12:698672. [PMID: 34220861 DOI: 10.3389/fimmu.2021.698672] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
513 Awano N, Inomata M, Kuse N, Tone M, Takada K, Muto Y, Fujimoto K, Akagi Y, Mawatari M, Ueda A, Izumo T. Serum KL-6 level is a useful biomarker for evaluating the severity of coronavirus disease 2019. Respir Investig 2020:S2212-5345(20)30115-5. [PMID: 32863199 DOI: 10.1016/j.resinv.2020.07.004] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
514 Huang Y, Ling Q, Manyande A, Wu D, Xiang B. Brain Imaging Changes in Patients Recovered From COVID-19: A Narrative Review. Front Neurosci 2022;16:855868. [DOI: 10.3389/fnins.2022.855868] [Reference Citation Analysis]
515 Oyler-Yaniv J, Oyler-Yaniv A, Maltz E, Wollman R. TNF controls a speed-accuracy tradeoff in the cell death decision to restrict viral spread. Nat Commun 2021;12:2992. [PMID: 34016976 DOI: 10.1038/s41467-021-23195-9] [Reference Citation Analysis]
516 Zhou Z, Huang C, Zhou Z, Huang Z, Su L, Kang S, Chen X, Chen Q, He S, Rong X, Xiao F, Chen J, Chen S. Structural insight reveals SARS-CoV-2 ORF7a as an immunomodulating factor for human CD14+ monocytes. iScience 2021;24:102187. [PMID: 33615195 DOI: 10.1016/j.isci.2021.102187] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 10.0] [Reference Citation Analysis]
517 Sugiyama M, Kinoshita N, Ide S, Nomoto H, Nakamoto T, Saito S, Ishikane M, Kutsuna S, Hayakawa K, Hashimoto M, Suzuki M, Izumi S, Hojo M, Tsuchiya K, Gatanaga H, Takasaki J, Usami M, Kano T, Yanai H, Nishida N, Kanto T, Sugiyama H, Ohmagari N, Mizokami M. Serum CCL17 level becomes a predictive marker to distinguish between mild/moderate and severe/critical disease in patients with COVID-19. Gene 2021;766:145145. [PMID: 32941953 DOI: 10.1016/j.gene.2020.145145] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 6.0] [Reference Citation Analysis]
518 Xu K, Miao L, Chen W, Wu H, Gong Y, Tu X, Guo W, Pan B, Qu C, Wu X, Wang B. Establishment of the reference intervals of lymphocyte subsets for healthy Chinese Han adults and its influencing factors. Ann Transl Med 2021;9:1495. [PMID: 34805357 DOI: 10.21037/atm-21-4031] [Reference Citation Analysis]
519 Lin HS, Lin XH, Wang JW, Wen DN, Xiang J, Fan YQ, Li HD, Wu J, Lin Y, Lin YL, Sun XR, Chen YF, Chen CJ, Lian NF, Xie HS, Lin SH, Xie QF, Li CW, Peng FZ, Wang N, Lin JQ, Chen WJ, Huang CL, Fu Y. Exhausting T Cells During HIV Infection May Improve the Prognosis of Patients with COVID-19. Front Cell Infect Microbiol 2021;11:564938. [PMID: 34646783 DOI: 10.3389/fcimb.2021.564938] [Reference Citation Analysis]
520 Nakano H, Shiina K, Tomiyama H. Cardiovascular Outcomes in the Acute Phase of COVID-19. Int J Mol Sci 2021;22:4071. [PMID: 33920790 DOI: 10.3390/ijms22084071] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
521 Kang YW, Park S, Lee KJ, Moon D, Kim YM, Lee SW. Understanding the Host Innate Immune Responses against SARS-CoV-2 Infection and COVID-19 Pathogenesis. Immune Netw 2021;21:e1. [PMID: 33728094 DOI: 10.4110/in.2021.21.e1] [Reference Citation Analysis]
522 Zhang J, Gao XL, Yang LH. [Research progress in coagulation dysfunction and its relationship with cytokine storm syndrome in patients with severe/critical COVID-19]. Zhonghua Xue Ye Xue Za Zhi 2021;42:700-4. [PMID: 34547883 DOI: 10.3760/cma.j.issn.0253-2727.2021.08.019] [Reference Citation Analysis]
523 Chen R, Sang L, Jiang M, Yang Z, Jia N, Fu W, Xie J, Guan W, Liang W, Ni Z, Hu Y, Liu L, Shan H, Lei C, Peng Y, Wei L, Liu Y, Hu Y, Peng P, Wang J, Liu J, Chen Z, Li G, Zheng Z, Qiu S, Luo J, Ye C, Zhu S, Zheng J, Zhang N, Li Y, He J, Li J, Li S, Zhong N; Medical Treatment Expert Group for COVID-19. Longitudinal hematologic and immunologic variations associated with the progression of COVID-19 patients in China. J Allergy Clin Immunol 2020;146:89-100. [PMID: 32407836 DOI: 10.1016/j.jaci.2020.05.003] [Cited by in Crossref: 96] [Cited by in F6Publishing: 93] [Article Influence: 48.0] [Reference Citation Analysis]
524 Cainelli F, Dzudzor B, Lanzafame M, Goushchi A, Chhem S, Vento S. HIV and SARS-Coronavirus-2 Epidemics: Possible Interactions and Need for Studies, Especially in Africa. Front Med (Lausanne) 2020;7:216. [PMID: 32574323 DOI: 10.3389/fmed.2020.00216] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
525 Fu W, Wang W, Yuan L, Lin Y, Huang X, Chen R, Cai M, Liu C, Chen L, Zhou M, Wu K, Zhao H, Pan D, Ma J, Hong J, Zhai B, Zhang Y, Kong Z, Wang Y, Chen Y, Yuan Q, Zhu H, Cheng T, Guan Y, Xia N. A SCID mouse-human lung xenograft model of SARS-CoV-2 infection. Theranostics 2021;11:6607-15. [PMID: 33995679 DOI: 10.7150/thno.58321] [Reference Citation Analysis]
526 Su CM, Wang L, Yoo D. Activation of NF-κB and induction of proinflammatory cytokine expressions mediated by ORF7a protein of SARS-CoV-2. Sci Rep 2021;11:13464. [PMID: 34188167 DOI: 10.1038/s41598-021-92941-2] [Cited by in Crossref: 22] [Cited by in F6Publishing: 15] [Article Influence: 22.0] [Reference Citation Analysis]
527 Orumaa K, Dunne MR. The role of unconventional T cells in COVID-19. Ir J Med Sci 2021. [PMID: 34050887 DOI: 10.1007/s11845-021-02653-9] [Reference Citation Analysis]
528 Patel BV, Arachchillage DJ, Ridge CA, Bianchi P, Doyle JF, Garfield B, Ledot S, Morgan C, Passariello M, Price S, Singh S, Thakuria L, Trenfield S, Trimlett R, Weaver C, Wort SJ, Xu T, Padley SPG, Devaraj A, Desai SR. Pulmonary Angiopathy in Severe COVID-19: Physiologic, Imaging, and Hematologic Observations. Am J Respir Crit Care Med. 2020;202:690-699. [PMID: 32667207 DOI: 10.1164/rccm.202004-1412oc] [Cited by in Crossref: 93] [Cited by in F6Publishing: 60] [Article Influence: 46.5] [Reference Citation Analysis]
529 Kar M. Vascular Dysfunction and Its Cardiovascular Consequences During and After COVID-19 Infection: A Narrative Review. VHRM 2022;Volume 18:105-12. [DOI: 10.2147/vhrm.s355410] [Reference Citation Analysis]
530 Jiang L, Tang K, Irfan O, Li X, Zhang E, Bhutta Z. Epidemiology, Clinical Features, and Outcomes of Multisystem Inflammatory Syndrome in Children (MIS-C) and Adolescents—a Live Systematic Review and Meta-analysis. Curr Pediatr Rep. [DOI: 10.1007/s40124-022-00264-1] [Reference Citation Analysis]
531 Buckley LF, Wohlford GF, Ting C, Alahmed A, Van Tassell BW, Abbate A, Devlin JW, Libby P. Role for Anti-Cytokine Therapies in Severe Coronavirus Disease 2019. Crit Care Explor 2020;2:e0178. [PMID: 32832913 DOI: 10.1097/CCE.0000000000000178] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 6.0] [Reference Citation Analysis]
532 Robbins-Juarez SY, Qian L, King KL, Stevens JS, Husain SA, Radhakrishnan J, Mohan S. Outcomes for Patients with COVID-19 and Acute Kidney Injury: A Systematic Review and Meta-Analysis. Kidney Int Rep. 2020;5:1149-1160. [PMID: 32775814 DOI: 10.1016/j.ekir.2020.06.013] [Cited by in Crossref: 55] [Cited by in F6Publishing: 47] [Article Influence: 27.5] [Reference Citation Analysis]
533 Amigues I, Pearlman AH, Patel A, Reid P, Robinson PC, Sinha R, Kim AH, Youngstein T, Jayatilleke A, Konig M. Coronavirus disease 2019: investigational therapies in the prevention and treatment of hyperinflammation. Expert Rev Clin Immunol 2020;16:1185-204. [PMID: 33146561 DOI: 10.1080/1744666X.2021.1847084] [Cited by in Crossref: 13] [Cited by in F6Publishing: 4] [Article Influence: 6.5] [Reference Citation Analysis]
534 Hwang YC, Lu RM, Su SC, Chiang PY, Ko SH, Ke FY, Liang KH, Hsieh TY, Wu HC. Monoclonal antibodies for COVID-19 therapy and SARS-CoV-2 detection. J Biomed Sci 2022;29:1. [PMID: 34983527 DOI: 10.1186/s12929-021-00784-w] [Reference Citation Analysis]
535 Zeng Z, Yu H, Chen H, Qi W, Chen L, Chen G, Yan W, Chen T, Ning Q, Han M, Wu D. Longitudinal changes of inflammatory parameters and their correlation with disease severity and outcomes in patients with COVID-19 from Wuhan, China. Crit Care. 2020;24:525. [PMID: 32854750 DOI: 10.1186/s13054-020-03255-0] [Cited by in Crossref: 42] [Cited by in F6Publishing: 40] [Article Influence: 21.0] [Reference Citation Analysis]
536 Carneiro AS, Mafort TT, Lopes AJ. A 34-Year-Old Woman from Brazil with Pulmonary Lymphangioleiomyomatosis Diagnosed by Raised Serum Vascular Endothelial Growth Factor-D (VEGF-D) Levels and Lung Cysts on Computed Tomography Imaging Presenting with COVID-19 Pneumonia. Am J Case Rep 2021;22:e932660. [PMID: 34330886 DOI: 10.12659/AJCR.932660] [Reference Citation Analysis]
537 O'Brien ER, Sandhu JK. Sex differences in COVID-19 mortality: opportunity to develop HSP27 (HSPB1) immunotherapy to treat hyper-inflammation? Cell Stress Chaperones 2020;25:725-9. [PMID: 32761452 DOI: 10.1007/s12192-020-01146-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
538 Hausfater P, Charles P. Le dosage de la procalcitonine peut-il être utile à la prise en charge d’une infection à SARS-CoV-2 aux urgences et en réanimation ? Ann Fr Med Urgence 2021;11:243-8. [DOI: 10.3166/afmu-2021-0341] [Reference Citation Analysis]
539 Varghese GM, John R, Manesh A, Karthik R, Abraham OC. Clinical management of COVID-19. Indian J Med Res 2020;151:401-10. [PMID: 32611911 DOI: 10.4103/ijmr.IJMR_957_20] [Cited by in Crossref: 15] [Cited by in F6Publishing: 8] [Article Influence: 7.5] [Reference Citation Analysis]
540 Zhang J, Hao Y, Ou W, Ming F, Liang G, Qian Y, Cai Q, Dong S, Hu S, Wang W, Wei S. Serum interleukin-6 is an indicator for severity in 901 patients with SARS-CoV-2 infection: a cohort study. J Transl Med 2020;18:406. [PMID: 33121497 DOI: 10.1186/s12967-020-02571-x] [Cited by in Crossref: 27] [Cited by in F6Publishing: 30] [Article Influence: 13.5] [Reference Citation Analysis]
541 Mobasheri A. COVID-19, Companion Animals, Comparative Medicine, and One Health. Front Vet Sci 2020;7:522. [PMID: 32923472 DOI: 10.3389/fvets.2020.00522] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
542 Kohansal Vajari M, Shirin M, Pourbagheri-Sigaroodi A, Akbari ME, Abolghasemi H, Bashash D. COVID-19-related coagulopathy: A review of pathophysiology and pharmaceutical management. Cell Biol Int 2021. [PMID: 33945651 DOI: 10.1002/cbin.11623] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
543 Milovanovic L, Hessey E, Sebastianski M, Keto-Lambert D, Vandermeer B, Bagshaw SM, Rewa O. Epidemiology, clinical characteristics and treatment of critically ill patients with COVID-19): a protocol for a living systematic review. BMJ Open 2021;11:e042008. [PMID: 33402406 DOI: 10.1136/bmjopen-2020-042008] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
544 Vihinen M. Strategy for Disease Diagnosis, Progression Prediction, Risk Group Stratification and Treatment-Case of COVID-19. Front Med (Lausanne) 2020;7:294. [PMID: 32613004 DOI: 10.3389/fmed.2020.00294] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
545 Bernal-Monterde V, Casas-Deza D, Letona-Giménez L, de la Llama-Celis N, Calmarza P, Sierra-Gabarda O, Betoré-Glaria E, Martínez-de Lagos M, Martínez-Barredo L, Espinosa-Pérez M, M Arbones-Mainar J. SARS-CoV-2 Infection Induces a Dual Response in Liver Function Tests: Association with Mortality during Hospitalization. Biomedicines 2020;8:E328. [PMID: 32899640 DOI: 10.3390/biomedicines8090328] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
546 Tomerak S, Khan S, Almasri M, Hussein R, Abdelati A, Aly A, Salameh MA, Saed Aldien A, Naveed H, Elshazly MB, Zakaria D. Systemic inflammation in COVID‐19 patients may induce various types of venous and arterial thrombosis: A systematic review. Scand J Immunol 2021;94. [DOI: 10.1111/sji.13097] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
547 Sinha P, Mostaghim A, Bielick CG, McLaughlin A, Hamer DH, Wetzler LM, Bhadelia N, Fagan MA, Linas BP, Assoumou SA, Ieong MH, Lin NH, Cooper ER, Brade KD, White LF, Barlam TF, Sagar M; Boston Medical Center Covid-19 Treatment Panel. Early administration of interleukin-6 inhibitors for patients with severe COVID-19 disease is associated with decreased intubation, reduced mortality, and increased discharge. Int J Infect Dis 2020;99:28-33. [PMID: 32721528 DOI: 10.1016/j.ijid.2020.07.023] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 14.5] [Reference Citation Analysis]
548 Liu QQ, Cheng A, Wang Y, Li H, Hu L, Zhao X, Wang T, He F. Cytokines and their relationship with the severity and prognosis of coronavirus disease 2019 (COVID-19): a retrospective cohort study. BMJ Open 2020;10:e041471. [PMID: 33257492 DOI: 10.1136/bmjopen-2020-041471] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
549 Rahman AK, Purdy AG, Ender PT. COVID-19 Pneumonia in Patients on Chronic Hydroxychloroquine Therapy: Three Cases of COVID-19 Pneumonia. Case Rep Infect Dis 2020;2020:8822753. [PMID: 33123391 DOI: 10.1155/2020/8822753] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
550 Hu ZJ, Xu J, Yin JM, Li L, Hou W, Zhang LL, Zhou Z, Yu YZ, Li HJ, Feng YM, Jin RH. Lower Circulating Interferon-Gamma Is a Risk Factor for Lung Fibrosis in COVID-19 Patients. Front Immunol 2020;11:585647. [PMID: 33133104 DOI: 10.3389/fimmu.2020.585647] [Cited by in Crossref: 21] [Cited by in F6Publishing: 24] [Article Influence: 10.5] [Reference Citation Analysis]
551 Bintoro SUY, Dwijayanti NMI, Pramudya D, Amrita PN, Romadhon PZ, Asmarawati TP, Bachtiar A, Hadi U. Hematologic and coagulopathy parameter as a survival predictor among moderate to severe COVID-19 patients in non- ICU ward: a single-center study at the main referral hospital in Surabaya, East Java, Indonesia. F1000Res 2021;10:791. [PMID: 34904053 DOI: 10.12688/f1000research.53803.3] [Reference Citation Analysis]
552 Dvornikova KA, Bystrova EY, Churilov LP, Lerner A. Pathogenesis of the inflammatory bowel disease in context of SARS-COV-2 infection. Mol Biol Rep 2021;48:5745-58. [PMID: 34296352 DOI: 10.1007/s11033-021-06565-w] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
553 Ambrosino P, Di Minno A, Maniscalco M, Di Minno MND. COVID-19 and venous thromboembolism: current insights and prophylactic strategies. Ann Med 2020;52:239-42. [PMID: 32619360 DOI: 10.1080/07853890.2020.1791355] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
554 Wang X, Fang X, Cai Z, Wu X, Gao X, Min J, Wang F. Comorbid Chronic Diseases and Acute Organ Injuries Are Strongly Correlated with Disease Severity and Mortality among COVID-19 Patients: A Systemic Review and Meta-Analysis. Research (Wash D C) 2020;2020:2402961. [PMID: 32377638 DOI: 10.34133/2020/2402961] [Cited by in Crossref: 71] [Cited by in F6Publishing: 89] [Article Influence: 35.5] [Reference Citation Analysis]
555 Hamali HA, Saboor M, Dobie G, Madkhali AM, Akhter MS, Hakamy A, Al-mekhlafi HM, Jackson DE, Matari YH, Mobarki AA. Procoagulant Microvesicles in COVID-19 Patients: Possible Modulators of Inflammation and Prothrombotic Tendency. IDR 2022;Volume 15:2359-68. [DOI: 10.2147/idr.s355395] [Reference Citation Analysis]
556 Luan YY, Liu Y, Liu XY, Yu BJ, Chen RL, Peng M, Ren D, Li HL, Huang L, Li JX, Feng YW, Wu M. Coronavirus disease 2019 (COVID-19) associated coagulopathy and its impact on outcomes in Shenzhen, China: A retrospective cohort study. Thromb Res. 2020;195:62-68. [PMID: 32659462 DOI: 10.1016/j.thromres.2020.07.015] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
557 Cornelissen A, Kutyna M, Cheng Q, Sato Y, Kawakami R, Sakamoto A, Kawai K, Mori M, Fernandez R, Guo L, Pellegrini D, Guagliumi G, Barakat M, Virmani R, Finn A. Effects of simulated COVID-19 cytokine storm on stent thrombogenicity. Cardiovasc Revasc Med 2021:S1553-8389(21)00183-4. [PMID: 33863660 DOI: 10.1016/j.carrev.2021.03.023] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
558 Vellas C, Delobel P, de Souto Barreto P, Izopet J. COVID-19, Virology and Geroscience: A Perspective. J Nutr Health Aging 2020;24:685-91. [PMID: 32744561 DOI: 10.1007/s12603-020-1416-2] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 12.5] [Reference Citation Analysis]
559 Li P, Lu Z, Li Q, Wang Z, Guo Y, Cai C, Wang S, Liu P, Su X, Huang Y, Dong Y, Qiu W, Ling Y, Yarmus L, Luo F, Zeng L, Bai C, Zhang W. Administration Timing and Efficacy of Tocilizumab in Patients With COVID-19 and Elevated IL-6. Front Mol Biosci 2021;8:651662. [PMID: 33937333 DOI: 10.3389/fmolb.2021.651662] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
560 Husain-Syed F, Vadász I, Wilhelm J, Walmrath HD, Seeger W, Birk HW, Jennert B, Dietrich H, Herold S, Trauth J, Tello K, Sander M, Morty RE, Slanina H, Schüttler CG, Ziebuhr J, Kassoumeh S, Ronco C, Ferrari F, Warnatz K, Stahl K, Seeliger B, Hoeper MM, Welte T, David S. Immunoglobulin deficiency as an indicator of disease severity in patients with COVID-19. Am J Physiol Lung Cell Mol Physiol 2021;320:L590-9. [PMID: 33237794 DOI: 10.1152/ajplung.00359.2020] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
561 Kilic G, Bulut O, Jaeger M, Ter Horst R, Koeken VACM, Moorlag SJCFM, Mourits VP, de Bree C, Domínguez-Andrés J, Joosten LAB, Netea MG. The Immunological Factors Predisposing to Severe Covid-19 Are Already Present in Healthy Elderly and Men. Front Immunol 2021;12:720090. [PMID: 34434199 DOI: 10.3389/fimmu.2021.720090] [Reference Citation Analysis]
562 Lucas C, Klein J, Sundaram M, Liu F, Wong P, Silva J, Mao T, Oh JE, Tokuyama M, Lu P, Venkataraman A, Park A, Israelow B, Wyllie AL, Vogels CBF, Muenker MC, Casanovas-Massana A, Schulz WL, Zell J, Campbell M, Fournier JB, Grubaugh ND, Farhadian S, Wisnewski AV, Cruz CD, Omer S, Ko AI, Ring A, Iwasaki A. Kinetics of antibody responses dictate COVID-19 outcome. medRxiv 2020:2020. [PMID: 33398304 DOI: 10.1101/2020.12.18.20248331] [Cited by in Crossref: 11] [Cited by in F6Publishing: 15] [Article Influence: 5.5] [Reference Citation Analysis]
563 Inchingolo AD, Inchingolo AM, Bordea IR, Malcangi G, Xhajanka E, Scarano A, Lorusso F, Farronato M, Tartaglia GM, Isacco CG, Marinelli G, D'Oria MT, Hazballa D, Santacroce L, Ballini A, Contaldo M, Inchingolo F, Dipalma G. SARS-CoV-2 Disease Adjuvant Therapies and Supplements Breakthrough for the Infection Prevention. Microorganisms 2021;9:525. [PMID: 33806624 DOI: 10.3390/microorganisms9030525] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 8.0] [Reference Citation Analysis]
564 Pirofski LA, Casadevall A. Pathogenesis of COVID-19 from the Perspective of the Damage-Response Framework. mBio 2020;11:e01175-20. [PMID: 32616514 DOI: 10.1128/mBio.01175-20] [Cited by in Crossref: 27] [Cited by in F6Publishing: 18] [Article Influence: 13.5] [Reference Citation Analysis]
565 Dicker D, Bettini S, Farpour-Lambert N, Frühbeck G, Golan R, Goossens G, Halford J, O'Malley G, Mullerova D, Ramos Salas X, Hassapiou MN, Sagen J, Woodward E, Yumuk V, Busetto L. Obesity and COVID-19: The Two Sides of the Coin. Obes Facts 2020;13:430-8. [PMID: 32659766 DOI: 10.1159/000510005] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 7.5] [Reference Citation Analysis]
566 Colafrancesco S, Alessandri C, Conti F, Priori R. COVID-19 gone bad: A new character in the spectrum of the hyperferritinemic syndrome? Autoimmun Rev. 2020;19:102573. [PMID: 32387470 DOI: 10.1016/j.autrev.2020.102573] [Cited by in Crossref: 96] [Cited by in F6Publishing: 78] [Article Influence: 48.0] [Reference Citation Analysis]
567 Makedonas G, Mehta SK, Scheuring RA, Haddon R, Crucian BE. SARS-CoV-2 Pandemic Impacts on NASA Ground Operations to Protect ISS Astronauts. J Allergy Clin Immunol Pract 2020;8:3247-50. [PMID: 32971311 DOI: 10.1016/j.jaip.2020.08.064] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
568 Stark K, Massberg S. Interplay between inflammation and thrombosis in cardiovascular pathology. Nat Rev Cardiol 2021;18:666-82. [PMID: 33958774 DOI: 10.1038/s41569-021-00552-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
569 Pascreau T, Tcherakian C, Zuber B, Farfour E, Vasse M, Lassalle P. A high blood endocan profile during COVID-19 distinguishes moderate from severe acute respiratory distress syndrome. Crit Care 2021;25:166. [PMID: 33957951 DOI: 10.1186/s13054-021-03589-3] [Reference Citation Analysis]
570 Chandler CM, Reid MC, Cherian S, Sabath DE, Edlefsen KL. Comparison of Blood Counts and Markers of Inflammation and Coagulation in Patients With and Without COVID-19 Presenting to the Emergency Department in Seattle, WA. Am J Clin Pathol 2021;156:185-97. [PMID: 34151348 DOI: 10.1093/ajcp/aqab052] [Reference Citation Analysis]
571 Naderi M, Malek F, Miri Aliabad G, Behnampoor M, Karimi M, De Sanctis V. Congenital Bleeding Disorders amid the COVID-19 pandemic: Open questions and recommendations. Acta Biomed 2020;91:e2020028. [PMID: 32921723 DOI: 10.23750/abm.v91i3.10203] [Reference Citation Analysis]
572 Nicastro E, Verdoni L, Bettini LR, Zuin G, Balduzzi A, Montini G, Biondi A, D'Antiga L. COVID-19 in Immunosuppressed Children. Front Pediatr 2021;9:629240. [PMID: 33996683 DOI: 10.3389/fped.2021.629240] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
573 Bao J, Li C, Zhang K, Kang H, Chen W, Gu B. Comparative analysis of laboratory indexes of severe and non-severe patients infected with COVID-19. Clin Chim Acta 2020;509:180-94. [PMID: 32511971 DOI: 10.1016/j.cca.2020.06.009] [Cited by in Crossref: 34] [Cited by in F6Publishing: 30] [Article Influence: 17.0] [Reference Citation Analysis]
574 Chambers ES, Akbar AN. Reply. J Allergy Clin Immunol 2020;146:922-3. [PMID: 32718758 DOI: 10.1016/j.jaci.2020.06.020] [Reference Citation Analysis]
575 Wei XS, Wang XR, Zhang JC, Yang WB, Ma WL, Yang BH, Jiang NC, Gao ZC, Shi HZ, Zhou Q. A cluster of health care workers with COVID-19 pneumonia caused by SARS-CoV-2. J Microbiol Immunol Infect 2021;54:54-60. [PMID: 32359943 DOI: 10.1016/j.jmii.2020.04.013] [Cited by in Crossref: 24] [Cited by in F6Publishing: 29] [Article Influence: 12.0] [Reference Citation Analysis]
576 Sadd C, Rowe T, Nazeef M, Kory P, Sultan S, Faust H. Thromboelastography to Detect Hypercoagulability and Reduced Fibrinolysis in Coronavirus Disease 2019 Acute Respiratory Distress Syndrome Patients. Crit Care Explor 2020;2:e0192. [PMID: 32984828 DOI: 10.1097/CCE.0000000000000192] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
577 Sfera A, Osorio C, Zapata Martín Del Campo CM, Pereida S, Maurer S, Maldonado JC, Kozlakidis Z. Endothelial Senescence and Chronic Fatigue Syndrome, a COVID-19 Based Hypothesis. Front Cell Neurosci 2021;15:673217. [PMID: 34248502 DOI: 10.3389/fncel.2021.673217] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
578 Liu C, Chu D, Kalantar-Zadeh K, George J, Young HA, Liu G. Cytokines: From Clinical Significance to Quantification. Adv Sci (Weinh) 2021;8:e2004433. [PMID: 34114369 DOI: 10.1002/advs.202004433] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
579 Rha MS, Jeong HW, Ko JH, Choi SJ, Seo IH, Lee JS, Sa M, Kim AR, Joo EJ, Ahn JY, Kim JH, Song KH, Kim ES, Oh DH, Ahn MY, Choi HK, Jeon JH, Choi JP, Kim HB, Kim YK, Park SH, Choi WS, Choi JY, Peck KR, Shin EC. PD-1-Expressing SARS-CoV-2-Specific CD8+ T Cells Are Not Exhausted, but Functional in Patients with COVID-19. Immunity 2021;54:44-52.e3. [PMID: 33338412 DOI: 10.1016/j.immuni.2020.12.002] [Cited by in Crossref: 44] [Cited by in F6Publishing: 45] [Article Influence: 22.0] [Reference Citation Analysis]
580 Yang L, Xie X, Tu Z, Fu J, Xu D, Zhou Y. The signal pathways and treatment of cytokine storm in COVID-19. Signal Transduct Target Ther 2021;6:255. [PMID: 34234112 DOI: 10.1038/s41392-021-00679-0] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
581 Guo L, Xiong W, Liu D, Feng Y, Wang P, Dong X, Chen R, Wang Y, Zhang L, Huang J, Summah HD, Lu F, Xie Y, Lin H, Yan J, Lu H, Zhou M, Qu J. The mNCP-SPI Score Predicting Risk of Severe COVID-19 among Mild-Pneumonia Patients on Admission. Infect Drug Resist 2020;13:3593-600. [PMID: 33116679 DOI: 10.2147/IDR.S263157] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
582 Gutiérrez-Chamorro L, Riveira-Muñoz E, Barrios C, Palau V, Nevot M, Pedreño-López S, Senserrich J, Massanella M, Clotet B, Cabrera C, Mitjà O, Crespo M, Pascual J, Riera M, Ballana E. SARS-CoV-2 Infection Modulates ACE2 Function and Subsequent Inflammatory Responses in Swabs and Plasma of COVID-19 Patients. Viruses 2021;13:1715. [PMID: 34578296 DOI: 10.3390/v13091715] [Reference Citation Analysis]
583 Vojvodic Hernandez IM, Ortega-checa DA, Pinares-carrillo D, Alemán-lópez J, Aburto-loroña V. Operaciones abdominopélvicas de emergencia en pacientes con COVID-19 en el Hospital Edgardo Rebagliati- EsSALUD. Rev Colomb Cir 2020;35:414-21. [DOI: 10.30944/20117582.697] [Reference Citation Analysis]
584 Denson JL, Gillet AS, Zu Y, Brown M, Pham T, Yoshida Y, Mauvais-Jarvis F, Douglas IS, Moore M, Tea K, Wetherbie A, Stevens R, Lefante J, Shaffer JG, Armaignac DL, Belden KA, Kaufman M, Heavner SF, Danesh VC, Cheruku SR, St Hill CA, Boman K, Deo N, Bansal V, Kumar VK, Walkey AJ, Kashyap R; Society of Critical Care Medicine Discovery Viral Infection and Respiratory Illness Universal Study (VIRUS): COVID-19 Registry Investigator Group. Metabolic Syndrome and Acute Respiratory Distress Syndrome in Hospitalized Patients With COVID-19. JAMA Netw Open 2021;4:e2140568. [PMID: 34935924 DOI: 10.1001/jamanetworkopen.2021.40568] [Reference Citation Analysis]
585 Hornick A, Tashtish N, Osnard M, Shah B, Bradigan A, Albar Z, Tomalka J, Dalton J, Sharma A, Sekaly RP, Hejal R, Simon DI, Zidar DA, Al-Kindi SG; Inaction Study Group. Anisocytosis is Associated With Short-Term Mortality in COVID-19 and May Reflect Proinflammatory Signature in Uninfected Ambulatory Adults. Pathog Immun 2020;5:312-26. [PMID: 33089037 DOI: 10.20411/pai.v5i1.391] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
586 Dutta S, Das N, Mukherjee P. Picking up a Fight: Fine Tuning Mitochondrial Innate Immune Defenses Against RNA Viruses. Front Microbiol 2020;11:1990. [PMID: 32983015 DOI: 10.3389/fmicb.2020.01990] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
587 Flanagan KL, Best E, Crawford NW, Giles M, Koirala A, Macartney K, Russell F, Teh BW, Wen SC. Progress and Pitfalls in the Quest for Effective SARS-CoV-2 (COVID-19) Vaccines. Front Immunol 2020;11:579250. [PMID: 33123165 DOI: 10.3389/fimmu.2020.579250] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 12.0] [Reference Citation Analysis]
588 Muscogiuri G, Bettini S, Boschetti M, Barrea L, Savastano S, Colao A; Obesity Programs of nutrition, Education, Research and Assessment (OPERA) group. Low-grade inflammation, CoVID-19, and obesity: clinical aspect and molecular insights in childhood and adulthood. Int J Obes (Lond) 2022. [PMID: 35393519 DOI: 10.1038/s41366-022-01111-5] [Reference Citation Analysis]
589 Copaescu A, Smibert O, Gibson A, Phillips EJ, Trubiano JA. The role of IL-6 and other mediators in the cytokine storm associated with SARS-CoV-2 infection. J Allergy Clin Immunol. 2020;146:518-534.e1. [PMID: 32896310 DOI: 10.1016/j.jaci.2020.07.001] [Cited by in Crossref: 38] [Cited by in F6Publishing: 43] [Article Influence: 19.0] [Reference Citation Analysis]
590 Guillon A, Hiemstra PS, Si-Tahar M. Pulmonary immune responses against SARS-CoV-2 infection: harmful or not? Intensive Care Med 2020;46:1897-900. [PMID: 32681297 DOI: 10.1007/s00134-020-06170-8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
591 Tang G, Huang M, Luo Y, Liu W, Lin Q, Mao L, Wu S, Xiong Z, Hou H, Sun Z, Wang F. The Dynamic Immunological Parameter Landscape in Coronavirus Disease 2019 Patients With Different Outcomes. Front Immunol 2021;12:697622. [PMID: 34777333 DOI: 10.3389/fimmu.2021.697622] [Reference Citation Analysis]
592 Luo H, Jia T, Chen J, Zeng S, Qiu Z, Wu S, Li X, Lei Y, Wang X, Wu W, Zhang R, Zou X, Feng T, Ding R, Zhang Y, Chen YQ, Sun C, Wang T, Fang S, Shu Y. The Characterization of Disease Severity Associated IgG Subclasses Response in COVID-19 Patients. Front Immunol 2021;12:632814. [PMID: 33763078 DOI: 10.3389/fimmu.2021.632814] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
593 Petrara MR, Bonfante F, Costenaro P, Cantarutti A, Carmona F, Ruffoni E, Di Chiara C, Zanchetta M, Barzon L, Donà D, Da Dalt L, Bortolami A, Pagliari M, Plebani M, Rossi P, Cotugno N, Palma P, Giaquinto C, De Rossi A. Asymptomatic and Mild SARS-CoV-2 Infections Elicit Lower Immune Activation and Higher Specific Neutralizing Antibodies in Children Than in Adults. Front Immunol 2021;12:741796. [PMID: 34659235 DOI: 10.3389/fimmu.2021.741796] [Reference Citation Analysis]
594 Viswanathan S. Management of Idiopathic CNS inflammatory diseases during the COVID-19 pandemic: Perspectives and strategies for continuity of care from a South East Asian Center with limited resources. Mult Scler Relat Disord 2020;44:102353. [PMID: 32653804 DOI: 10.1016/j.msard.2020.102353] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
595 Ghasemzadeh M, Ghasemzadeh A, Hosseini E. Exhausted NK cells and cytokine storms in COVID-19: Whether NK cell therapy could be a therapeutic choice. Hum Immunol 2021:S0198-8859(21)00230-5. [PMID: 34583856 DOI: 10.1016/j.humimm.2021.09.004] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
596 Bertoletti A, Le Bert N, Qui M, Tan AT. SARS-CoV-2-specific T cells in infection and vaccination. Cell Mol Immunol 2021;18:2307-12. [PMID: 34471260 DOI: 10.1038/s41423-021-00743-3] [Cited by in Crossref: 4] [Article Influence: 4.0] [Reference Citation Analysis]
597 Wang H, Wang Z, Cao W, Wu Q, Yuan Y, Zhang X. Regulatory T cells in COVID-19. Aging Dis 2021;12:1545-53. [PMID: 34631206 DOI: 10.14336/AD.2021.0709] [Reference Citation Analysis]
598 Desai N, Neyaz A, Szabolcs A, Shih AR, Chen JH, Thapar V, Nieman LT, Solovyov A, Mehta A, Lieb DJ, Kulkarni AS, Jaicks C, Xu KH, Raabe MJ, Pinto CJ, Juric D, Chebib I, Colvin RB, Kim AY, Monroe R, Warren SE, Danaher P, Reeves JW, Gong J, Rueckert EH, Greenbaum BD, Hacohen N, Lagana SM, Rivera MN, Sholl LM, Stone JR, Ting DT, Deshpande V. Temporal and spatial heterogeneity of host response to SARS-CoV-2 pulmonary infection. Nat Commun 2020;11:6319. [PMID: 33298930 DOI: 10.1038/s41467-020-20139-7] [Cited by in Crossref: 37] [Cited by in F6Publishing: 46] [Article Influence: 18.5] [Reference Citation Analysis]
599 Belvis R. Headaches During COVID-19: My Clinical Case and Review of the Literature. Headache 2020;60:1422-6. [PMID: 32413158 DOI: 10.1111/head.13841] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 15.5] [Reference Citation Analysis]
600 Rogers JP, Chesney E, Oliver D, Pollak TA, McGuire P, Fusar-Poli P, Zandi MS, Lewis G, David AS. Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta-analysis with comparison to the COVID-19 pandemic. Lancet Psychiatry. 2020;7:611-627. [PMID: 32437679 DOI: 10.1016/s2215-0366(20)30203-0] [Cited by in Crossref: 617] [Cited by in F6Publishing: 374] [Article Influence: 308.5] [Reference Citation Analysis]
601 Delavari S, Abolhassani H, Abolnezhadian F, Babaha F, Iranparast S, Ahanchian H, Moazzen N, Nabavi M, Arshi S, Fallahpour M, Bemanian MH, Shokri S, Momen T, Sadeghi-Shabestari M, Molatefi R, Shirkani A, Vosughimotlagh A, Safarirad M, Sharifzadeh M, Pashangzadeh S, Salami F, Shirmast P, Rezaei A, Moeini Shad T, Mohraz M, Rezaei N, Hammarström L, Yazdani R, Aghamohamamdi A. Impact of SARS-CoV-2 Pandemic on Patients with Primary Immunodeficiency. J Clin Immunol 2021;41:345-55. [PMID: 33263173 DOI: 10.1007/s10875-020-00928-x] [Cited by in Crossref: 23] [Cited by in F6Publishing: 26] [Article Influence: 11.5] [Reference Citation Analysis]
602 Zeng X, Song X, Ma T, Pan X, Zhou Y, Hou Y, Zhang Z, Li K, Karypis G, Cheng F. Repurpose Open Data to Discover Therapeutics for COVID-19 Using Deep Learning. J Proteome Res 2020;19:4624-36. [PMID: 32654489 DOI: 10.1021/acs.jproteome.0c00316] [Cited by in Crossref: 48] [Cited by in F6Publishing: 38] [Article Influence: 24.0] [Reference Citation Analysis]
603 Tang Y, Liu J, Zhang D, Xu Z, Ji J, Wen C. Cytokine Storm in COVID-19: The Current Evidence and Treatment Strategies. Front Immunol. 2020;11:1708. [PMID: 32754163 DOI: 10.3389/fimmu.2020.01708] [Cited by in Crossref: 246] [Cited by in F6Publishing: 229] [Article Influence: 123.0] [Reference Citation Analysis]
604 Eisenhut M, Shin JI. Pathways in the Pathophysiology of Coronavirus 19 Lung Disease Accessible to Prevention and Treatment. Front Physiol 2020;11:872. [PMID: 32922301 DOI: 10.3389/fphys.2020.00872] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
605 Das S, Kar SS, Samanta S, Banerjee J, Giri B, Dash SK. Immunogenic and reactogenic efficacy of Covaxin and Covishield: a comparative review. Immunol Res 2022. [PMID: 35192185 DOI: 10.1007/s12026-022-09265-0] [Reference Citation Analysis]
606 Bleyzac N, Goutelle S, Bourguignon L, Tod M. Azithromycin for COVID-19: More Than Just an Antimicrobial? Clin Drug Investig. 2020;40:683-686. [PMID: 32533455 DOI: 10.1007/s40261-020-00933-3] [Cited by in Crossref: 32] [Cited by in F6Publishing: 28] [Article Influence: 16.0] [Reference Citation Analysis]
607 Janik E, Niemcewicz M, Podogrocki M, Saluk-Bijak J, Bijak M. Existing Drugs Considered as Promising in COVID-19 Therapy. Int J Mol Sci 2021;22:5434. [PMID: 34063964 DOI: 10.3390/ijms22115434] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
608 Karimian M, Azami M. Chest computed tomography scan findings of coronavirus disease 2019 (COVID-19) patients: a comprehensive systematic review and meta-analysis. Pol J Radiol 2021;86:e31-49. [PMID: 33708271 DOI: 10.5114/pjr.2021.103379] [Reference Citation Analysis]
609 Vella L, Giles JR, Baxter AE, Oldridge DA, Diorio C, Kuri-Cervantes L, Alanio C, Pampena MB, Wu JE, Chen Z, Huang YJ, Anderson EM, Gouma S, McNerney KO, Chase J, Burudpakdee C, Lee JH, Apostolidis SA, Huang AC, Mathew D, Kuthuru O, Goodwin EC, Weirick ME, Bolton MJ, Arevalo CP, Ramos A, Jasen C, Giannini HM, DAndrea K, Meyer NJ, Behrens EM, Bassiri H, Hensley SE, Henrickson SE, Teachey DT, Betts MR, Wherry EJ. Deep Immune Profiling of MIS-C demonstrates marked but transient immune activation compared to adult and pediatric COVID-19. medRxiv 2020:2020. [PMID: 32995826 DOI: 10.1101/2020.09.25.20201863] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 3.5] [Reference Citation Analysis]
610 Fan Y, Wang Y, Yu S, Chang J, Yan Y, Wang Y, Bian Y. Natural products provide a new perspective for anti-complement treatment of severe COVID-19: a review. Chin Med 2021;16:67. [PMID: 34321065 DOI: 10.1186/s13020-021-00478-3] [Reference Citation Analysis]
611 Hu D, Li L, Shi W, Zhang L. Less expression of CD4+ and CD8+ T cells might reflect the severity of infection and predict worse prognosis in patients with COVID-19: Evidence from a pooled analysis. Clin Chim Acta 2020;510:1-4. [PMID: 32598880 DOI: 10.1016/j.cca.2020.06.040] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
612 Berthelot JM, Drouet L, Lioté F. Kawasaki-like diseases and thrombotic coagulopathy in COVID-19: delayed over-activation of the STING pathway? Emerg Microbes Infect 2020;9:1514-22. [PMID: 32574107 DOI: 10.1080/22221751.2020.1785336] [Cited by in Crossref: 24] [Cited by in F6Publishing: 29] [Article Influence: 12.0] [Reference Citation Analysis]
613 Neurath MF. COVID-19 and immunomodulation in IBD. Gut 2020;69:1335-42. [PMID: 32303609 DOI: 10.1136/gutjnl-2020-321269] [Cited by in Crossref: 108] [Cited by in F6Publishing: 102] [Article Influence: 54.0] [Reference Citation Analysis]
614 Borie R, Savale L, Dossier A, Ghosn J, Taillé C, Visseaux B, Jebreen K, Diallo A, Tesmoingt C, Morer L, Goletto T, Faucher N, Hajouji L, Neukirch C, Phillips M, Stelianides S, Bouadma L, Brosseau S, Ottaviani S, Pluvy J, Le Pluart D, Debray MP, Raynaud-Simon A, Descamps D, Khalil A, Timsit JF, Lescure FX, Descamps V, Papo T, Humbert M, Crestani B, Dieude P, Vicaut E, Zalcman G; Bichat & Kremlin-Bicêtre AP-HP COVID teams. Glucocorticoids with low-dose anti-IL1 anakinra rescue in severe non-ICU COVID-19 infection: A cohort study. PLoS One 2020;15:e0243961. [PMID: 33326457 DOI: 10.1371/journal.pone.0243961] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
615 Le NPK, Herz C, Gomes JVD, Förster N, Antoniadou K, Mittermeier-Kleßinger VK, Mewis I, Dawid C, Ulrichs C, Lamy E. Comparative Anti-Inflammatory Effects of Salix Cortex Extracts and Acetylsalicylic Acid in SARS-CoV-2 Peptide and LPS-Activated Human In Vitro Systems. Int J Mol Sci 2021;22:6766. [PMID: 34201817 DOI: 10.3390/ijms22136766] [Reference Citation Analysis]
616 Dennison JJ, Carlson S, Faehling S, Phelan H, Tariq M, Mubarik A. Splenic infarction and spontaneous rectus sheath hematomas in COVID-19 patient. Radiol Case Rep 2021;16:999-1004. [PMID: 33619439 DOI: 10.1016/j.radcr.2021.02.016] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
617 Del Nonno F, Nardacci R, Colombo D, Visco-Comandini U, Cicalini S, Antinori A, Marchioni L, D'Offizi G, Piacentini M, Falasca L. Hepatic Failure in COVID-19: Is Iron Overload the Dangerous Trigger? Cells 2021;10:1103. [PMID: 34064487 DOI: 10.3390/cells10051103] [Reference Citation Analysis]
618 Kaser A. Genetic Risk of Severe Covid-19. N Engl J Med 2020;383:1590-1. [PMID: 33053291 DOI: 10.1056/NEJMe2025501] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
619 Xiao LS, Zhang WF, Gong MC, Zhang YP, Chen LY, Zhu HB, Hu CY, Kang P, Liu L, Zhu H. Development and validation of the HNC-LL score for predicting the severity of coronavirus disease 2019. EBioMedicine 2020;57:102880. [PMID: 32645614 DOI: 10.1016/j.ebiom.2020.102880] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 8.0] [Reference Citation Analysis]
620 Vella LA, Giles JR, Baxter AE, Oldridge DA, Diorio C, Kuri-Cervantes L, Alanio C, Pampena MB, Wu JE, Chen Z, Huang YJ, Anderson EM, Gouma S, McNerney KO, Chase J, Burudpakdee C, Lee JH, Apostolidis SA, Huang AC, Mathew D, Kuthuru O, Goodwin EC, Weirick ME, Bolton MJ, Arevalo CP, Ramos A, Jasen CJ, Conrey PE, Sayed S, Giannini HM, D'Andrea K, Meyer NJ, Behrens EM, Bassiri H, Hensley SE, Henrickson SE, Teachey DT, Betts MR, Wherry EJ; UPenn COVID Processing Unit. Deep immune profiling of MIS-C demonstrates marked but transient immune activation compared to adult and pediatric COVID-19. Sci Immunol 2021;6:eabf7570. [PMID: 33653907 DOI: 10.1126/sciimmunol.abf7570] [Cited by in Crossref: 22] [Cited by in F6Publishing: 29] [Article Influence: 22.0] [Reference Citation Analysis]
621 Lasbleiz A, Gaborit B, Soghomonian A, Bartoli A, Ancel P, Jacquier A, Dutour A. COVID-19 and Obesity: Role of Ectopic Visceral and Epicardial Adipose Tissues in Myocardial Injury. Front Endocrinol (Lausanne) 2021;12:726967. [PMID: 34484128 DOI: 10.3389/fendo.2021.726967] [Reference Citation Analysis]
622 Polidoro RB, Hagan RS, de Santis Santiago R, Schmidt NW. Overview: Systemic Inflammatory Response Derived From Lung Injury Caused by SARS-CoV-2 Infection Explains Severe Outcomes in COVID-19. Front Immunol 2020;11:1626. [PMID: 32714336 DOI: 10.3389/fimmu.2020.01626] [Cited by in Crossref: 43] [Cited by in F6Publishing: 40] [Article Influence: 21.5] [Reference Citation Analysis]
623 Han Q, Guo M, Zheng Y, Zhang Y, De Y, Xu C, Zhang L, Sun R, Lv Y, Liang Y, Xu F, Pang J, Chen Y. Current Evidence of Interleukin-6 Signaling Inhibitors in Patients With COVID-19: A Systematic Review and Meta-Analysis. Front Pharmacol 2020;11:615972. [PMID: 33384605 DOI: 10.3389/fphar.2020.615972] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 6.0] [Reference Citation Analysis]
624 Mahboubi Mehrabani M, Karvandi MS, Maafi P, Doroudian M. Neurological complications associated with Covid-19; molecular mechanisms and therapeutic approaches. Rev Med Virol 2022;:e2334. [PMID: 35138001 DOI: 10.1002/rmv.2334] [Reference Citation Analysis]
625 Kifle ZD. Bruton tyrosine kinase inhibitors as potential therapeutic agents for COVID-19: A review. Metabol Open 2021;11:100116. [PMID: 34345815 DOI: 10.1016/j.metop.2021.100116] [Reference Citation Analysis]
626 Manosso LM, Arent CO, Borba LA, Ceretta LB, Quevedo J, Réus GZ. Microbiota-Gut-Brain Communication in the SARS-CoV-2 Infection. Cells 2021;10:1993. [PMID: 34440767 DOI: 10.3390/cells10081993] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
627 Bibert S, Guex N, Lourenco J, Brahier T, Papadimitriou-Olivgeris M, Damonti L, Manuel O, Liechti R, Götz L, Tschopp J, Quinodoz M, Vollenweider P, Pagani JL, Oddo M, Hügli O, Lamoth F, Erard V, Voide C, Delorenzi M, Rufer N, Candotti F, Rivolta C, Boillat-Blanco N, Bochud PY; RegCOVID Study Group. Transcriptomic Signature Differences Between SARS-CoV-2 and Influenza Virus Infected Patients. Front Immunol 2021;12:666163. [PMID: 34135895 DOI: 10.3389/fimmu.2021.666163] [Reference Citation Analysis]
628 Liu P, Li S, Tang L. Nerve Growth Factor: A Potential Therapeutic Target for Lung Diseases. Int J Mol Sci 2021;22:9112. [PMID: 34502019 DOI: 10.3390/ijms22179112] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
629 Li M, Yeung CHC, Schooling CM. Circulating Cytokines and Coronavirus Disease: A Bi-Directional Mendelian Randomization Study. Front Genet 2021;12:680646. [PMID: 34163532 DOI: 10.3389/fgene.2021.680646] [Reference Citation Analysis]
630 Saunders HA, Schwartz JM. COVID-19 vaccination strategies depend on the underlying network of social interactions. Sci Rep 2021;11:24051. [PMID: 34912001 DOI: 10.1038/s41598-021-03167-1] [Reference Citation Analysis]
631 Basso C, Leone O, Rizzo S, De Gaspari M, van der Wal AC, Aubry MC, Bois MC, Lin PT, Maleszewski JJ, Stone JR. Pathological features of COVID-19-associated myocardial injury: a multicentre cardiovascular pathology study. Eur Heart J. 2020;41:3827-3835. [PMID: 32968776 DOI: 10.1093/eurheartj/ehaa664] [Cited by in Crossref: 108] [Cited by in F6Publishing: 109] [Article Influence: 108.0] [Reference Citation Analysis]
632 Yue-liang X, Jiang-lin W, Hui-qin Y, Ge Z, Hongyu D, Wei-jin F, Xiao-cong Z. The risk factors for severe patients with COVID-19 in China: A systematic review and meta-analysis. Eur J Inflamm 2021;19:205873922110008. [DOI: 10.1177/20587392211000890] [Reference Citation Analysis]
633 Elkoshi Z. The Binary Model of Chronic Diseases Applied to COVID-19. Front Immunol 2021;12:716084. [PMID: 34539649 DOI: 10.3389/fimmu.2021.716084] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
634 Noris M, Benigni A, Remuzzi G. The case of complement activation in COVID-19 multiorgan impact. Kidney Int. 2020;98:314-322. [PMID: 32461141 DOI: 10.1016/j.kint.2020.05.013] [Cited by in Crossref: 116] [Cited by in F6Publishing: 110] [Article Influence: 58.0] [Reference Citation Analysis]
635 Peñaloza HF, Lee JS, Ray P. Neutrophils and lymphopenia, an unknown axis in severe COVID-19 disease. PLoS Pathog 2021;17:e1009850. [PMID: 34473802 DOI: 10.1371/journal.ppat.1009850] [Reference Citation Analysis]
636 Gallieni M, Sabiu G, Scorza D. Delivering Safe and Effective Hemodialysis in Patients with Suspected or Confirmed COVID-19 Infection: A Single-Center Perspective from Italy. Kidney360 2020;1:403-9. [DOI: 10.34067/kid.0001782020] [Cited by in Crossref: 7] [Article Influence: 3.5] [Reference Citation Analysis]
637 Ramtohul T, Cabel L, Paoletti X, Chiche L, Moreau P, Noret A, Vuagnat P, Cherel P, Tardivon A, Cottu P, Bidard FC, Servois V. Quantitative CT Extent of Lung Damage in COVID-19 Pneumonia Is an Independent Risk Factor for Inpatient Mortality in a Population of Cancer Patients: A Prospective Study. Front Oncol 2020;10:1560. [PMID: 33014804 DOI: 10.3389/fonc.2020.01560] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
638 Corrao S, Gervasi F, Di Bernardo F, Natoli G, Raspanti M, Catalano N, Argano C. Immunological Characteristics of Non-Intensive Care Hospitalized COVID-19 Patients: A Preliminary Report. J Clin Med 2021;10:849. [PMID: 33669527 DOI: 10.3390/jcm10040849] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
639 Dziedzic A, Saluk-Bijak J, Miller E, Niemcewicz M, Bijak M. The Impact of SARS-CoV-2 Infection on the Development of Neurodegeneration in Multiple Sclerosis. Int J Mol Sci 2021;22:1804. [PMID: 33670394 DOI: 10.3390/ijms22041804] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
640 Saji R, Nishii M, Sakai K, Miyakawa K, Yamaoka Y, Ban T, Abe T, Ohyama Y, Nakajima K, Hiromi T, Matsumura R, Suzuki N, Taniguchi H, Otsuka T, Oi Y, Ogawa F, Uchiyama M, Takahashi K, Iwashita M, Kimura Y, Fujii S, Furuya R, Tamura T, Ryo A, Takeuchi I. Combining IL-6 and SARS-CoV-2 RNAaemia-based risk stratification for fatal outcomes of COVID-19. PLoS One 2021;16:e0256022. [PMID: 34379684 DOI: 10.1371/journal.pone.0256022] [Reference Citation Analysis]
641 Mudgal R, Nehul S, Tomar S. Prospects for mucosal vaccine: shutting the door on SARS-CoV-2. Hum Vaccin Immunother 2020;16:2921-31. [PMID: 32931361 DOI: 10.1080/21645515.2020.1805992] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
642 Gies V, Bekaddour N, Dieudonné Y, Guffroy A, Frenger Q, Gros F, Rodero MP, Herbeuval JP, Korganow AS. Beyond Anti-viral Effects of Chloroquine/Hydroxychloroquine. Front Immunol 2020;11:1409. [PMID: 32714335 DOI: 10.3389/fimmu.2020.01409] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 10.0] [Reference Citation Analysis]
643 Elhamzaoui H, Rebahi H, Hachimi A. Coronavirus disease 2019 (COVID-19) pathogenesis: a concise narrative review. Pan Afr Med J 2021;39:8. [PMID: 34178236 DOI: 10.11604/pamj.2021.39.8.23546] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
644 Hemida MG. The next-generation coronavirus diagnostic techniques with particular emphasis on the SARS-CoV-2. J Med Virol 2021;93:4219-41. [PMID: 33751621 DOI: 10.1002/jmv.26926] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
645 Puray-Chavez M, LaPak KM, Schrank TP, Elliott JL, Bhatt DP, Agajanian MJ, Jasuja R, Lawson DQ, Davis K, Rothlauf PW, Liu Z, Jo H, Lee N, Tenneti K, Eschbach JE, Shema Mugisha C, Cousins EM, Cloer EW, Vuong HR, VanBlargan LA, Bailey AL, Gilchuk P, Crowe JE Jr, Diamond MS, Hayes DN, Whelan SPJ, Horani A, Brody SL, Goldfarb D, Major MB, Kutluay SB. Systematic analysis of SARS-CoV-2 infection of an ACE2-negative human airway cell. Cell Rep 2021;36:109364. [PMID: 34214467 DOI: 10.1016/j.celrep.2021.109364] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
646 Gu SX, Tyagi T, Jain K, Gu VW, Lee SH, Hwa JM, Kwan JM, Krause DS, Lee AI, Halene S, Martin KA, Chun HJ, Hwa J. Thrombocytopathy and endotheliopathy: crucial contributors to COVID-19 thromboinflammation. Nat Rev Cardiol 2021;18:194-209. [PMID: 33214651 DOI: 10.1038/s41569-020-00469-1] [Cited by in Crossref: 49] [Cited by in F6Publishing: 51] [Article Influence: 24.5] [Reference Citation Analysis]
647 Vogel TP, Top KA, Karatzios C, Hilmers DC, Tapia LI, Moceri P, Giovannini-Chami L, Wood N, Chandler RE, Klein NP, Schlaudecker EP, Poli MC, Muscal E, Munoz FM. Multisystem inflammatory syndrome in children and adults (MIS-C/A): Case definition & guidelines for data collection, analysis, and presentation of immunization safety data. Vaccine. 2021;. [PMID: 33640145 DOI: 10.1016/j.vaccine.2021.01.054] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 16.0] [Reference Citation Analysis]
648 Salvio G, Gianfelice C, Firmani F, Lunetti S, Balercia G, Giacchetti G. Bone Metabolism in SARS-CoV-2 Disease: Possible Osteoimmunology and Gender Implications. Clin Rev Bone Miner Metab 2020;:1-7. [PMID: 32904892 DOI: 10.1007/s12018-020-09274-3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
649 Jia F, Wang G, Xu J, Long J, Deng F, Jiang W. Role of tumor necrosis factor-α in the mortality of hospitalized patients with severe and critical COVID-19 pneumonia. Aging (Albany NY) 2021;13:23895-912. [PMID: 34725309 DOI: 10.18632/aging.203663] [Reference Citation Analysis]
650 Negri EM, Piloto BM, Morinaga LK, Jardim CVP, Lamy SAE, Ferreira MA, D'Amico EA, Deheinzelin D. Heparin Therapy Improving Hypoxia in COVID-19 Patients - A Case Series. Front Physiol 2020;11:573044. [PMID: 33192569 DOI: 10.3389/fphys.2020.573044] [Cited by in Crossref: 7] [Cited by in F6Publishing: 12] [Article Influence: 3.5] [Reference Citation Analysis]
651 Deng H, Tang TX, Chen D, Tang LS, Yang XP, Tang ZH. Endothelial Dysfunction and SARS-CoV-2 Infection: Association and Therapeutic Strategies. Pathogens 2021;10:582. [PMID: 34064553 DOI: 10.3390/pathogens10050582] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
652 Angioni R, Sánchez-Rodríguez R, Munari F, Bertoldi N, Arcidiacono D, Cavinato S, Marturano D, Zaramella A, Realdon S, Cattelan A, Viola A, Molon B. Age-severity matched cytokine profiling reveals specific signatures in Covid-19 patients. Cell Death Dis 2020;11:957. [PMID: 33159040 DOI: 10.1038/s41419-020-03151-z] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 8.5] [Reference Citation Analysis]
653 Picchianti Diamanti A, Rosado MM, Nicastri E, Sesti G, Pioli C, Laganà B. Severe Acute Respiratory Syndrome Coronavirus-2 Infection and Autoimmunity 1 Year Later: The Era of Vaccines. Front Immunol 2021;12:708848. [PMID: 34659200 DOI: 10.3389/fimmu.2021.708848] [Reference Citation Analysis]
654 Anisenkova AY, Apalko SV, Asaulenko ZP, Bogdanov AN, Vologzhanin DA, Garbuzov EY, Glotov OS, Kamilova TA, Klitsenko OA, Minina EM, Mosenko SV, Khobotnikov DN, Sсherbak SG. Major predictive risk factors for а cytokine storm in COVID-19 patients (a retrospective clinical trials). Journal of Clinical Practice 2021;12:5-15. [DOI: 10.17816/clinpract63552] [Reference Citation Analysis]
655 Pedersen SF, Ho YC. SARS-CoV-2: a storm is raging. J Clin Invest 2020;130:2202-5. [PMID: 32217834 DOI: 10.1172/JCI137647] [Cited by in Crossref: 533] [Cited by in F6Publishing: 374] [Article Influence: 266.5] [Reference Citation Analysis]
656 Sorokin AV, Karathanasis SK, Yang ZH, Freeman L, Kotani K, Remaley AT. COVID-19-Associated dyslipidemia: Implications for mechanism of impaired resolution and novel therapeutic approaches. FASEB J 2020;34:9843-53. [PMID: 32588493 DOI: 10.1096/fj.202001451] [Cited by in Crossref: 45] [Cited by in F6Publishing: 43] [Article Influence: 22.5] [Reference Citation Analysis]
657 Marques da Silva B, Oliveira J, Pereira M, Lopes JA, Pinto Abreu C. Acute pericarditis after COVID 19 in a peritoneal dialysis patient. CEN Case Rep 2022. [PMID: 35507290 DOI: 10.1007/s13730-022-00705-2] [Reference Citation Analysis]
658 Napoli C, Tritto I, Benincasa G, Mansueto G, Ambrosio G. Cardiovascular involvement during COVID-19 and clinical implications in elderly patients. A review. Ann Med Surg (Lond) 2020;57:236-43. [PMID: 32802325 DOI: 10.1016/j.amsu.2020.07.054] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 8.5] [Reference Citation Analysis]
659 Kremer JM, Reed G, Pappas DA, Harold LR, Kane K, Greenberg J, Winthrop K. Hydroxychloroquine and the risk of respiratory infections among RA patients. RMD Open 2020;6:e001389. [PMID: 33161375 DOI: 10.1136/rmdopen-2020-001389] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
660 Schwab N, Nienhold R, Henkel M, Baschong A, Graber A, Frank A, Mensah N, Koike J, Hernach C, Sachs M, Daun T, Zsikla V, Willi N, Junt T, Mertz KD. COVID-19 Autopsies Reveal Underreporting of SARS-CoV-2 Infection and Scarcity of Co-infections. Front Med 2022;9:868954. [DOI: 10.3389/fmed.2022.868954] [Reference Citation Analysis]
661 Morrissey SM, Geller AE, Hu X, Tieri D, Ding C, Klaes CK, Cooke EA, Woeste MR, Martin ZC, Chen O, Bush SE, Zhang HG, Cavallazzi R, Clifford SP, Chen J, Ghare S, Barve SS, Cai L, Kong M, Rouchka EC, McLeish KR, Uriarte SM, Watson CT, Huang J, Yan J. A specific low-density neutrophil population correlates with hypercoagulation and disease severity in hospitalized COVID-19 patients. JCI Insight 2021;6:148435. [PMID: 33986193 DOI: 10.1172/jci.insight.148435] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
662 Sims JT, Poorbaugh J, Chang CY, Holzer TR, Zhang L, Engle SM, Beasley S, Doman TN, Naughton L, Higgs RE, Kallewaard N, Benschop RJ. Relationship between gene expression patterns from nasopharyngeal swabs and serum biomarkers in patients hospitalized with COVID-19, following treatment with the neutralizing monoclonal antibody bamlanivimab. J Transl Med 2022;20:134. [PMID: 35303909 DOI: 10.1186/s12967-022-03345-3] [Reference Citation Analysis]
663 Frigault MJ, Nikiforow S, Mansour MK, Hu ZH, Horowitz MM, Riches ML, Hematti P, Turtle CJ, Zhang MJ, Perales MA, Pasquini MC. Tocilizumab not associated with increased infection risk after CAR T-cell therapy: implications for COVID-19? Blood 2020;136:137-9. [PMID: 32457999 DOI: 10.1182/blood.2020006216] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 13.0] [Reference Citation Analysis]
664 [DOI: 10.1101/2021.01.13.21249725] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
665 Dorward DA, Russell CD, Um IH, Elshani M, Armstrong SD, Penrice-Randal R, Millar T, Lerpiniere CEB, Tagliavini G, Hartley CS, Randle NP, Gachanja NN, Potey PMD, Dong X, Anderson AM, Campbell VL, Duguid AJ, Al Qsous W, BouHaidar R, Baillie JK, Dhaliwal K, Wallace WA, Bellamy COC, Prost S, Smith C, Hiscox JA, Harrison DJ, Lucas CD. Tissue-Specific Immunopathology in Fatal COVID-19. Am J Respir Crit Care Med. 2021;203:192-201. [PMID: 33217246 DOI: 10.1164/rccm.202008-3265oc] [Cited by in Crossref: 53] [Cited by in F6Publishing: 39] [Article Influence: 53.0] [Reference Citation Analysis]
666 Abers MS, Delmonte OM, Ricotta EE, Fintzi J, Fink DL, de Jesus AAA, Zarember KA, Alehashemi S, Oikonomou V, Desai JV, Canna SW, Shakoory B, Dobbs K, Imberti L, Sottini A, Quiros-Roldan E, Castelli F, Rossi C, Brugnoni D, Biondi A, Bettini LR, D'Angio' M, Bonfanti P, Castagnoli R, Montagna D, Licari A, Marseglia GL, Gliniewicz EF, Shaw E, Kahle DE, Rastegar AT, Stack M, Myint-Hpu K, Levinson SL, DiNubile MJ, Chertow DW, Burbelo PD, Cohen JI, Calvo KR, Tsang JS, Su HC, Gallin JI, Kuhns DB, Goldbach-Mansky R, Lionakis MS, Notarangelo LD; NIAID COVID-19 Consortium. An immune-based biomarker signature is associated with mortality in COVID-19 patients. JCI Insight 2021;6:144455. [PMID: 33232303 DOI: 10.1172/jci.insight.144455] [Cited by in Crossref: 53] [Cited by in F6Publishing: 52] [Article Influence: 53.0] [Reference Citation Analysis]
667 Schönrich G, Raftery MJ, Samstag Y. Devilishly radical NETwork in COVID-19: Oxidative stress, neutrophil extracellular traps (NETs), and T cell suppression. Adv Biol Regul 2020;77:100741. [PMID: 32773102 DOI: 10.1016/j.jbior.2020.100741] [Cited by in Crossref: 63] [Cited by in F6Publishing: 62] [Article Influence: 31.5] [Reference Citation Analysis]
668 Chan AS, Rout A. Use of Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios in COVID-19. J Clin Med Res 2020;12:448-53. [PMID: 32655740 DOI: 10.14740/jocmr4240] [Cited by in Crossref: 42] [Cited by in F6Publishing: 38] [Article Influence: 21.0] [Reference Citation Analysis]
669 Zhu DD, Tan XM, Lu LQ, Yu SJ, Jian RL, Liang XF, Liao YX, Fan W, Barbier-Torres L, Yang A, Yang HP, Liu T. Interplay between nuclear factor erythroid 2-related factor 2 and inflammatory mediators in COVID-19-related liver injury. World J Gastroenterol 2021; 27(22): 2944-2962 [PMID: 34168400 DOI: 10.3748/wjg.v27.i22.2944] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
670 Wessels I, Rolles B, Rink L. The Potential Impact of Zinc Supplementation on COVID-19 Pathogenesis. Front Immunol 2020;11:1712. [PMID: 32754164 DOI: 10.3389/fimmu.2020.01712] [Cited by in Crossref: 68] [Cited by in F6Publishing: 62] [Article Influence: 34.0] [Reference Citation Analysis]
671 Wang H, Li X, Li T, Zhang S, Wang L, Wu X, Liu J. The genetic sequence, origin, and diagnosis of SARS-CoV-2. Eur J Clin Microbiol Infect Dis 2020;39:1629-35. [PMID: 32333222 DOI: 10.1007/s10096-020-03899-4] [Cited by in Crossref: 184] [Cited by in F6Publishing: 1] [Article Influence: 92.0] [Reference Citation Analysis]
672 Huang YK, Li YJ, Li B, Wang P, Wang QH. Dysregulated liver function in SARS-CoV-2 infection: Current understanding and perspectives. World J Gastroenterol 2021; 27(27): 4358-4370 [PMID: 34366609 DOI: 10.3748/wjg.v27.i27.4358] [Reference Citation Analysis]
673 Pizzol JLD, Hora VPD, Reis AJ, Vianna J, Ramis I, Groll AV, Silva PAD. Laboratory diagnosis for Covid-19: A mini-review. Rev Soc Bras Med Trop 2020;53:e20200451. [PMID: 32876316 DOI: 10.1590/0037-8682-0451-2020] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
674 Moreno-Fernandez J, Ochoa J, Ojeda ML, Nogales F, Carreras O, Díaz-Castro J. Inflammation and oxidative stress, the links between obesity and COVID-19: a narrative review. J Physiol Biochem 2022. [PMID: 35316507 DOI: 10.1007/s13105-022-00887-4] [Reference Citation Analysis]
675 Lebeau G, Vagner D, Frumence É, Ah-Pine F, Guillot X, Nobécourt E, Raffray L, Gasque P. Deciphering SARS-CoV-2 Virologic and Immunologic Features. Int J Mol Sci 2020;21:E5932. [PMID: 32824753 DOI: 10.3390/ijms21165932] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 4.5] [Reference Citation Analysis]
676 Liu F, Liu H, Yu WY, Liu Z, Zhang X, Wang Y, Miao LB, Li ZY, Huang JS, Bao JF. The Associations of Lymphocyte Ratio and Neutrophil Ratio on Liver Dysfunction in COVID-19 Patients. Front Immunol 2021;12:717461. [PMID: 34552588 DOI: 10.3389/fimmu.2021.717461] [Reference Citation Analysis]
677 Zheng M. The Gradient of Immune/Inflammatory Response and COVID-19 Prognosis with Therapeutic Implications. Front Immunol 2021;12:739482. [PMID: 34777350 DOI: 10.3389/fimmu.2021.739482] [Reference Citation Analysis]
678 Fu L, Fei J, Xu S, Xiang HX, Xiang Y, Hu B, Li MD, Liu FF, Li Y, Li XY, Zhao H, Xu DX. Liver Dysfunction and Its Association with the Risk of Death in COVID-19 Patients: A Prospective Cohort Study. J Clin Transl Hepatol. 2020;8:246-254. [PMID: 33083246 DOI: 10.14218/jcth.2020.00043] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
679 Mendoza R, Saha N, Momeni A, Gabutan E, Alawad M, Dehghani A, Diks J, Lin B, Wang D, Alshal M, Fyke W, Wang B, Himanen JP, Premsrirut P, Nikolov DB. Ephrin-A1 and the sheddase ADAM12 are upregulated in COVID-19. Heliyon 2021;7:e07200. [PMID: 34095559 DOI: 10.1016/j.heliyon.2021.e07200] [Reference Citation Analysis]
680 Das AK, Nanda PK, Chowdhury NR, Dandapat P, Gagaoua M, Chauhan P, Pateiro M, Lorenzo JM. Application of Pomegranate by-Products in Muscle Foods: Oxidative Indices, Colour Stability, Shelf Life and Health Benefits. Molecules 2021;26:467. [PMID: 33477314 DOI: 10.3390/molecules26020467] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
681 Hammad R, Elshafei A, Khidr EG, El-Husseiny AA, Gomaa MH, Kotb HG, Eltrawy HH, Farhoud H. Copeptin: a neuroendocrine biomarker of COVID-19 severity. Biomark Med 2022. [PMID: 35350852 DOI: 10.2217/bmm-2021-1100] [Reference Citation Analysis]
682 Kotsev SV, Miteva D, Krayselska S, Shopova M, Pishmisheva-Peleva M, Stanilova SA, Velikova T. Hypotheses and facts for genetic factors related to severe COVID-19. World J Virol 2021; 10(4): 137-155 [PMID: 34367930 DOI: 10.5501/wjv.v10.i4.137] [Reference Citation Analysis]
683 Lotfi R, Kalmarzi RN, Roghani SA. A review on the immune responses against novel emerging coronavirus (SARS-CoV-2). Immunol Res 2021;69:213-24. [PMID: 33928531 DOI: 10.1007/s12026-021-09198-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
684 Dai Y, Zhao Z, Zhou H, Huang D, Luo J, Zhang C, Chen Q, Chen X, Yao Y, Jiang X, Cheng J. Traditional Chinese Medicine Enema Therapy in a Patient With a Confirmed Negative SARS-CoV-2 Test in the Respiratory Tract but Positive in the Intestinal Tract: A Case Report. Front Public Health 2021;9:687283. [PMID: 34307281 DOI: 10.3389/fpubh.2021.687283] [Reference Citation Analysis]
685 Battina HL, Alentado VJ, Srour EF, Moliterno AR, Kacena MA. Interaction of the inflammatory response and megakaryocytes in COVID-19 infection. Exp Hematol 2021:S0301-472X(21)00328-3. [PMID: 34563606 DOI: 10.1016/j.exphem.2021.09.005] [Reference Citation Analysis]
686 Taefehshokr N, Taefehshokr S, Heit B. Mechanisms of Dysregulated Humoral and Cellular Immunity by SARS-CoV-2. Pathogens 2020;9:E1027. [PMID: 33302366 DOI: 10.3390/pathogens9121027] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
687 Yates AG, Weglinski CM, Ying Y, Dunstan IK, Strekalova T, Anthony DC. Nafamostat reduces systemic inflammation in TLR7-mediated virus-like illness. J Neuroinflammation 2022;19:8. [PMID: 34991643 DOI: 10.1186/s12974-021-02357-y] [Reference Citation Analysis]
688 Córdova-Martínez A, Caballero-García A, Roche E, Noriega DC. β-Glucans Could Be Adjuvants for SARS-CoV-2 Virus Vaccines (COVID-19). Int J Environ Res Public Health 2021;18:12636. [PMID: 34886361 DOI: 10.3390/ijerph182312636] [Reference Citation Analysis]
689 Fadl N, Ali E, Salem TZ. COVID-19: Risk Factors Associated with Infectivity and Severity. Scand J Immunol 2021;93:e13039. [PMID: 33710663 DOI: 10.1111/sji.13039] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
690 Akbari H, Tabrizi R, Lankarani KB, Aria H, Vakili S, Asadian F, Noroozi S, Keshavarz P, Faramarz S. The role of cytokine profile and lymphocyte subsets in the severity of coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis. Life Sci 2020;258:118167. [PMID: 32735885 DOI: 10.1016/j.lfs.2020.118167] [Cited by in Crossref: 48] [Cited by in F6Publishing: 49] [Article Influence: 24.0] [Reference Citation Analysis]
691 Ahmed S, Ansar Ahmed Z, Siddiqui I, Haroon Rashid N, Mansoor M, Jafri L. Evaluation of serum ferritin for prediction of severity and mortality in COVID-19- A cross sectional study. Ann Med Surg (Lond) 2021;63:102163. [PMID: 33614024 DOI: 10.1016/j.amsu.2021.02.009] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
692 Liu Z, Li J, Chen D, Gao R, Zeng W, Chen S, Huang Y, Huang J, Long W, Li M, Guo L, Wang X, Wu X. Dynamic Interleukin-6 Level Changes as a Prognostic Indicator in Patients With COVID-19. Front Pharmacol 2020;11:1093. [PMID: 32765283 DOI: 10.3389/fphar.2020.01093] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 9.5] [Reference Citation Analysis]
693 Bhattacharjee S, Banerjee M, Pal R. COVID-19 Associated Hemophagocytic Lymphohistiocytosis and Coagulopathy: Targeting the Duumvirate. Indian Pediatr 2020;57:827-33. [DOI: 10.1007/s13312-020-1962-z] [Cited by in Crossref: 9] [Article Influence: 4.5] [Reference Citation Analysis]
694 Chen Z, John Wherry E. T cell responses in patients with COVID-19. Nat Rev Immunol. 2020;20:529-536. [PMID: 32728222 DOI: 10.1038/s41577-020-0402-6] [Cited by in Crossref: 282] [Cited by in F6Publishing: 243] [Article Influence: 141.0] [Reference Citation Analysis]
695 Birati EY, Najjar SS, Tedford RJ, Houston BA, Shore S, Vorovich E, Atluri P, Urgo K, Molina M, Chambers S, Escobar N, Hsich E, Estep JD, Alexander KM, Teuteberg JJ, Chaudhry SP, Ravichandran A, DeVore AD, Margulies KB, Hanff TC, Zimmer R, Kilic A, Wald JW, Vidula H, Martens J, Blumberg EA, Mazurek JA, Owens AT, Goldberg LR, Alvarez-Garcia J, Mancini DM, Moss N, Genuardi MV. Characteristics and Outcomes of COVID-19 in Patients on Left Ventricular Assist Device Support. Circ Heart Fail 2021;14:e007957. [PMID: 33813838 DOI: 10.1161/CIRCHEARTFAILURE.120.007957] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
696 Mutiawati E, Syahrul S, Fahriani M, Fajar JK, Mamada SS, Maliga HA, Samsu N, Ilmawan M, Purnamasari Y, Asmiragani AA, Ichsan I, Emran TB, Rabaan AA, Masyeni S, Nainu F, Harapan H. Global prevalence and pathogenesis of headache in COVID-19: A systematic review and meta-analysis. F1000Res 2020;9:1316. [PMID: 33953911 DOI: 10.12688/f1000research.27334.2] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
697 Silverio A, Di Maio M, Citro R, Esposito L, Iuliano G, Bellino M, Baldi C, De Luca G, Ciccarelli M, Vecchione C, Galasso G. Cardiovascular risk factors and mortality in hospitalized patients with COVID-19: systematic review and meta-analysis of 45 studies and 18,300 patients.BMC Cardiovasc Disord. 2021;21:23. [PMID: 33413093 DOI: 10.1186/s12872-020-01816-3] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 13.0] [Reference Citation Analysis]
698 Lira FS, Pereira T, Guerra Minuzzi L, Figueiredo C, Olean-Oliveira T, Figueira Freire APC, Coelho-E-Silva MJ, Caseiro A, Thomatieli-Santos RV, Dos Santos VR, Gobbo LA, Seelaender M, Krüger K, Pinho RA, Rosa-Neto JC, de Alencar Silva BS. Modulatory Effects of Physical Activity Levels on Immune Responses and General Clinical Functions in Adult Patients with Mild to Moderate SARS-CoV-2 Infections-A Protocol for an Observational Prospective Follow-Up Investigation: Fit-COVID-19 Study. Int J Environ Res Public Health 2021;18:13249. [PMID: 34948858 DOI: 10.3390/ijerph182413249] [Reference Citation Analysis]
699 Pouladzadeh M, Safdarian M, Eshghi P, Abolghasemi H, Bavani AG, Sheibani B, Moradi Choghakabodi P, Feghhi A, Ghafourian Boroujerdnia M, Forouzan A, Jalali Far MA, Kaydani GA, Rajaei E, Amin M, Torabizadeh M, Yousefi F, Hadaddezfuli R. A randomized clinical trial evaluating the immunomodulatory effect of convalescent plasma on COVID-19-related cytokine storm. Intern Emerg Med 2021. [PMID: 33837906 DOI: 10.1007/s11739-021-02734-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
700 Wang J, Yang X, Li Y, Huang JA, Jiang J, Su N. Specific cytokines in the inflammatory cytokine storm of patients with COVID-19-associated acute respiratory distress syndrome and extrapulmonary multiple-organ dysfunction. Virol J 2021;18:117. [PMID: 34088317 DOI: 10.1186/s12985-021-01588-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
701 Latif F, Bint Abdul Jabbar H, Malik H, Sadaf H, Sarfraz A, Sarfraz Z, Cherrez-Ojeda I. Atezolizumab and pembrolizumab in triple-negative breast cancer: a meta-analysis. Expert Rev Anticancer Ther 2021. [PMID: 34949142 DOI: 10.1080/14737140.2022.2023011] [Reference Citation Analysis]
702 Wang Z, Yang X, Mei X, Zhou Y, Tang Z, Li G, Zhong J, Yu M, Huang M, Su X, Lin B, Cao P, Yang J, Ran P. SARS-CoV-2-specific CD4+ T cells are associated with long-term persistence of neutralizing antibodies. Signal Transduct Target Ther 2022;7:132. [PMID: 35461307 DOI: 10.1038/s41392-022-00978-0] [Reference Citation Analysis]
703 Wurzel D, Neeland MR, Anderson J, Abo Y, Do LAH, Donato CM, Bines JE, Toh ZQ, Higgins RA, Jalali S, Cole T, Subbarao K, Mcminn A, Dohle K, Haeusler GM, Mcnab S, Alafaci A, Overmars I, Clifford V, Lee L, Daley AJ, Buttery J, Bryant PA, Burgner D, Steer A, Tosif S, Konstantinov IE, Duke T, Licciardi PV, Pellicci DG, Crawford NW. A case report describing the immune response of an infant with congenital heart disease and severe COVID-19. Commun Med 2021;1. [DOI: 10.1038/s43856-021-00047-7] [Reference Citation Analysis]
704 Neevel AJ, Smith JD, Morrison RJ, Hogikyan ND, Kupfer RA, Stein AP. Postacute COVID-19 Laryngeal Injury and Dysfunction. OTO Open 2021;5:2473974X211041040. [PMID: 34458661 DOI: 10.1177/2473974X211041040] [Reference Citation Analysis]
705 Smith JC, Sausville EL, Girish V, Yuan ML, Vasudevan A, John KM, Sheltzer JM. Cigarette Smoke Exposure and Inflammatory Signaling Increase the Expression of the SARS-CoV-2 Receptor ACE2 in the Respiratory Tract. Dev Cell 2020;53:514-529.e3. [PMID: 32425701 DOI: 10.1016/j.devcel.2020.05.012] [Cited by in Crossref: 173] [Cited by in F6Publishing: 168] [Article Influence: 86.5] [Reference Citation Analysis]
706 So A, Yang Z, Li L, Li W, Pan C, Vivekanantha P, Yun HW, Xie XY, Yun CH, Huang WM, Hung CL, Gao M, Zhang X, Zha Y, Shen J. Relationship between lung injury extent and phenotype manifested in non-contrast CT and cardiac injury during acute stage of COVID-19. Int J Cardiol Heart Vasc 2022;38:100938. [PMID: 34977329 DOI: 10.1016/j.ijcha.2021.100938] [Reference Citation Analysis]
707 Fu YQ, Sun YL, Lu SW, Yang Y, Wang Y, Xu F. Effect of blood analysis and immune function on the prognosis of patients with COVID-19. PLoS One 2020;15:e0240751. [PMID: 33125396 DOI: 10.1371/journal.pone.0240751] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
708 Baumer Y, Farmer N, Premeaux TA, Wallen GR, Powell-Wiley TM. Health Disparities in COVID-19: Addressing the Role of Social Determinants of Health in Immune System Dysfunction to Turn the Tide. Front Public Health 2020;8:559312. [PMID: 33134238 DOI: 10.3389/fpubh.2020.559312] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
709 Yang Q, Yang X. Incidence and risk factors of kidney impairment on patients with COVID-19: A meta-analysis of 10180 patients. PLoS One 2020;15:e0241953. [PMID: 33196669 DOI: 10.1371/journal.pone.0241953] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
710 Tincati C, Cannizzo ES, Giacomelli M, Badolato R, d'Arminio Monforte A, Marchetti G. Heightened Circulating Interferon-Inducible Chemokines, and Activated Pro-Cytolytic Th1-Cell Phenotype Features Covid-19 Aggravation in the Second Week of Illness. Front Immunol 2020;11:580987. [PMID: 33193384 DOI: 10.3389/fimmu.2020.580987] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 6.0] [Reference Citation Analysis]
711 Fabião J, Sassi B, Pedrollo E, Gerchman F, Kramer C, Leitão C, Pinto L. Why do men have worse COVID-19-related outcomes? A systematic review and meta-analysis with sex adjusted for age. Braz J Med Biol Res 2022;55:e11711. [DOI: 10.1590/1414-431x2021e11711] [Reference Citation Analysis]
712 Shi S, Nie B, Chen X, Cai Q, Lin C, Zhao G, Zhang X. Clinical and laboratory characteristics of severe and non-severe patients with COVID-19: A retrospective cohort study in China. J Clin Lab Anal 2021;35:e23692. [PMID: 33389777 DOI: 10.1002/jcla.23692] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
713 Bodei L, Bergsland E, de Herder WW, Ferone D, Hicks RJ, Hope TA, Kunikowska J, Pavel M, Reidy-Lagunes D, Siveke J, Strosberg J, Dittmer U, Herrmann K. Peptide Receptor Radionuclide Therapy During the COVID-19 Pandemic: Are There Any Concerns? J Nucl Med 2020;61:1094-5. [PMID: 32576637 DOI: 10.2967/jnumed.120.249136] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
714 Langford BJ, So M, Raybardhan S, Leung V, Soucy JR, Westwood D, Daneman N, MacFadden DR. Antibiotic prescribing in patients with COVID-19: rapid review and meta-analysis. Clin Microbiol Infect 2021;27:520-31. [PMID: 33418017 DOI: 10.1016/j.cmi.2020.12.018] [Cited by in Crossref: 42] [Cited by in F6Publishing: 40] [Article Influence: 42.0] [Reference Citation Analysis]
715 Bernardes JP, Mishra N, Tran F, Bahmer T, Best L, Blase JI, Bordoni D, Franzenburg J, Geisen U, Josephs-Spaulding J, Köhler P, Künstner A, Rosati E, Aschenbrenner AC, Bacher P, Baran N, Boysen T, Brandt B, Bruse N, Dörr J, Dräger A, Elke G, Ellinghaus D, Fischer J, Forster M, Franke A, Franzenburg S, Frey N, Friedrichs A, Fuß J, Glück A, Hamm J, Hinrichsen F, Hoeppner MP, Imm S, Junker R, Kaiser S, Kan YH, Knoll R, Lange C, Laue G, Lier C, Lindner M, Marinos G, Markewitz R, Nattermann J, Noth R, Pickkers P, Rabe KF, Renz A, Röcken C, Rupp J, Schaffarzyk A, Scheffold A, Schulte-Schrepping J, Schunk D, Skowasch D, Ulas T, Wandinger KP, Wittig M, Zimmermann J, Busch H, Hoyer BF, Kaleta C, Heyckendorf J, Kox M, Rybniker J, Schreiber S, Schultze JL, Rosenstiel P; HCA Lung Biological Network., Deutsche COVID-19 Omics Initiative (DeCOI). Longitudinal Multi-omics Analyses Identify Responses of Megakaryocytes, Erythroid Cells, and Plasmablasts as Hallmarks of Severe COVID-19. Immunity 2020;53:1296-1314.e9. [PMID: 33296687 DOI: 10.1016/j.immuni.2020.11.017] [Cited by in Crossref: 50] [Cited by in F6Publishing: 57] [Article Influence: 25.0] [Reference Citation Analysis]
716 Elshereye A, Erdinc B. Multiple Lacunar Cerebral Infarcts as the Initial Presentation of COVID-19. Cureus 2020;12:e9638. [PMID: 32789103 DOI: 10.7759/cureus.9638] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
717 Deng F, Zhang L, Lyu L, Lu Z, Gao D, Ma X, Guo Y, Wang R, Gong S, Jiang W. Increased levels of ferritin on admission predicts intensive care unit mortality in patients with COVID-19. Med Clin (Engl Ed) 2021;156:324-31. [PMID: 33824908 DOI: 10.1016/j.medcle.2020.11.015] [Reference Citation Analysis]
718 Ye C, Zhong J, Cai S, Dong L, Li C, Hou X, Chen X, Zhang A, Chen W, He D, Zhou T, Shang G, Chu A, Li H, Liu Q, Wu B, Yu X, Peng T, Wen C, Huang GH, Huang H, Huang Q, Su L, Chen W, Yang H, Dong L. COVID-19 infection in patients with connective tissue disease: A multicity study in Hubei province, China. MedComm (Beijing) 2021;2:82-90. [PMID: 33821253 DOI: 10.1002/mco2.56] [Reference Citation Analysis]
719 Buzhdygan TP, DeOre BJ, Baldwin-Leclair A, Bullock TA, McGary HM, Khan JA, Razmpour R, Hale JF, Galie PA, Potula R, Andrews AM, Ramirez SH. The SARS-CoV-2 spike protein alters barrier function in 2D static and 3D microfluidic in-vitro models of the human blood-brain barrier. Neurobiol Dis 2020;146:105131. [PMID: 33053430 DOI: 10.1016/j.nbd.2020.105131] [Cited by in Crossref: 57] [Cited by in F6Publishing: 75] [Article Influence: 28.5] [Reference Citation Analysis]
720 Paolucci S, Cassaniti I, Novazzi F, Fiorina L, Piralla A, Comolli G, Bruno R, Maserati R, Gulminetti R, Novati S, Mojoli F, Baldanti F; San Matteo Pavia COVID-19 Task Force. EBV DNA increase in COVID-19 patients with impaired lymphocyte subpopulation count. Int J Infect Dis 2021;104:315-9. [PMID: 33359064 DOI: 10.1016/j.ijid.2020.12.051] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
721 Burbelo PD, Riedo FX, Morishima C, Rawlings S, Smith D, Das S, Strich JR, Chertow DS, Davey RT Jr, Cohen JI. Detection of Nucleocapsid Antibody to SARS-CoV-2 is More Sensitive than Antibody to Spike Protein in COVID-19 Patients. medRxiv 2020:2020. [PMID: 32511445 DOI: 10.1101/2020.04.20.20071423] [Cited by in Crossref: 48] [Cited by in F6Publishing: 11] [Article Influence: 24.0] [Reference Citation Analysis]
722 Tscherne A, Schwarz JH, Rohde C, Kupke A, Kalodimou G, Limpinsel L, Okba NMA, Bošnjak B, Sandrock I, Odak I, Halwe S, Sauerhering L, Brosinski K, Liangliang N, Duell E, Jany S, Freudenstein A, Schmidt J, Werner A, Gellhorn Serra M, Klüver M, Guggemos W, Seilmaier M, Wendtner CM, Förster R, Haagmans BL, Becker S, Sutter G, Volz A. Immunogenicity and efficacy of the COVID-19 candidate vector vaccine MVA-SARS-2-S in preclinical vaccination. Proc Natl Acad Sci U S A 2021;118:e2026207118. [PMID: 34162739 DOI: 10.1073/pnas.2026207118] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
723 Singh K, Chen YC, Hassanzadeh S, Han K, Judy JT, Seifuddin F, Tunc I, Sack MN, Pirooznia M. Network Analysis and Transcriptome Profiling Identify Autophagic and Mitochondrial Dysfunctions in SARS-CoV-2 Infection. Front Genet 2021;12:599261. [PMID: 33796130 DOI: 10.3389/fgene.2021.599261] [Cited by in Crossref: 4] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
724 Simões JLB, de Araújo JB, Bagatini MD. Anti-inflammatory Therapy by Cholinergic and Purinergic Modulation in Multiple Sclerosis Associated with SARS-CoV-2 Infection. Mol Neurobiol 2021. [PMID: 34247339 DOI: 10.1007/s12035-021-02464-0] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
725 Ahmad T, Chaudhuri R, Joshi MC, Almatroudi A, Rahmani AH, Ali SM. COVID-19: The Emerging Immunopathological Determinants for Recovery or Death. Front Microbiol 2020;11:588409. [PMID: 33335518 DOI: 10.3389/fmicb.2020.588409] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
726 Barbosa JR, de Carvalho Junior RN. Polysaccharides obtained from natural edible sources and their role in modulating the immune system: Biologically active potential that can be exploited against COVID-19. Trends Food Sci Technol 2021;108:223-35. [PMID: 33424125 DOI: 10.1016/j.tifs.2020.12.026] [Cited by in Crossref: 14] [Cited by in F6Publishing: 1] [Article Influence: 14.0] [Reference Citation Analysis]
727 Sinaci S, Ocal DF, Ozden Tokalioglu E, Halici Ozturk F, Aydin Senel S, Keskin LH, Moraloglu Tekin O, Sahin D. Cardiotocographic features in COVID-19 infected pregnant women. J Perinat Med 2021. [PMID: 34411469 DOI: 10.1515/jpm-2021-0132] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
728 Battaglia R, Alonzo R, Pennisi C, Caponnetto A, Ferrara C, Stella M, Barbagallo C, Barbagallo D, Ragusa M, Purrello M, Di Pietro C. MicroRNA-Mediated Regulation of the Virus Cycle and Pathogenesis in the SARS-CoV-2 Disease. Int J Mol Sci 2021;22:13192. [PMID: 34947989 DOI: 10.3390/ijms222413192] [Reference Citation Analysis]
729 Mottola FF, Verde N, Ricciolino R, Di Mauro MD, Migliaccio MG, Carfora V, Spiniello G, Coppola N, Vanvitelli Covid-Group. Cardiovascular System in COVID-19: Simply a Viewer or a Leading Actor? Life (Basel) 2020;10:E165. [PMID: 32867137 DOI: 10.3390/life10090165] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
730 Cauchois R, Koubi M, Delarbre D, Manet C, Carvelli J, Blasco VB, Jean R, Fouche L, Bornet C, Pauly V, Mazodier K, Pestre V, Jarrot PA, Dinarello CA, Kaplanski G. Early IL-1 receptor blockade in severe inflammatory respiratory failure complicating COVID-19. Proc Natl Acad Sci U S A 2020;117:18951-3. [PMID: 32699149 DOI: 10.1073/pnas.2009017117] [Cited by in Crossref: 73] [Cited by in F6Publishing: 65] [Article Influence: 36.5] [Reference Citation Analysis]
731 Kim MH, Salloum S, Wang JY, Wong LP, Regan J, Lefteri K, Manickas-Hill Z, Li JZ, Sadreyev RI, Yu XG, Chung RT; MGH COVID-19 Collection & Processing Team. Type I, II, and III interferon signatures correspond to COVID-19 disease severity. medRxiv 2021:2021. [PMID: 33758894 DOI: 10.1101/2021.03.10.21253317] [Reference Citation Analysis]
732 Ngamprasertchai T, Kajeekul R, Sivakorn C, Ruenroegnboon N, Luvira V, Siripoon T, Luangasanatip N. Efficacy and Safety of Immunomodulators in Patients with COVID-19: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials. Infect Dis Ther 2021. [PMID: 34757578 DOI: 10.1007/s40121-021-00545-0] [Reference Citation Analysis]
733 Halim C, Mirza AF, Sari MI. The Association between TNF-α, IL-6, and Vitamin D Levels and COVID-19 Severity and Mortality: A Systematic Review and Meta-Analysis. Pathogens 2022;11:195. [DOI: 10.3390/pathogens11020195] [Reference Citation Analysis]
734 Ljungman P, de la Camara R, Mikulska M, Tridello G, Aguado B, Zahrani MA, Apperley J, Berceanu A, Bofarull RM, Calbacho M, Ciceri F, Lopez-Corral L, Crippa C, Fox ML, Grassi A, Jimenez MJ, Demir SK, Kwon M, Llamas CV, Lorenzo JLL, Mielke S, Orchard K, Porras RP, Vallisa D, Xhaard A, Knelange NS, Cedillo A, Kröger N, Piñana JL, Styczynski J. COVID-19 and stem cell transplantation; results from an EBMT and GETH multicenter prospective survey. Leukemia 2021. [PMID: 34079042 DOI: 10.1038/s41375-021-01302-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
735 Yaghi S, Ishida K, Torres J, Mac Grory B, Raz E, Humbert K, Henninger N, Trivedi T, Lillemoe K, Alam S, Sanger M, Kim S, Scher E, Dehkharghani S, Wachs M, Tanweer O, Volpicelli F, Bosworth B, Lord A, Frontera J. SARS-CoV-2 and Stroke in a New York Healthcare System. Stroke 2020;51:2002-11. [PMID: 32432996 DOI: 10.1161/STROKEAHA.120.030335] [Cited by in Crossref: 270] [Cited by in F6Publishing: 175] [Article Influence: 135.0] [Reference Citation Analysis]
736 Okwor CJ, Meka IA, Akinwande KS, Edem VF, Okwor VC. Assessment of thyroid function of newly diagnosed SARS-CoV-2 infected patients in Nigeria. Pan Afr Med J 2021;40:9. [PMID: 34650659 DOI: 10.11604/pamj.2021.40.9.26358] [Reference Citation Analysis]
737 Hessami A, Shamshirian A, Heydari K, Pourali F, Alizadeh-Navaei R, Moosazadeh M, Abrotan S, Shojaie L, Sedighi S, Shamshirian D, Rezaei N. Cardiovascular diseases burden in COVID-19: Systematic review and meta-analysis. Am J Emerg Med 2021;46:382-91. [PMID: 33268238 DOI: 10.1016/j.ajem.2020.10.022] [Cited by in Crossref: 27] [Cited by in F6Publishing: 17] [Article Influence: 13.5] [Reference Citation Analysis]
738 Zhang Y, Chen Y, Meng Z. Immunomodulation for Severe COVID-19 Pneumonia: The State of the Art.Front Immunol. 2020;11:577442. [PMID: 33240265 DOI: 10.3389/fimmu.2020.577442] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [